GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,GO:0003845,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HSD11B2
14-3-3 protein binding,GO:0071889,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,IRS2|PRKCE|TP53|TRP53
14-3-3 protein binding,GO:0071889,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,AKT1|IRS2|NFATC2
16-hydroxypalmitate dehydrogenase activity,GO:0103002,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP4A14
17-beta-hydroxysteroid dehydrogenase (NADP+) activity,GO:0072582,Diabetes Mellitus,MESH:D003920,3,Docosahexaenoic Acids|docosapentaenoic acid|Tetrachlorodibenzodioxin,0,
17-beta-hydroxysteroid dehydrogenase (NADP+) activity,GO:0072582,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity",GO:0062181,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
1-phosphatidylinositol-3-kinase activity,GO:0016303,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
1-phosphatidylinositol-3-kinase activity,GO:0016303,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
1-phosphatidylinositol-3-kinase activity,GO:0016303,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PIK3CG
1-phosphatidylinositol 4-kinase activity,GO:0004430,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0035005,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PIK3CG
"2,4-dienoyl-CoA reductase (NADPH) activity",GO:0008670,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,USP48
"2 iron, 2 sulfur cluster binding",GO:0051537,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AIFM1
"2 iron, 2 sulfur cluster binding",GO:0051537,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
"2 iron, 2 sulfur cluster binding",GO:0051537,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CISD2
2-oxoglutarate-dependent dioxygenase activity,GO:0016706,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,FTO|KCNU1|TNFRSF1B
"3',5'-cyclic-AMP phosphodiesterase activity",GO:0004115,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
"3',5'-cyclic-AMP phosphodiesterase activity",GO:0004115,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|Curcumin,1,ENPP1
3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0003854,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0003854,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0003854,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
3beta-hydroxysteroid dehydrogenase activity,GO:0102727,Diabetes Mellitus,MESH:D003920,2,Chlorpromazine|Tetrachlorodibenzodioxin,0,
3beta-hydroxysteroid dehydrogenase activity,GO:0102727,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|Taurine,0,
3beta-hydroxysteroid dehydrogenase activity,GO:0102727,"Diabetes Mellitus, Type 1",MESH:D003922,4,decabromobiphenyl ether|sodium arsenite|Taurine|Tetrachlorodibenzodioxin,0,
3'-phosphoadenosine 5'-phosphosulfate binding,GO:0050656,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
3-phosphoinositide-dependent protein kinase activity,GO:0004676,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
3-phosphoinositide-dependent protein kinase activity,GO:0004676,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
3-phosphoinositide-dependent protein kinase binding,GO:0043423,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
3-phosphoinositide-dependent protein kinase binding,GO:0043423,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
"4 iron, 4 sulfur cluster binding",GO:0051539,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDKAL1
5'-deoxyribose-5-phosphate lyase activity,GO:0051575,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMGA1
5'-nucleotidase activity,GO:0008253,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Metformin|Streptozocin,0,
5'-nucleotidase activity,GO:0008253,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Fructose|Metformin|sodium arsenite|Streptozocin|thymoquinone,0,
5'-nucleotidase activity,GO:0008253,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Streptozocin,0,
5'-nucleotidase activity,GO:0008253,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Fructose|Metformin|Streptozocin,0,
6-phosphofructokinase activity,GO:0003872,Diabetes Mellitus,MESH:D003920,1,Lead,0,
6-phosphofructokinase activity,GO:0003872,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
6-phosphofructokinase activity,GO:0003872,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
7-beta-hydroxysteroid dehydrogenase (NADP+) activity,GO:0047022,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HSD11B1
"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity",GO:0034039,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
8-oxo-(d)RTP hydrolase activity,GO:0106379,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
ABC-type transporter activity,GO:0140359,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
ABC-type transporter activity,GO:0140359,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
ABC-type transporter activity,GO:0140359,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
ABC-type transporter activity,GO:0140359,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,1,ABCC8
ABC-type xenobiotic transporter activity,GO:0008559,Diabetes Mellitus,MESH:D003920,2,alachlor|Chlorpyrifos,0,
ABC-type xenobiotic transporter activity,GO:0008559,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
acetate-CoA ligase activity,GO:0003987,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
acetylation-dependent protein binding,GO:0140033,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
acetylcholine-gated monoatomic cation-selective channel activity,GO:0022848,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|Nicotine,0,
acetylcholine-gated monoatomic cation-selective channel activity,GO:0022848,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
acetylcholine receptor regulator activity,GO:0030548,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EPC2
acetylcholinesterase activity,GO:0003990,Diabetes Mellitus,MESH:D003920,10,"bisphenol A|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Flavonoids|Metals, Heavy|Particulate Matter|Pesticides|Plant Extracts|Selenium|Sodium Selenite",0,
acetylcholinesterase activity,GO:0003990,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Coconut Oil|Diethylhexyl Phthalate|Dronabinol|Plant Extracts|Quercetin|Sodium Selenite,1,ACE
acetylcholinesterase activity,GO:0003990,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
acetylcholinesterase activity,GO:0003990,"Diabetes Mellitus, Type 2",MESH:D003924,8,Ascorbic Acid|bisphenol A|Diethylhexyl Phthalate|epigallocatechin gallate|Particulate Matter|Pesticides|Plant Extracts|Vehicle Emissions,0,
acetyl-CoA carboxylase activity,GO:0003989,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
acetyl-CoA carboxylase activity,GO:0003989,"Diabetes Mellitus, Experimental",MESH:D003921,8,Bile Acids and Salts|bisphenol A|Dietary Fats|Glucose|Inositol|Lithocholic Acid|Niacinamide|Resveratrol,0,
acetyl-CoA carboxylase activity,GO:0003989,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Niacinamide|Resveratrol,0,
acetyl-CoA carboxylase activity,GO:0003989,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Dietary Fats|Glucose|Lithocholic Acid|Niacinamide|Resveratrol,0,
[acetyl-CoA carboxylase] kinase activity,GO:0050405,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
[acetyl-CoA carboxylase] kinase activity,GO:0050405,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
acetylesterase activity,GO:0008126,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
acidic amino acid transmembrane transporter activity,GO:0015172,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
acid phosphatase activity,GO:0003993,Diabetes Mellitus,MESH:D003920,13,Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Cyclosporine|Flavonoids|Gallic Acid|Iron|Lead|Plant Extracts|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin,0,
acid phosphatase activity,GO:0003993,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Diethylhexyl Phthalate|Gallic Acid|Plant Extracts|Quercetin|Resveratrol|S-allylcysteine|sodium arsenite|Streptozocin|thymoquinone,0,
acid phosphatase activity,GO:0003993,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Iron|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
acid phosphatase activity,GO:0003993,"Diabetes Mellitus, Type 2",MESH:D003924,14,alpha-Tocopherol|Arsenic|Ascorbic Acid|bisphenol A|Cadmium|Curcumin|Diethylhexyl Phthalate|Folic Acid|Iron|Lead|Plant Extracts|Resveratrol|Silver|Streptozocin,0,
aconitate hydratase activity,GO:0003994,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Pyruvaldehyde|Streptozocin|Zinc,0,
aconitate hydratase activity,GO:0003994,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dietary Fats|Hydrogen Peroxide|Streptozocin,0,
aconitate hydratase activity,GO:0003994,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
aconitate hydratase activity,GO:0003994,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dietary Fats|Streptozocin|Zinc,0,
actin binding,GO:0003779,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ACE|NOS2|NOS3|YWHAH
actin binding,GO:0003779,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
actin binding,GO:0003779,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
actin binding,GO:0003779,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,INPPL1|MAEA|NOS2|NOS3|PTPN1
actin filament binding,GO:0051015,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
actinin binding,GO:0042805,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
actinin binding,GO:0042805,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
actinin binding,GO:0042805,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
actin monomer binding,GO:0003785,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS3|PRKCE
actin monomer binding,GO:0003785,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
actin monomer binding,GO:0003785,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS3
active monoatomic ion transmembrane transporter activity,GO:0022853,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
active monoatomic ion transmembrane transporter activity,GO:0022853,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
acyl-CoA hydrolase activity,GO:0047617,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACOT1
acyl-CoA oxidase activity,GO:0003997,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACOX1
acyl-CoA oxidase activity,GO:0003997,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluoroundecanoic acid,0,
acylglycerol lipase activity,GO:0047372,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
acyl-L-homoserine-lactone lactonohydrolase activity,GO:0102007,Diabetes Mellitus,MESH:D003920,0,,1,PON1
acylphosphatase activity,GO:0003998,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
acylphosphatase activity,GO:0003998,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glutathione,0,
acyltransferase activity,GO:0016746,Diabetes Mellitus,MESH:D003920,0,,1,CPT1A
acyltransferase activity,GO:0016746,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CPT1A|CPT1B|GPAM
acyltransferase activity,GO:0016746,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CPT1A|LIPC
adenosine deaminase activity,GO:0004000,Diabetes Mellitus,MESH:D003920,1,Zinc,0,
adenosine deaminase activity,GO:0004000,"Diabetes Mellitus, Type 2",MESH:D003924,2,efavirenz|Zinc,0,
adenylate cyclase activity,GO:0004016,Diabetes Mellitus,MESH:D003920,1,triphenyltin,0,
adenylate cyclase activity,GO:0004016,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dronabinol|sodium arsenite|tributyltin,0,
adenylate cyclase activity,GO:0004016,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
adenylate cyclase activity,GO:0004016,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
adenylate cyclase binding,GO:0008179,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
adenylate kinase activity,GO:0004017,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
adenylate kinase activity,GO:0004017,"Diabetes Mellitus, Experimental",MESH:D003921,1,Berberine,0,
adenylate kinase activity,GO:0004017,"Diabetes Mellitus, Type 2",MESH:D003924,1,Berberine,0,
ADP binding,GO:0043531,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GCK
ADP binding,GO:0043531,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
ADP binding,GO:0043531,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
ADP binding,GO:0043531,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
ADP binding,GO:0043531,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ABCC8|GCK|GCLC|MAT1A
ADP phosphatase activity,GO:0043262,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
ADP phosphatase activity,GO:0043262,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
ADP phosphatase activity,GO:0043262,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
ADP phosphatase activity,GO:0043262,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
adrenergic receptor activity,GO:0004935,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,1,ADRB1
adrenergic receptor activity,GO:0004935,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
adrenergic receptor activity,GO:0004935,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
alcohol dehydrogenase (NAD+) activity,GO:0004022,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Diethylhexyl Phthalate,0,
alcohol dehydrogenase (NAD+) activity,GO:0004022,"Diabetes Mellitus, Type 2",MESH:D003924,4,Curcumin|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate,0,
aldehyde dehydrogenase [NAD(P)+] activity,GO:0004030,Diabetes Mellitus,MESH:D003920,2,Dieldrin|Plant Extracts,0,
aldehyde dehydrogenase [NAD(P)+] activity,GO:0004030,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
aldehyde dehydrogenase [NAD(P)+] activity,GO:0004030,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Plant Extracts,0,
alditol:NADP+ 1-oxidoreductase activity,GO:0004032,Diabetes Mellitus,MESH:D003920,3,Berberine|Metformin|Streptozocin,0,
alditol:NADP+ 1-oxidoreductase activity,GO:0004032,"Diabetes Mellitus, Experimental",MESH:D003921,6,Berberine|Capsaicin|Losartan|Metformin|Quercetin|Streptozocin,0,
alditol:NADP+ 1-oxidoreductase activity,GO:0004032,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
alditol:NADP+ 1-oxidoreductase activity,GO:0004032,"Diabetes Mellitus, Type 2",MESH:D003924,3,Berberine|Metformin|Streptozocin,0,
aliphatic amine oxidase activity,GO:0052595,Diabetes Mellitus,MESH:D003920,0,,1,AOC3
aliphatic amine oxidase activity,GO:0052595,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AOC3
alkaline phosphatase activity,GO:0004035,Diabetes Mellitus,MESH:D003920,26,"2,2',4,4'-tetrabromodiphenyl ether|Alloxan|Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Cyclosporine|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Lead|Mercury|Metformin|Niacin|Pioglitazone|Plant Extracts|Prednisolone|Raloxifene Hydrochloride|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Telmisartan|Tetrachlorodibenzodioxin|Zinc",0,
alkaline phosphatase activity,GO:0004035,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
alkaline phosphatase activity,GO:0004035,"Diabetes Mellitus, Experimental",MESH:D003921,31,"Alloxan|bisphenol A|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|Fatty Acids, Omega-3|Fructose|Gallic Acid|Glucose|Glyburide|Hydrogen Peroxide|Imatinib Mesylate|Inositol|Metformin|Niacinamide|Nicotine|Pioglitazone|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Taurine|Telmisartan|thymoquinone|tributyltin|Vitamin E",0,
alkaline phosphatase activity,GO:0004035,"Diabetes Mellitus, Type 1",MESH:D003922,17,Alloxan|bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Genistein|Imatinib Mesylate|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin|Vitamin A|Warfarin,0,
alkaline phosphatase activity,GO:0004035,"Diabetes Mellitus, Type 2",MESH:D003924,35,Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|bisphenol A|Cadmium|Curcumin|Cysteine|daidzein|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|Genistein|Glucose|Glyburide|Lead|Malathion|Mercury|Metformin|Niacinamide|Nickel|Nicotine|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|Silver|Streptozocin|Telmisartan|titanium dioxide|Zinc,0,
alkane 1-monooxygenase activity,GO:0018685,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP4A10|CYP4A14
alpha1-adrenergic receptor activity,GO:0004937,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRA1A
alpha-2A adrenergic receptor binding,GO:0031694,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
alpha2-adrenergic receptor activity,GO:0004938,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
alpha-actinin binding,GO:0051393,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
alpha-actinin binding,GO:0051393,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
alpha-actinin binding,GO:0051393,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARG
alpha-amylase activity,GO:0004556,Diabetes Mellitus,MESH:D003920,2,Berberine|Resveratrol,0,
alpha-amylase activity,GO:0004556,"Diabetes Mellitus, Experimental",MESH:D003921,2,Berberine|Resveratrol,0,
alpha-amylase activity,GO:0004556,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
alpha-amylase activity,GO:0004556,"Diabetes Mellitus, Type 2",MESH:D003924,4,Acarbose|Berberine|Curcumin|Resveratrol,0,
alpha-glucosidase activity,GO:0090599,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
alpha-glucosidase activity,GO:0090599,"Diabetes Mellitus, Experimental",MESH:D003921,1,Berberine,0,
alpha-glucosidase activity,GO:0090599,"Diabetes Mellitus, Type 2",MESH:D003924,2,Acarbose|Berberine,0,
alpha-mannosidase activity,GO:0004559,Diabetes Mellitus,MESH:D003920,1,Plant Preparations,0,
alpha-mannosidase activity,GO:0004559,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Preparations,0,
alpha-N-acetylglucosaminidase activity,GO:0004561,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
alpha-tubulin binding,GO:0043014,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CAV3|PPARGC1A
alpha-tubulin binding,GO:0043014,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
amine binding,GO:0043176,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
amino acid binding,GO:0016597,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAT1A
amino acid transmembrane transporter activity,GO:0015171,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorohexanesulfonic acid,0,
aminoacylase activity,GO:0004046,Diabetes Mellitus,MESH:D003920,0,,1,CAT
aminoacylase activity,GO:0004046,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAT
aminoacylase activity,GO:0004046,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CAT
aminoacylase activity,GO:0004046,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAT
aminopeptidase activity,GO:0004177,Diabetes Mellitus,MESH:D003920,4,Chlorpyrifos|Dichlorodiphenyl Dichloroethylene|Streptozocin|Zinc,0,
aminopeptidase activity,GO:0004177,"Diabetes Mellitus, Experimental",MESH:D003921,3,Glucose|Hydrogen Peroxide|Streptozocin,0,
aminopeptidase activity,GO:0004177,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,1,CTSH
aminopeptidase activity,GO:0004177,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dichlorodiphenyl Dichloroethylene|Glucose|Streptozocin|Zinc,0,
AMP-activated protein kinase activity,GO:0004679,Diabetes Mellitus,MESH:D003920,5,Berberine|bisphenol A|Metformin|Resveratrol|Streptozocin,1,ALPK1
AMP-activated protein kinase activity,GO:0004679,"Diabetes Mellitus, Experimental",MESH:D003921,14,Berberine|Bile Acids and Salts|bisphenol A|Cholesterol|Dietary Fats|Glucose|Hydrogen Peroxide|Imatinib Mesylate|Lithocholic Acid|Metformin|Niacinamide|Nicotine|Resveratrol|Streptozocin,0,
AMP-activated protein kinase activity,GO:0004679,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Imatinib Mesylate|Lipopolysaccharides|Niacinamide|Resveratrol|Streptozocin,0,
AMP-activated protein kinase activity,GO:0004679,"Diabetes Mellitus, Type 2",MESH:D003924,14,Amino Acids|Berberine|bisphenol A|Dietary Fats|Ethanol|Folic Acid|Glucose|Linagliptin|Lithocholic Acid|Metformin|Niacinamide|Nicotine|Resveratrol|Streptozocin,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
AMP binding,GO:0016208,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
AMP deaminase activity,GO:0003876,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
AMP deaminase activity,GO:0003876,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
AMP deaminase activity,GO:0003876,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HECTD4
amylase activity,GO:0016160,Diabetes Mellitus,MESH:D003920,3,Cadmium|Metformin|Streptozocin,0,
amylase activity,GO:0016160,"Diabetes Mellitus, Experimental",MESH:D003921,3,Fructose|Metformin|Streptozocin,0,
amylase activity,GO:0016160,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Streptozocin,0,
amylase activity,GO:0016160,"Diabetes Mellitus, Type 2",MESH:D003924,5,Cadmium|Ethanol|Fructose|Metformin|Streptozocin,0,
amyloid-beta binding,GO:0001540,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IAPP|INSR
amyloid-beta binding,GO:0001540,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
amyloid-beta binding,GO:0001540,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CD36|IAPP
"anandamide 11,12 epoxidase activity",GO:0062188,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP2B10|CYP2B9
"anandamide 14,15 epoxidase activity",GO:0062189,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP2B10|CYP2B9
"anandamide 8,9 epoxidase activity",GO:0062187,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP2B10|CYP2B9
androgen binding,GO:0005497,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SHBG
ankyrin binding,GO:0030506,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,KCNJ11
ankyrin binding,GO:0030506,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
ankyrin binding,GO:0030506,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,KCNJ11
ankyrin binding,GO:0030506,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNJ11
ankyrin repeat binding,GO:0071532,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
antigen binding,GO:0003823,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
antigen binding,GO:0003823,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GP2|TNFRSF1B
antioxidant activity,GO:0016209,Diabetes Mellitus,MESH:D003920,8,"bisphenol A|Chlorpyrifos|Hexachlorobenzene|Particulate Matter|Pravastatin|pregna-4,17-diene-3,16-dione|Selenium|Sodium Selenite",2,CAT|SOD1
antioxidant activity,GO:0016209,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
antioxidant activity,GO:0016209,"Diabetes Mellitus, Experimental",MESH:D003921,12,bisphenol A|Cholesterol|Coconut Oil|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|Malondialdehyde|platycodin D|pterostilbene|Quercetin|sodium arsenite|Sodium Selenite,3,CAT|SOD1|SOD2
antioxidant activity,GO:0016209,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Cyclophosphamide|sodium arsenite,2,CAT|HP
antioxidant activity,GO:0016209,"Diabetes Mellitus, Type 2",MESH:D003924,13,alpha-Tocopherol|Ascorbic Acid|benidipine|bisphenol A|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Glutathione|Malondialdehyde|mono-(2-ethylhexyl)phthalate|Particulate Matter|Pentoxifylline|perfluorooctane sulfonic acid,4,CAT|HP|SOD1|SOD2
antiporter activity,GO:0015297,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,SLC9A1|SLC9A3|UCP2
antiporter activity,GO:0015297,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,SLC30A8|UCP2
apolipoprotein binding,GO:0034185,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
arachidonate-CoA ligase activity,GO:0047676,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
arachidonic acid binding,GO:0050544,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
arachidonic acid binding,GO:0050544,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP4A14|PPARG
arachidonic acid binding,GO:0050544,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HNF4A|PPARG
arachidonic acid epoxygenase activity,GO:0008392,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP4A10|CYP4A14
arachidonic acid monooxygenase activity,GO:0008391,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CYP1A1|CYP4A10|CYP4A14
arachidonic acid omega-hydroxylase activity,GO:0052869,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP4A10|HMOX1
arachidonic acid omega-hydroxylase activity,GO:0052869,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
arginase activity,GO:0004053,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Streptozocin|Zinc,0,
arginase activity,GO:0004053,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Streptozocin,0,
arginase activity,GO:0004053,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
arginase activity,GO:0004053,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|bisphenol S|diethyl phthalate|Streptozocin|Zinc,0,
arginine binding,GO:0034618,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS2|NOS3
arginine binding,GO:0034618,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
arginine binding,GO:0034618,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
arginine kinase activity,GO:0004054,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
armadillo repeat domain binding,GO:0070016,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TCF7L2
aromatase activity,GO:0070330,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
aromatase activity,GO:0070330,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP1A2
arrestin family protein binding,GO:1990763,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CHRM2
arrestin family protein binding,GO:1990763,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
aryldialkylphosphatase activity,GO:0004063,Diabetes Mellitus,MESH:D003920,0,,1,PON1
aryldialkylphosphatase activity,GO:0004063,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
arylesterase activity,GO:0004064,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Parathion,1,PON1
arylesterase activity,GO:0004064,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
arylsulfatase activity,GO:0004065,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,STS
aspartic-type endopeptidase activity,GO:0004190,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CASP3|REN
aspartic-type endopeptidase activity,GO:0004190,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902944,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902944,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
ATP-activated inward rectifier potassium channel activity,GO:0015272,Diabetes Mellitus,MESH:D003920,2,Glyburide|Zinc,0,
ATP-activated inward rectifier potassium channel activity,GO:0015272,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glyburide,1,KCNJ11
ATP-activated inward rectifier potassium channel activity,GO:0015272,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
ATP-activated inward rectifier potassium channel activity,GO:0015272,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
ATP-activated inward rectifier potassium channel activity,GO:0015272,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,ABCC8|KCNJ11
ATP-activated inward rectifier potassium channel activity,GO:0015272,"Diabetes Mellitus, Type 2",MESH:D003924,3,Glyburide|Tolbutamide|Zinc,2,ABCC8|KCNJ11
ATPase binding,GO:0051117,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
ATPase binding,GO:0051117,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
ATPase binding,GO:0051117,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
ATPase binding,GO:0051117,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EGFR|WFS1
ATPase-coupled intramembrane lipid transporter activity,GO:0140326,Diabetes Mellitus,MESH:D003920,1,Chlorpromazine,0,
ATPase-coupled intramembrane lipid transporter activity,GO:0140326,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
ATPase-coupled intramembrane lipid transporter activity,GO:0140326,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
ATPase-coupled intramembrane lipid transporter activity,GO:0140326,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,RNF6
ATPase-coupled monoatomic cation transmembrane transporter activity,GO:0019829,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,KCNJ11
ATPase-coupled monoatomic cation transmembrane transporter activity,GO:0019829,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
ATPase-coupled monoatomic cation transmembrane transporter activity,GO:0019829,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
ATPase-coupled monoatomic cation transmembrane transporter activity,GO:0019829,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,ABCC8|KCNJ11
ATPase-coupled monoatomic cation transmembrane transporter activity,GO:0019829,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ABCC8|KCNJ11
ATP binding,GO:0005524,Diabetes Mellitus,MESH:D003920,0,,4,ALPK1|KIF1A|KIF5B|MAP3K5
ATP binding,GO:0005524,"Diabetes Mellitus, Experimental",MESH:D003921,0,,17,ACSL1|ATP2A2|ATP2A3|GCK|HK1|INSR|KCNJ11|MAP3K5|PCX|PDK4|PFKM|PKLR|PRKCA|PRKCD|PRKCE|SNAP25|STS
ATP binding,GO:0005524,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
ATP binding,GO:0005524,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
ATP binding,GO:0005524,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
ATP binding,GO:0005524,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
ATP binding,GO:0005524,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,ABCC8|ITPR3|KCNJ11|PRKCQ|TYK2
ATP binding,GO:0005524,"Diabetes Mellitus, Type 2",MESH:D003924,0,,23,ABCC8|ADCY5|AKT1|AKT2|ATP2A2|ATP2A3|BRAF|DGKD|EGFR|ENPP1|GCK|GCLC|HK1|IL13RA1|KCNJ11|KSR2|MAT1A|PCX|PIK3CG|PRKCB|RNF6|SNAP25|UBE2E2
ATP-dependent activity,GO:0140657,Diabetes Mellitus,MESH:D003920,6,Arsenic|bisphenol A|Iron|Lead|Selenium|Streptozocin,0,
ATP-dependent activity,GO:0140657,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Streptozocin,0,
ATP-dependent activity,GO:0140657,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Iron|Streptozocin,0,
ATP-dependent activity,GO:0140657,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|bisphenol A|Iron|Lead|Streptozocin,0,
ATP-dependent DNA/DNA annealing activity,GO:0036310,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
ATP-dependent protein folding chaperone,GO:0140662,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,STS
ATP diphosphatase activity,GO:0047693,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
ATP hydrolysis activity,GO:0016887,Diabetes Mellitus,MESH:D003920,12,Arsenic|arsenite|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Metformin|Particulate Matter|Plant Extracts|Pyruvaldehyde|Resveratrol|Streptozocin,1,KIF1A
ATP hydrolysis activity,GO:0016887,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Glucose|Hydrogen Peroxide|Losartan|Metformin|Plant Extracts|Quercetin|Resveratrol|Sodium Glutamate|Streptozocin|tangeretin|Taurine,4,ATP2A2|ATP2A3|HK1|STS
ATP hydrolysis activity,GO:0016887,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
ATP hydrolysis activity,GO:0016887,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Genistein|Lipopolysaccharides|Resveratrol|Streptozocin|Taurine|Thioctic Acid,1,ABCC8
ATP hydrolysis activity,GO:0016887,"Diabetes Mellitus, Type 2",MESH:D003924,18,Arsenic|bisphenol A|bisphenol S|Cadmium|Cysteine|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|epigallocatechin gallate|Genistein|Glucose|Malathion|Metformin|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Vehicle Emissions,5,ABCC8|ATP2A2|ATP2A3|HK1|RNF6
A-type (transient outward) potassium channel activity,GO:0005250,Diabetes Mellitus,MESH:D003920,1,Serotonin,0,
beta1-adrenergic receptor activity,GO:0004940,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
beta1-adrenergic receptor activity,GO:0004940,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
beta2-adrenergic receptor activity,GO:0004941,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
beta2-adrenergic receptor activity,GO:0004941,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
beta3-adrenergic receptor activity,GO:0015052,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
beta-3 adrenergic receptor binding,GO:0031699,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
beta-adrenergic receptor activity,GO:0004939,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
beta-adrenergic receptor activity,GO:0004939,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
beta-catenin binding,GO:0008013,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CAV1|FOXO3|NOS2|NOS3
beta-catenin binding,GO:0008013,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
beta-catenin binding,GO:0008013,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,NOS2|NOS3|TCF7L2
beta-galactosidase activity,GO:0004565,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Particulate Matter|Resveratrol,0,
beta-galactosidase activity,GO:0004565,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dronabinol|Losartan|Quercetin|Resveratrol,0,
beta-galactosidase activity,GO:0004565,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
beta-galactosidase activity,GO:0004565,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|Irbesartan|Particulate Matter|Resveratrol|Vehicle Emissions,0,
"beta-galactoside alpha-2,6-sialyltransferase activity",GO:0003835,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ST6GAL1
beta-glucosidase activity,GO:0008422,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KL
beta-glucuronidase activity,GO:0004566,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KL
betaine-homocysteine S-methyltransferase activity,GO:0047150,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
betaine-homocysteine S-methyltransferase activity,GO:0047150,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
beta-N-acetylhexosaminidase activity,GO:0004563,Diabetes Mellitus,MESH:D003920,1,Cyclosporine,0,
beta-tubulin binding,GO:0048487,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
beta-tubulin binding,GO:0048487,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL2RA
beta-tubulin binding,GO:0048487,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
BH3 domain binding,GO:0051434,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BAX|BCL2|BCL2L1
BH3 domain binding,GO:0051434,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BAX|BCL2|BCL2L1
BH domain binding,GO:0051400,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BAX|BCL2|BCL2L1
BH domain binding,GO:0051400,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BAX|BCL2|BCL2L1
bHLH transcription factor binding,GO:0043425,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
bHLH transcription factor binding,GO:0043425,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
bHLH transcription factor binding,GO:0043425,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
biotin binding,GO:0009374,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCX
biotin binding,GO:0009374,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCX
boss receptor activity,GO:0008288,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
boss receptor activity,GO:0008288,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
boss receptor activity,GO:0008288,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
bradykinin receptor activity,GO:0004947,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BDKRB1
bradykinin receptor binding,GO:0031711,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
brain-derived neurotrophic factor receptor activity,GO:0060175,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
brain-derived neurotrophic factor receptor activity,GO:0060175,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
brain-derived neurotrophic factor receptor activity,GO:0060175,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
C5L2 anaphylatoxin chemotactic receptor binding,GO:0031715,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
cadherin binding,GO:0045296,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS2|NOS3
cadherin binding,GO:0045296,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
cadherin binding,GO:0045296,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
cadmium ion binding,GO:0046870,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS3
cadmium ion binding,GO:0046870,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
cadmium ion binding,GO:0046870,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS3
cadmium ion transmembrane transporter activity,GO:0015086,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
cADPR-sensitive calcium-release channel activity,GO:0072346,Diabetes Mellitus,MESH:D003920,1,Lead,0,
cADPR-sensitive calcium-release channel activity,GO:0072346,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
caffeine oxidase activity,GO:0034875,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYP1A2|CYP3A2
calcium- and calmodulin-responsive adenylate cyclase activity,GO:0008294,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
calcium channel activity,GO:0005262,Diabetes Mellitus,MESH:D003920,2,Raloxifene Hydrochloride|Zinc,0,
calcium channel activity,GO:0005262,"Diabetes Mellitus, Experimental",MESH:D003921,2,Capsaicin|Dronabinol,0,
calcium channel activity,GO:0005262,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
calcium channel activity,GO:0005262,"Diabetes Mellitus, Type 2",MESH:D003924,2,Calcium|Zinc,0,
calcium channel inhibitor activity,GO:0019855,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,THADA
calcium channel regulator activity,GO:0005246,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV3
calcium channel regulator activity,GO:0005246,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
calcium channel regulator activity,GO:0005246,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PRKCB
calcium-dependent ATPase activity,GO:0030899,Diabetes Mellitus,MESH:D003920,7,Aspirin|Berberine|Cadmium|Chlorpromazine|Chlorpyrifos|Glyburide|Magnesium,0,
calcium-dependent ATPase activity,GO:0030899,"Diabetes Mellitus, Experimental",MESH:D003921,5,Berberine|Dietary Fats|Glyburide|Quercetin|Taurine,1,ATP2A3
calcium-dependent ATPase activity,GO:0030899,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
calcium-dependent ATPase activity,GO:0030899,"Diabetes Mellitus, Type 2",MESH:D003924,5,Berberine|Cadmium|Dietary Fats|Glyburide|Magnesium,1,ATP2A3
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,Diabetes Mellitus,MESH:D003920,2,Arsenic|Glyburide,0,
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,"Diabetes Mellitus, Experimental",MESH:D003921,4,Glucose|Glyburide|sodium arsenite|tributyltin,0,
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Thioctic Acid,0,
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Glucose|Glyburide,1,CAPN10
calcium-dependent phospholipase A2 activity,GO:0047498,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
calcium-dependent phospholipase A2 activity,GO:0047498,"Diabetes Mellitus, Type 1",MESH:D003922,1,Vitamin A,0,
calcium-dependent phospholipid binding,GO:0005544,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAEA
calcium-dependent protein binding,GO:0048306,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,S100A6|SLC9A1|SNAP25
calcium-dependent protein binding,GO:0048306,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
calcium-dependent protein binding,GO:0048306,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,S100A6|SNAP25|WFS1
calcium-dependent protein kinase C activity,GO:0004698,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PRKCA|PRKCD|PRKCE
calcium-dependent protein kinase C activity,GO:0004698,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PRKCQ
calcium-dependent protein kinase C activity,GO:0004698,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PRKCB
calcium-dependent protein serine/threonine phosphatase activity,GO:0004723,Diabetes Mellitus,MESH:D003920,1,Tacrolimus,0,
calcium-dependent protein serine/threonine phosphatase activity,GO:0004723,"Diabetes Mellitus, Experimental",MESH:D003921,1,Tacrolimus,0,
calcium-dependent protein serine/threonine phosphatase activity,GO:0004723,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tacrolimus,0,
calcium-independent phospholipase A2 activity,GO:0047499,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,REN
calcium-independent protein kinase C activity,GO:0004699,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PRKCA|PRKCD|PRKCE
calcium-independent protein kinase C activity,GO:0004699,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PRKCQ
calcium-independent protein kinase C activity,GO:0004699,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PRKCB
calcium ion binding,GO:0005509,Diabetes Mellitus,MESH:D003920,0,,4,ALPK1|AOC3|PON1|THBS2
calcium ion binding,GO:0005509,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,AOC3|ATP2A2|GPD2|MFGE8|S100A6
calcium ion binding,GO:0005509,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,CD69|CRP|ITPR3|NOS1
calcium ion binding,GO:0005509,"Diabetes Mellitus, Type 2",MESH:D003924,0,,11,ATP2A2|BRAF|DGKD|ENPP1|GPD2|ITLN1|MAEA|NOTCH2|PAM|S100A6|SLC1A2
calcium ion transmembrane transporter activity,GO:0015085,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A3
calcium ion transmembrane transporter activity,GO:0015085,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
calcium ion transmembrane transporter activity,GO:0015085,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A3
calcium-release channel activity,GO:0015278,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
calmodulin binding,GO:0005516,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,ACE|FAS|NOS2|NOS3|SLC9A1
calmodulin binding,GO:0005516,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
calmodulin binding,GO:0005516,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,AKT1|EGFR|FAS|KCNQ1|NOS2|NOS3|WFS1
calmodulin-dependent protein kinase activity,GO:0004683,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ascorbic Acid,0,
calmodulin-dependent protein phosphatase activity,GO:0033192,Diabetes Mellitus,MESH:D003920,2,arsenite|bisphenol A,0,
calmodulin-dependent protein phosphatase activity,GO:0033192,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
calmodulin-dependent protein phosphatase activity,GO:0033192,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
calmodulin-dependent protein phosphatase activity,GO:0033192,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cAMP-dependent protein kinase activity,GO:0004691,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cAMP-dependent protein kinase activity,GO:0004691,"Diabetes Mellitus, Experimental",MESH:D003921,4,"Dibutyl Phthalate|Diethylhexyl Phthalate|Glucose|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cAMP-dependent protein kinase activity,GO:0004691,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol S|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Glucose|Sitagliptin Phosphate,0,
cAMP-dependent protein kinase regulator activity,GO:0008603,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS2
cAMP-dependent protein kinase regulator activity,GO:0008603,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS2
cAMP response element binding protein binding,GO:0008140,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
carbohydrate binding,GO:0030246,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
carbohydrate binding,GO:0030246,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CD69
carbohydrate binding,GO:0030246,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCKR|ITLN1
carbohydrate derivative binding,GO:0097367,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCKR
carbonate dehydratase activity,GO:0004089,Diabetes Mellitus,MESH:D003920,3,Copper|Mercury|Streptozocin,0,
carbonate dehydratase activity,GO:0004089,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,0,
carbonate dehydratase activity,GO:0004089,"Diabetes Mellitus, Type 1",MESH:D003922,2,Mercury|Streptozocin,0,
carbonate dehydratase activity,GO:0004089,"Diabetes Mellitus, Type 2",MESH:D003924,3,Copper|Mercury|Streptozocin,0,
carbon monoxide binding,GO:0070025,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
carboxylesterase activity,GO:0106435,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
carboxylic acid binding,GO:0031406,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PCK1|PCX
carboxylic acid binding,GO:0031406,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCX
carboxylic ester hydrolase activity,GO:0052689,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
carboxylic ester hydrolase activity,GO:0052689,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,1,ACOT1
carboxylic ester hydrolase activity,GO:0052689,"Diabetes Mellitus, Type 2",MESH:D003924,2,coumarin|Dietary Fats,1,LIPC
carboxy-lyase activity,GO:0016831,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
carboxypeptidase activity,GO:0004180,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
cardiolipin binding,GO:1901612,Diabetes Mellitus,MESH:D003920,1,Lead,0,
cardiolipin binding,GO:1901612,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
cargo receptor activity,GO:0038024,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
cargo receptor activity,GO:0038024,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
cargo receptor activity,GO:0038024,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
carnitine O-octanoyltransferase activity,GO:0008458,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
carnitine O-octanoyltransferase activity,GO:0008458,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dietary Fats,0,
carnitine O-octanoyltransferase activity,GO:0008458,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
carnitine O-octanoyltransferase activity,GO:0008458,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Dietary Fats,0,
carnitine O-palmitoyltransferase activity,GO:0004095,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Copper|Resveratrol,1,CPT1A
carnitine O-palmitoyltransferase activity,GO:0004095,"Diabetes Mellitus, Experimental",MESH:D003921,7,Bile Acids and Salts|bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Inositol|Resveratrol|Sodium Glutamate,2,CPT1A|CPT1B
carnitine O-palmitoyltransferase activity,GO:0004095,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Norepinephrine|Resveratrol,0,
carnitine O-palmitoyltransferase activity,GO:0004095,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Copper|Dietary Fats|Diethylhexyl Phthalate|Resveratrol,1,CPT1A
caspase binding,GO:0089720,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
caspase binding,GO:0089720,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
caspase binding,GO:0089720,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
catalase activity,GO:0004096,Diabetes Mellitus,MESH:D003920,1,Pesticides,1,CAT
catalase activity,GO:0004096,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAT
catalase activity,GO:0004096,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CAT
catalase activity,GO:0004096,"Diabetes Mellitus, Type 2",MESH:D003924,2,Pesticides|titanium dioxide,1,CAT
catalytic activity,GO:0003824,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,AGT|CYP1A1|PKLR
catalytic activity,GO:0003824,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,CDKAL1|CISD2|GCLC|OGG1|PAM|THADA
"catalytic activity, acting on DNA",GO:0140097,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
C-C chemokine binding,GO:0019957,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BDKRB1
C-C chemokine binding,GO:0019957,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
C-C chemokine receptor activity,GO:0016493,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BDKRB1
C-C chemokine receptor activity,GO:0016493,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
CCR5 chemokine receptor binding,GO:0031730,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
CCR6 chemokine receptor binding,GO:0031731,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CCL20
CCR6 chemokine receptor binding,GO:0031731,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
CCR chemokine receptor binding,GO:0048020,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CCL20|CX3CL1
CCR chemokine receptor binding,GO:0048020,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
CD154 receptor binding,GO:0042615,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNFRSF1B
CD40 receptor binding,GO:0005174,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNF
CD40 receptor binding,GO:0005174,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
CD40 receptor binding,GO:0005174,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
CD4 receptor binding,GO:0042609,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
cell adhesion molecule binding,GO:0050839,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
channel activity,GO:0015267,Diabetes Mellitus,MESH:D003920,3,Cadmium|Copper|Zinc,0,
channel activity,GO:0015267,"Diabetes Mellitus, Experimental",MESH:D003921,4,Capsaicin|Glucose|Quercetin|sodium arsenite,2,BAX|BCL2
channel activity,GO:0015267,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
channel activity,GO:0015267,"Diabetes Mellitus, Type 2",MESH:D003924,5,Cadmium|Calcium|Copper|Glucose|Zinc,2,BAX|BCL2
channel inhibitor activity,GO:0016248,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
channel inhibitor activity,GO:0016248,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
chaperone binding,GO:0051087,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
chaperone binding,GO:0051087,Diabetes Mellitus,MESH:D003920,0,,2,CP|SOD1
chaperone binding,GO:0051087,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BAX|SOD1|TP53|TRP53
chaperone binding,GO:0051087,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
chaperone binding,GO:0051087,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BAX|SOD1
chemoattractant activity,GO:0042056,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CX3CL1|VEGFA
chemokine activity,GO:0008009,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CCL20|CX3CL1
chemokine activity,GO:0008009,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
chemokine activity,GO:0008009,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
chemokine activity,GO:0008009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAPN10
chemokine (C-C motif) ligand 5 binding,GO:0071791,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
chemokine receptor activity,GO:0004950,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
chemokine receptor activity,GO:0004950,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
chemokine receptor activity,GO:0004950,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAPN10
chloride channel activity,GO:0005254,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,0,
chloride ion binding,GO:0031404,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
chloride transmembrane transporter activity,GO:0015108,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,1,UCP2
chloride transmembrane transporter activity,GO:0015108,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
cholesterol binding,GO:0015485,"Diabetes Mellitus, Experimental",MESH:D003921,1,platycodin D,1,CAV1
cholesterol binding,GO:0015485,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
choline binding,GO:0033265,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
choline kinase activity,GO:0004103,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CPT1B
cholinesterase activity,GO:0004104,Diabetes Mellitus,MESH:D003920,5,Chlorpyrifos|Diazinon|Insecticides|Magnesium|Pesticides,0,
cholinesterase activity,GO:0004104,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Manganese|Monocrotophos|sodium arsenite,1,ACE
cholinesterase activity,GO:0004104,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cholinesterase activity,GO:0004104,"Diabetes Mellitus, Type 2",MESH:D003924,5,Dietary Fats|Magnesium|Malathion|Manganese|Pesticides,0,
chromatin binding,GO:0003682,Diabetes Mellitus,MESH:D003920,0,,2,PPARG|ZFP57
chromatin binding,GO:0003682,"Diabetes Mellitus, Experimental",MESH:D003921,0,,12,ACOX1|MPO|NEUROD1|NKX6-1|PAX6|PDX1|PPARG|PPARGC1A|RELA|SREBF1|TP53|TRP53
chromatin binding,GO:0003682,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
chromatin binding,GO:0003682,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
chromatin binding,GO:0003682,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
chromatin binding,GO:0003682,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
chromatin binding,GO:0003682,"Diabetes Mellitus, Type 2",MESH:D003924,0,,18,AUTS2|EGFR|HHEX|HMGA1|HNF1A|HNF4A|KLF14|NEUROD1|NFATC2|NFKB1|NKX6-1|PAM|PAX6|PDX1|PPARG|PPARGC1A|PRKCB|TCF7L2
chromatin DNA binding,GO:0031490,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,FOXO3|PAX6|PPARGC1A|RELA
chromatin DNA binding,GO:0031490,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
chromatin DNA binding,GO:0031490,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PAX6|PPARGC1A
chromium ion transmembrane transporter activity,GO:0070835,Diabetes Mellitus,MESH:D003920,1,Chromium,0,
chromium ion transmembrane transporter activity,GO:0070835,"Diabetes Mellitus, Experimental",MESH:D003921,1,Chromium,0,
chromium ion transmembrane transporter activity,GO:0070835,"Diabetes Mellitus, Type 2",MESH:D003924,1,Chromium,0,
chylomicron binding,GO:0035478,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
ciliary neurotrophic factor receptor binding,GO:0005127,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL27
cis-regulatory region sequence-specific DNA binding,GO:0000987,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
cis-regulatory region sequence-specific DNA binding,GO:0000987,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,HMGA1|HNF1B|HNF4A|NOTCH2
citrate synthase activity,GO:0036440,Diabetes Mellitus,MESH:D003920,3,arsenite|bisphenol A|Streptozocin,0,
citrate synthase activity,GO:0036440,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Glucose|Streptozocin,0,
citrate synthase activity,GO:0036440,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
citrate synthase activity,GO:0036440,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|bisphenol S|Glucose|Streptozocin,0,
class I DNA-(apurinic or apyrimidinic site) endonuclease activity,GO:0140078,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
clathrin binding,GO:0030276,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
clathrin binding,GO:0030276,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2L1
CoA pyrophosphatase activity,GO:0010945,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
collagen binding,GO:0005518,Diabetes Mellitus,MESH:D003920,0,,1,FN1
collagen binding,GO:0005518,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP9
collagen binding,GO:0005518,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ITGA1
collagen binding involved in cell-matrix adhesion,GO:0098639,Diabetes Mellitus,MESH:D003920,2,Pravastatin|Resveratrol,0,
collagen binding involved in cell-matrix adhesion,GO:0098639,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
collagen binding involved in cell-matrix adhesion,GO:0098639,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
collagen binding involved in cell-matrix adhesion,GO:0098639,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,1,ITGA1
complement component C1q complex binding,GO:0001849,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
connexin binding,GO:0071253,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV3
copper ion binding,GO:0005507,Diabetes Mellitus,MESH:D003920,0,,4,AOC3|CP|LEPR|SOD1
copper ion binding,GO:0005507,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,AOC3|COX2|LEPR|SOD1|TP53|TRP53
copper ion binding,GO:0005507,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
copper ion binding,GO:0005507,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,LEPR|PAM|SOD1
coreceptor activity,GO:0015026,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
core promoter sequence-specific DNA binding,GO:0001046,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
cortisol dehydrogenase activity,GO:0102196,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HSD11B1
co-SMAD binding,GO:0070410,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
co-SMAD binding,GO:0070410,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
creatine kinase activity,GO:0004111,Diabetes Mellitus,MESH:D003920,12,Arsenic|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Gallic Acid|Lead|Mercury|Metformin|Resveratrol|Selenium|Sodium Selenite|Streptozocin,0,
creatine kinase activity,GO:0004111,"Diabetes Mellitus, Experimental",MESH:D003921,15,7-hydroxycoumarin|bisphenol A|cobaltiprotoporphyrin|corilagin|Dietary Fats|fenugreek seed meal|Gallic Acid|Metformin|Quercetin|Resveratrol|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Valsartan,0,
creatine kinase activity,GO:0004111,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin,0,
creatine kinase activity,GO:0004111,"Diabetes Mellitus, Type 2",MESH:D003924,16,Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Cadmium|Dietary Fats|Glutathione|Indium|Lead|Mercury|Metformin|Resveratrol|Silver|Sitagliptin Phosphate|Streptozocin|titanium dioxide,0,
CX3C chemokine receptor binding,GO:0031737,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CX3CL1
CXCR1 chemokine receptor binding,GO:0045237,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CX3CL1
cyclic-GMP-AMP hydrolase activity,GO:0106177,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
cyclin-dependent protein serine/threonine kinase activator activity,GO:0061575,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CCND2
cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0004861,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0004861,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
cyclin-dependent protein serine/threonine kinase regulator activity,GO:0016538,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CCND2
cystathionine beta-synthase activity,GO:0004122,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
cysteine dioxygenase activity,GO:0017172,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDO1
cysteine synthase activity,GO:0004124,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
cysteine transmembrane transporter activity,GO:0033229,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
cysteine-type deubiquitinase activity,GO:0004843,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,USP48
cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0008656,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A3
cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0008656,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0008656,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ATP2A3|CASP8
cysteine-type endopeptidase activity,GO:0004197,Diabetes Mellitus,MESH:D003920,8,Arsenic|arsenite|bisphenol A|Cadmium|Mercury|Particulate Matter|Pyruvaldehyde|Raloxifene Hydrochloride,0,
cysteine-type endopeptidase activity,GO:0004197,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cysteine-type endopeptidase activity,GO:0004197,"Diabetes Mellitus, Experimental",MESH:D003921,7,"bisphenol A|Capsaicin|Dronabinol|Glucose|Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|sodium arsenite",1,CASP3
cysteine-type endopeptidase activity,GO:0004197,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Lipopolysaccharides|Mercury|sodium arsenite,2,CASP12|CTSH
cysteine-type endopeptidase activity,GO:0004197,"Diabetes Mellitus, Type 2",MESH:D003924,9,Arsenic|bisphenol A|Cadmium|Ethanol|Glucose|Mercury|Particulate Matter|TAK-875|Vehicle Emissions,3,CASP3|CASP8|USP48
cysteine-type endopeptidase activity involved in apoptotic process,GO:0097153,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|dimethylarsinous acid,0,
cysteine-type endopeptidase activity involved in apoptotic process,GO:0097153,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
cysteine-type endopeptidase activity involved in apoptotic process,GO:0097153,"Diabetes Mellitus, Type 2",MESH:D003924,3,Folic Acid|Glucose|perfluorooctanoic acid,0,
cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043027,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043027,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2L1
cysteine-type peptidase activity,GO:0008234,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Dichlorodiphenyl Dichloroethylene,0,
cysteine-type peptidase activity,GO:0008234,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cysteine-type peptidase activity,GO:0008234,"Diabetes Mellitus, Experimental",MESH:D003921,4,astaxanthine|bisphenol A|Cyclophosphamide|tributyltin,1,CASP3
cysteine-type peptidase activity,GO:0008234,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
cysteine-type peptidase activity,GO:0008234,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Cyclophosphamide,2,CASP12|CTSH
cysteine-type peptidase activity,GO:0008234,"Diabetes Mellitus, Type 2",MESH:D003924,4,astaxanthine|bisphenol A|bisphenol S|Dichlorodiphenyl Dichloroethylene,4,CAPN10|CASP3|CASP8|USP48
cytidine deaminase activity,GO:0004126,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
cytidine deaminase activity,GO:0004126,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
cytidine transmembrane transporter activity,GO:0015212,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
"cytochrome-b5 reductase activity, acting on NADH",GO:0090524,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
"cytochrome-b5 reductase activity, acting on NADH",GO:0090524,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
"cytochrome-b5 reductase activity, acting on NAD(P)H",GO:0004128,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NQO1
cytochrome-c oxidase activity,GO:0004129,Diabetes Mellitus,MESH:D003920,20,Air Pollutants|Aspirin|Berberine|Bezafibrate|bisphenol A|Cadmium|Copper|Gallic Acid|Iron|Lead|Mercury|Molybdenum|Ozone|Particulate Matter|Pesticides|Resveratrol|Sodium Selenite|Streptozocin|Tobacco Smoke Pollution|Zinc,1,LEPR
cytochrome-c oxidase activity,GO:0004129,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cytochrome-c oxidase activity,GO:0004129,"Diabetes Mellitus, Experimental",MESH:D003921,22,"Berberine|Bezafibrate|bisphenol A|corilagin|Cyclophosphamide|Dietary Fats|Dronabinol|Exenatide|Gallic Acid|Glucose|honokiol|Hydrogen Peroxide|mangiferin|Monocrotophos|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin|Resveratrol|sodium arsenite|Sodium Selenite|Streptozocin|Taurine|Tetracyclines",2,COX2|LEPR
cytochrome-c oxidase activity,GO:0004129,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
cytochrome-c oxidase activity,GO:0004129,"Diabetes Mellitus, Type 1",MESH:D003922,10,bisphenol A|Cyclophosphamide|Iron|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Taurine|Vitamin A,0,
cytochrome-c oxidase activity,GO:0004129,"Diabetes Mellitus, Type 2",MESH:D003924,23,Air Pollutants|Berberine|Bezafibrate|bisphenol A|Cadmium|Copper|Curcumin|Dietary Fats|epigallocatechin gallate|Ethanol|Exenatide|Glucose|Iron|Lead|Malathion|mangiferin|Mercury|Particulate Matter|Pesticides|Resveratrol|Streptozocin|Vehicle Emissions|Zinc,1,LEPR
cytokine activity,GO:0005125,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
cytokine activity,GO:0005125,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
cytokine activity,GO:0005125,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,CCL20|EDN1|IFNG|IL1B|IL6|LEP|TGFB1|TIMP1|TNF|VEGFA
cytokine activity,GO:0005125,"Diabetes Mellitus, Type 1",MESH:D003922,0,,8,CCL20|IFNG|IL10|IL19|IL20|IL27|IL6|TNF
cytokine activity,GO:0005125,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,ADIPOQ|EDN1|IL6|LEP|TIMP1|TNF
cytokine binding,GO:0019955,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
cytokine binding,GO:0019955,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
cytokine binding,GO:0019955,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IL13RA1|LEPR
cytokine receptor activity,GO:0004896,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
cytokine receptor activity,GO:0004896,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
cytokine receptor activity,GO:0004896,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IL13RA1|LEPR
cytokine receptor binding,GO:0005126,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
cytokine receptor binding,GO:0005126,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP8
cytoskeletal motor activity,GO:0003774,Diabetes Mellitus,MESH:D003920,0,,2,KIF1A|KIF5B
cytoskeletal protein binding,GO:0008092,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
cytoskeletal protein binding,GO:0008092,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAPN10
D-alanine:2-oxoglutarate aminotransferase activity,GO:0047810,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
D-alanine:2-oxoglutarate aminotransferase activity,GO:0047810,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
D-alanine:2-oxoglutarate aminotransferase activity,GO:0047810,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
D-alanine:2-oxoglutarate aminotransferase activity,GO:0047810,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Curcumin|Ethanol,0,
damaged DNA binding,GO:0003684,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
deacetylase activity,GO:0019213,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
deacetylase activity,GO:0019213,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
deacetylase activity,GO:0019213,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
DEAD/H-box RNA helicase binding,GO:0017151,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
death effector domain binding,GO:0035877,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP8
death receptor agonist activity,GO:0038177,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNF
death receptor agonist activity,GO:0038177,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
death receptor agonist activity,GO:0038177,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
death receptor binding,GO:0005123,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
death receptor binding,GO:0005123,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CASP3|CASP8
dehydroascorbic acid transmembrane transporter activity,GO:0033300,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
dehydroascorbic acid transmembrane transporter activity,GO:0033300,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,SLC2A1|SLC2A2
dehydrodolichyl diphosphate synthase activity,GO:0045547,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NUS1
delayed rectifier potassium channel activity,GO:0005251,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
demethylase activity,GO:0032451,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP1A1|CYP3A11
demethylase activity,GO:0032451,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CYP1A2|CYP3A2|CYP3A23-3A1
deubiquitinase activator activity,GO:0035800,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
deubiquitinase activity,GO:0101005,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,USP48
D-glucose transmembrane transporter activity,GO:0055056,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC2A2|SLC2A4
D-glucose transmembrane transporter activity,GO:0055056,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,SLC2A1|SLC2A2|SLC2A4
D-glutamyltransferase activity,GO:0047823,Diabetes Mellitus,MESH:D003920,6,Air Pollutants|bisphenol A|Flavonoids|Particulate Matter|Streptozocin|Zinc,0,
D-glutamyltransferase activity,GO:0047823,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Hydrogen Peroxide|Streptozocin,0,
D-glutamyltransferase activity,GO:0047823,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Streptozocin|Thioctic Acid,0,
D-glutamyltransferase activity,GO:0047823,"Diabetes Mellitus, Type 2",MESH:D003924,7,Air Pollutants|bisphenol A|Folic Acid|Nickel|Particulate Matter|Streptozocin|Zinc,0,
diacylglycerol binding,GO:0019992,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCA
diacylglycerol binding,GO:0019992,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,DGKD
diacylglycerol kinase activity,GO:0004143,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,DGKD
diamine oxidase activity,GO:0052597,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
diamine oxidase activity,GO:0052597,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
diamine oxidase activity,GO:0052597,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
diamine oxidase activity,GO:0052597,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Cysteine,0,
dimethylargininase activity,GO:0016403,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
dinucleotide phosphatase activity,GO:0004551,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
dioxygenase activity,GO:0051213,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
dioxygenase activity,GO:0051213,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PTGS2
dioxygenase activity,GO:0051213,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CDO1|FTO
dipeptidase activity,GO:0016805,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PEPD
dipeptidyl-peptidase activity,GO:0008239,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
dipeptidyl-peptidase activity,GO:0008239,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
dipeptidyl-peptidase activity,GO:0008239,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
dipeptidyl-peptidase activity,GO:0008239,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
disordered domain specific binding,GO:0097718,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
D-loop DNA binding,GO:0062037,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMGA1
DNA-(apurinic or apyrimidinic site) endonuclease activity,GO:0003906,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HMGA1|UBE2E2
DNA binding,GO:0003677,Diabetes Mellitus,MESH:D003920,0,,4,NR1I2|NR1I3|PPARG|ZFP57
DNA binding,GO:0003677,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,18,AIFM1|ATF3|ESRRA|FOXO3|GCK|LEP|NEUROD1|NKX6-1|PAX6|PDX1|PPARA|PPARG|PPARGC1A|RELA|SOD2|SREBF1|TP53|TRP53
DNA binding,GO:0003677,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
DNA binding,GO:0003677,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
DNA binding,GO:0003677,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
DNA binding,GO:0003677,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
DNA binding,GO:0003677,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
DNA binding,GO:0003677,"Diabetes Mellitus, Type 1",MESH:D003922,0,,8,AIFM1|BACH2|DDIT3|GLIS3|HNF1A|NOS1|PAX4|STAT3
DNA binding,GO:0003677,"Diabetes Mellitus, Type 2",MESH:D003924,0,,31,ATF3|ETS1|GCK|GLIS3|HHEX|HMG20A|HMGA1|HNF1A|HNF1B|HNF4A|KLF14|LEP|NEUROD1|NFATC2|NFKB1|NKX6-1|OGG1|PAX4|PAX6|PDX1|PPARA|PPARG|PPARGC1A|PROX1|RETN|RNF6|SMAD5|SOD2|TCF7L2|TMEM18|ZFAND3
"DNA binding, bending",GO:0008301,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HHEX|HMGA1
DNA binding domain binding,GO:0050692,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
DNA binding domain binding,GO:0050692,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
DNA binding domain binding,GO:0050692,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARG|PROX1
DNA-binding transcription activator activity,GO:0001216,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARA
DNA-binding transcription activator activity,GO:0001216,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARA
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,Diabetes Mellitus,MESH:D003920,0,,4,NR1I2|NR1I3|PPARG|ZFP57
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Experimental",MESH:D003921,0,,12,ATF3|ESRRA|FOXO3|NEUROD1|PAX6|PDX1|PPARA|PPARG|RELA|SREBF1|TP53|TRP53
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,DDIT3|GLIS3|HNF1A|STAT3
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Diabetes Mellitus, Type 2",MESH:D003924,0,,15,ATF3|ETS1|GLIS3|HHEX|HNF1A|HNF4A|NEUROD1|NFATC2|NFKB1|NOTCH2|PAX6|PDX1|PPARA|PPARG|TCF7L2
DNA-binding transcription factor activity,GO:0003700,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Ozone,4,NR1I2|NR1I3|PPARG|ZFP57
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,13,ATF3|ESRRA|FOXO3|NEUROD1|NKX6-1|PAX6|PDX1|PPARA|PPARG|RELA|SREBF1|TP53|TRP53
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,6,BACH2|DDIT3|GLIS3|HNF1A|PAX4|STAT3
DNA-binding transcription factor activity,GO:0003700,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|Cadmium,19,ATF3|ETS1|GLIS3|HHEX|HNF1A|HNF1B|HNF4A|NEUROD1|NFATC2|NFKB1|NKX6-1|PAX4|PAX6|PDX1|PPARA|PPARG|PROX1|SMAD5|TCF7L2
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,Diabetes Mellitus,MESH:D003920,0,,4,NR1I2|NR1I3|PPARG|ZFP57
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Experimental",MESH:D003921,0,,13,ATF3|ESRRA|FOXO3|NEUROD1|NKX6-1|PAX6|PDX1|PPARA|PPARG|RELA|SREBF1|TP53|TRP53
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Type 1",MESH:D003922,0,,7,BACH2|CRP|DDIT3|GLIS3|HNF1A|PAX4|STAT3
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Diabetes Mellitus, Type 2",MESH:D003924,0,,21,ATF3|ETS1|GLIS3|HHEX|HNF1A|HNF1B|HNF4A|KLF14|NEUROD1|NFATC2|NFKB1|NKX6-1|PAX4|PAX6|PDX1|PPARA|PPARG|PROX1|SMAD5|TCF7L2|ZNF257
DNA-binding transcription factor binding,GO:0140297,Diabetes Mellitus,MESH:D003920,0,,2,PPARG|SIRT1
DNA-binding transcription factor binding,GO:0140297,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,BCL2|PPARA|PPARG|PPARGC1A|RELA|SIRT1
DNA-binding transcription factor binding,GO:0140297,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
DNA-binding transcription factor binding,GO:0140297,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,BCL2|ETS1|HHEX|PPARA|PPARG|PPARGC1A|RETN|SIRT1|WFS1
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,Diabetes Mellitus,MESH:D003920,0,,2,PPARG|ZFP57
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,ATF3|ESRRA|FOXO3|NKX6-1|PAX6|PPARA|PPARG|RELA|TP53|TRP53
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,BACH2|GLIS3|PAX4
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,"Diabetes Mellitus, Type 2",MESH:D003924,0,,13,ATF3|GLIS3|HHEX|NFATC2|NFKB1|NKX6-1|PAX4|PAX6|PPARA|PPARG|PROX1|SMAD5|ZNF257
DNA-dependent protein kinase activity,GO:0004677,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
DNA-dependent protein kinase activity,GO:0004677,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
DNA-directed DNA polymerase activity,GO:0003887,Diabetes Mellitus,MESH:D003920,1,Metformin,0,
DNA-directed DNA polymerase activity,GO:0003887,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|Metformin,0,
DNA-directed DNA polymerase activity,GO:0003887,"Diabetes Mellitus, Type 2",MESH:D003924,1,Metformin,0,
DNA-methyltransferase activity,GO:0009008,Diabetes Mellitus,MESH:D003920,2,Liraglutide|Plant Extracts,0,
DNA-methyltransferase activity,GO:0009008,"Diabetes Mellitus, Experimental",MESH:D003921,5,Dibutyl Phthalate|Dietary Fats|Exenatide|Hydrogen Peroxide|Plant Extracts,0,
DNA-methyltransferase activity,GO:0009008,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
DNA-methyltransferase activity,GO:0009008,"Diabetes Mellitus, Type 2",MESH:D003924,10,Curcumin|Dibutyl Phthalate|Dietary Fats|epigallocatechin gallate|Exenatide|Folic Acid|Genistein|Liraglutide|Plant Extracts|procyanidin B2,0,
DNA N-glycosylase activity,GO:0019104,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity",GO:0003918,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ascorbic Acid,0,
dopamine:sodium symporter activity,GO:0005330,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
double-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0008311,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UBE2E2
double-stranded DNA binding,GO:0003690,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
double-stranded DNA binding,GO:0003690,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,NEUROD1|PAX6|PPARG|RELA
double-stranded DNA binding,GO:0003690,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
double-stranded DNA binding,GO:0003690,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,HNF1A|PAX4
double-stranded DNA binding,GO:0003690,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,EGFR|HNF1A|NEUROD1|NFKB1|PAX4|PAX6|PPARG
double-stranded methylated DNA binding,GO:0010385,Diabetes Mellitus,MESH:D003920,0,,1,ZFP57
double-stranded methylated DNA binding,GO:0010385,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
E-box binding,GO:0070888,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
E-box binding,GO:0070888,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NEUROD1|PPARG
E-box binding,GO:0070888,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
E-box binding,GO:0070888,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NEUROD1|PPARG
electron transfer activity,GO:0009055,Diabetes Mellitus,MESH:D003920,0,,2,CYBB|NCF1
electron transfer activity,GO:0009055,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CYBA|CYBB|GSR|NCF1
electron transfer activity,GO:0009055,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYBA|CYP1A2
electron-transferring-flavoprotein dehydrogenase activity,GO:0004174,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AIFM1
electron-transferring-flavoprotein dehydrogenase activity,GO:0004174,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
endonuclease activity,GO:0004519,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
endopeptidase activity,GO:0004175,Diabetes Mellitus,MESH:D003920,3,Particulate Matter|Streptozocin|Tobacco Smoke Pollution,0,
endopeptidase activity,GO:0004175,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,6,ACE|CASP3|MMP2|MMP9|PCSK2|REN
endopeptidase activity,GO:0004175,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,2,CASP12|CTSH
endopeptidase activity,GO:0004175,"Diabetes Mellitus, Type 2",MESH:D003924,4,epigallocatechin gallate|Glutathione|Particulate Matter|Streptozocin,5,ADAMTS9|CASP3|CASP8|ECE1|PCSK2
endopeptidase inhibitor activity,GO:0004866,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
endothelin A receptor binding,GO:0031707,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
endothelin A receptor binding,GO:0031707,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDN1
endothelin B receptor binding,GO:0031708,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
endothelin B receptor binding,GO:0031708,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDN1
endothelin receptor activity,GO:0004962,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDNRA|EDNRB
enzyme activator activity,GO:0008047,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
enzyme activator activity,GO:0008047,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,PRKCD|PRKCE|SIRT1|TIMP2
enzyme activator activity,GO:0008047,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
enzyme binding,GO:0019899,Diabetes Mellitus,MESH:D003920,0,,6,CAT|PPARG|PTGS2|RAC1|SIRT1|SOD1
enzyme binding,GO:0019899,"Diabetes Mellitus, Experimental",MESH:D003921,0,,19,ATP2A2|CAT|CAV1|CAV3|CYP1A1|HMOX1|PPARG|PRKCA|PRKCD|PRKCE|PTGS2|RELA|SIRT1|SOD1|SOD2|TGFB1|TP53|TRP53|YWHAH
enzyme binding,GO:0019899,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CAT|NOS1
enzyme binding,GO:0019899,"Diabetes Mellitus, Type 2",MESH:D003924,0,,19,AKT1|ATP2A2|CAT|CBS|CYP1A2|CYP3A2|EGFR|GCKR|GCLM|GSTM1|HMGA1|HMOX1|NOTCH2|OGG1|PPARG|PTPN1|SIRT1|SOD1|SOD2
enzyme inhibitor activity,GO:0004857,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCKR
enzyme regulator activity,GO:0030234,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCLM|THADA
ephrin receptor binding,GO:0046875,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PIK3CG|PTPN1
epidermal growth factor binding,GO:0048408,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
epidermal growth factor receptor activity,GO:0005006,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
epidermal growth factor receptor activity,GO:0005006,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
epidermal growth factor receptor activity,GO:0005006,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
epinephrine binding,GO:0051379,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
erythropoietin receptor activity,GO:0004900,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL13RA1
estradiol 17-beta-dehydrogenase activity,GO:0004303,Diabetes Mellitus,MESH:D003920,1,Chlorpromazine,0,
estradiol 17-beta-dehydrogenase activity,GO:0004303,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dibutyl Phthalate|sodium arsenite|Taurine,0,
estradiol 17-beta-dehydrogenase activity,GO:0004303,"Diabetes Mellitus, Type 1",MESH:D003922,3,decabromobiphenyl ether|sodium arsenite|Taurine,0,
estradiol 17-beta-dehydrogenase activity,GO:0004303,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Dibutyl Phthalate,0,
estrogen 16-alpha-hydroxylase activity,GO:0101020,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP1A1|CYP3A11
estrogen 16-alpha-hydroxylase activity,GO:0101020,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYP1A2|CYP3A2
estrogen 2-hydroxylase activity,GO:0101021,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CYP1A1|CYP2B10|CYP2B9
estrogen 2-hydroxylase activity,GO:0101021,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYP1A2|CYP3A2
estrogen response element binding,GO:0034056,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ESRRA
ethanolamine kinase activity,GO:0004305,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CPT1B
ethanol binding,GO:0035276,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCE
eukaryotic initiation factor 4E binding,GO:0008190,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
eukaryotic translation initiation factor 2alpha kinase activity,GO:0004694,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
eukaryotic translation initiation factor 2alpha kinase activity,GO:0004694,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
exonuclease activity,GO:0004527,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
exopeptidase activity,GO:0008238,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
extracellular matrix binding,GO:0050840,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
extracellular matrix structural constituent,GO:0005201,Diabetes Mellitus,MESH:D003920,0,,3,ADIPOQ|FN1|THBS2
extracellular matrix structural constituent,GO:0005201,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MFGE8
extracellular matrix structural constituent,GO:0005201,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADIPOQ
FAD binding,GO:0071949,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
FAD binding,GO:0071949,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ACOX1|AIFM1|CYBB
FAD binding,GO:0071949,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
fatty acid binding,GO:0005504,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ACOX1|CYP4A14
fatty acid binding,GO:0005504,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
fatty-acyl-CoA binding,GO:0000062,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
ferric iron binding,GO:0008199,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
ferric iron binding,GO:0008199,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CAPN10|ZFAND3
ferrous iron binding,GO:0008198,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CDO1|FTO|ZFAND3
ferroxidase activity,GO:0004322,Diabetes Mellitus,MESH:D003920,0,,1,CP
ferroxidase activity,GO:0004322,"Diabetes Mellitus, Experimental",MESH:D003921,1,Fructose,0,
ferroxidase activity,GO:0004322,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
ferroxidase activity,GO:0004322,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Fructose,0,
fibroblast growth factor binding,GO:0017134,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KL
fibroblast growth factor receptor activity,GO:0005007,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
fibroblast growth factor receptor activity,GO:0005007,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
fibroblast growth factor receptor activity,GO:0005007,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
fibroblast growth factor receptor binding,GO:0005104,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FGF21
fibroblast growth factor receptor binding,GO:0005104,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,FGF21
fibroblast growth factor receptor binding,GO:0005104,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,FGF21|KL
fibronectin binding,GO:0001968,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,MMP2|MMP9|VEGFA
flavin adenine dinucleotide binding,GO:0050660,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
flavin adenine dinucleotide binding,GO:0050660,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,ACOX1|AIFM1|CYBB|GSR|NOS2|NOS3
flavin adenine dinucleotide binding,GO:0050660,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,AIFM1|NOS1|NOS3
flavin adenine dinucleotide binding,GO:0050660,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
flavonoid 3'-monooxygenase activity,GO:0016711,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
FMN binding,GO:0010181,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS2|NOS3
FMN binding,GO:0010181,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
FMN binding,GO:0010181,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
fructokinase activity,GO:0008865,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GCK|HK1
fructokinase activity,GO:0008865,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
fructokinase activity,GO:0008865,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|HK1
"fructose 1,6-bisphosphate 1-phosphatase activity",GO:0042132,Diabetes Mellitus,MESH:D003920,2,Alloxan|Streptozocin,0,
"fructose 1,6-bisphosphate 1-phosphatase activity",GO:0042132,"Diabetes Mellitus, Experimental",MESH:D003921,6,Alloxan|chebulagic acid|Dietary Fats|Quercetin|Streptozocin|thymoquinone,0,
"fructose 1,6-bisphosphate 1-phosphatase activity",GO:0042132,"Diabetes Mellitus, Type 1",MESH:D003922,2,Alloxan|Streptozocin,0,
"fructose 1,6-bisphosphate 1-phosphatase activity",GO:0042132,"Diabetes Mellitus, Type 2",MESH:D003924,3,Alloxan|Dietary Fats|Streptozocin,0,
"fructose-2,6-bisphosphate 2-phosphatase activity",GO:0004331,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CCND2
fructose-6-phosphate binding,GO:0070095,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
fructose-6-phosphate binding,GO:0070095,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCKR
fructose binding,GO:0070061,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
fructose transmembrane transporter activity,GO:0005353,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
fructose transmembrane transporter activity,GO:0005353,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A2
fucose transmembrane transporter activity,GO:0015150,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A1
galactose transmembrane transporter activity,GO:0005354,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
galactose transmembrane transporter activity,GO:0005354,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A2
gamma-catenin binding,GO:0045295,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TCF7L2
gap junction channel activity,GO:0005243,Diabetes Mellitus,MESH:D003920,7,"2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|alachlor|DDT|Lead|Particulate Matter|Resveratrol",0,
gap junction channel activity,GO:0005243,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
gap junction channel activity,GO:0005243,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
gap junction channel activity,GO:0005243,"Diabetes Mellitus, Type 2",MESH:D003924,8,Air Pollutants|Diethylnitrosamine|Lead|Particulate Matter|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Resveratrol,0,
gastric inhibitory polypeptide receptor binding,GO:0031767,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCG
GDP binding,GO:0019003,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PCK1|UCP2
GDP binding,GO:0019003,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,MRAS|UCP2
general transcription initiation factor binding,GO:0140296,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,RELA|TP53|TRP53
Gi/o-coupled serotonin receptor activity,GO:0001586,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
glucagon-like peptide 1 receptor activity,GO:0044508,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GLP1R
glucagon receptor activity,GO:0004967,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GLP1R
glucagon receptor binding,GO:0031769,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCG
glucokinase activity,GO:0004340,Diabetes Mellitus,MESH:D003920,2,Plant Extracts|Streptozocin,0,
glucokinase activity,GO:0004340,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Streptozocin,2,GCK|HK1
glucokinase activity,GO:0004340,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glucokinase activity,GO:0004340,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
glucokinase activity,GO:0004340,"Diabetes Mellitus, Type 2",MESH:D003924,2,Plant Extracts|Streptozocin,2,GCK|HK1
glucosamine kinase activity,GO:0047931,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HK1
glucosamine kinase activity,GO:0047931,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HK1
glucose-6-phosphatase activity,GO:0004346,Diabetes Mellitus,MESH:D003920,5,Alloxan|Gliclazide|Metformin|Plant Extracts|Streptozocin,0,
glucose-6-phosphatase activity,GO:0004346,"Diabetes Mellitus, Experimental",MESH:D003921,12,Alloxan|Biguanides|chebulagic acid|Dietary Fats|Fructose|Gliclazide|Metformin|Plant Extracts|Quercetin|Streptozocin|thymoquinone|Vitamin E,0,
glucose-6-phosphatase activity,GO:0004346,"Diabetes Mellitus, Type 1",MESH:D003922,2,Alloxan|Streptozocin,0,
glucose-6-phosphatase activity,GO:0004346,"Diabetes Mellitus, Type 2",MESH:D003924,8,Alloxan|Ascorbic Acid|Dietary Fats|Fructose|Gliclazide|Metformin|Plant Extracts|Streptozocin,0,
glucose-6-phosphate dehydrogenase activity,GO:0004345,Diabetes Mellitus,MESH:D003920,2,Plant Extracts|Streptozocin,0,
glucose-6-phosphate dehydrogenase activity,GO:0004345,"Diabetes Mellitus, Experimental",MESH:D003921,4,chebulagic acid|Dietary Fats|Plant Extracts|Streptozocin,0,
glucose-6-phosphate dehydrogenase activity,GO:0004345,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
glucose-6-phosphate dehydrogenase activity,GO:0004345,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dietary Fats|Plant Extracts|Streptozocin,0,
glucose binding,GO:0005536,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GCK|HK1
glucose binding,GO:0005536,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glucose binding,GO:0005536,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|HK1
glucose uniporter activity,GO:0015304,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A4
glucose uniporter activity,GO:0015304,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A4
glucuronosyltransferase activity,GO:0015020,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Plant Preparations,0,
glucuronosyltransferase activity,GO:0015020,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Plant Preparations|Sodium Glutamate|Taurine,0,
glucuronosyltransferase activity,GO:0015020,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Taurine,0,
glucuronosyltransferase activity,GO:0015020,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|epigallocatechin gallate,0,
glutamate binding,GO:0016595,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,1,GCLC
glutamate-cysteine ligase activity,GO:0004357,Diabetes Mellitus,MESH:D003920,2,Cadmium|Lead,0,
glutamate-cysteine ligase activity,GO:0004357,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
glutamate-cysteine ligase activity,GO:0004357,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Lead,2,GCLC|GCLM
glutamate-cysteine ligase catalytic subunit binding,GO:0035226,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCLM
glutamate-cysteine ligase regulator activity,GO:1990609,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCLM
glutamate dehydrogenase (NADP+) activity,GO:0004354,"Diabetes Mellitus, Experimental",MESH:D003921,1,2-Hydroxypropyl-beta-cyclodextrin,0,
glutamate:sodium symporter activity,GO:0015501,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
glutaminase activity,GO:0004359,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
glutaminase activity,GO:0004359,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
glutaminase activity,GO:0004359,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
glutaminase activity,GO:0004359,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
glutathione binding,GO:0043295,Diabetes Mellitus,MESH:D003920,2,Copper|Mercury,0,
glutathione binding,GO:0043295,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,1,GSR
glutathione binding,GO:0043295,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
glutathione binding,GO:0043295,"Diabetes Mellitus, Type 2",MESH:D003924,3,Copper|Manganese|Mercury,1,GSTM1
glutathione-disulfide reductase (NADPH) activity,GO:0004362,Diabetes Mellitus,MESH:D003920,1,Pesticides,0,
glutathione-disulfide reductase (NADPH) activity,GO:0004362,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GSR
glutathione-disulfide reductase (NADPH) activity,GO:0004362,"Diabetes Mellitus, Type 2",MESH:D003924,1,Pesticides,0,
glutathione hydrolase activity,GO:0036374,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
glutathione hydrolase activity,GO:0036374,"Diabetes Mellitus, Type 2",MESH:D003924,2,alpha-Tocopherol|Arsenic,0,
glutathione peroxidase activity,GO:0004602,Diabetes Mellitus,MESH:D003920,51,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Alloxan|Arsenic|arsenite|Atrazine|Berberine|Bezafibrate|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Clozapine|Copper|Cyclosporine|Diazinon|Diazoxide|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Docosahexaenoic Acids|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Glyburide|Hexachlorobenzene|Iron|Lead|Mercury|Metformin|morroniside|Ozone|Particulate Matter|Pesticides|Pioglitazone|Plant Extracts|Plant Preparations|puerarin|Pyruvaldehyde|Resveratrol|Rosiglitazone|Selenium|Serotonin|Sodium Selenite|Streptozocin|Sulfur Dioxide|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Trichlorfon|Zinc",1,CP
glutathione peroxidase activity,GO:0004602,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
glutathione peroxidase activity,GO:0004602,"Diabetes Mellitus, Experimental",MESH:D003921,50,"7-hydroxycoumarin|Alloxan|Anthocyanins|Berberine|Bezafibrate|Bile Acids and Salts|bisphenol A|corilagin|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diosmin|Fatty Acids, Omega-3|Fructose|Gallic Acid|ginsenoside Re|Glucose|Glyburide|Hydrogen Peroxide|Inositol|Losartan|Malondialdehyde|Manganese|mangiferin|Metformin|Niacinamide|Nicotine|Pioglitazone|Plant Extracts|Plant Preparations|puerarin|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|tangeretin|Taurine|Telmisartan|Tetracyclines|thymoquinone|tributyltin|Ursolic Acid|Vitamin E|Zinc Compounds",1,GPX1
glutathione peroxidase activity,GO:0004602,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
glutathione peroxidase activity,GO:0004602,"Diabetes Mellitus, Type 1",MESH:D003922,17,Alloxan|bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Genistein|Iron|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid,1,CP
glutathione peroxidase activity,GO:0004602,"Diabetes Mellitus, Type 2",MESH:D003924,60,Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Benzoic Acid|Berberine|Bezafibrate|bisphenol A|bisphenol S|Cadmium|Calcium|Clozapine|Copper|coumarin|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|Genistein|ginsenoside Re|Glucose|Glutathione|Glyburide|Iron|Lead|Malathion|Malondialdehyde|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nickel|Nicotine|Orlistat|Particulate Matter|Pesticides|Pioglitazone|Plant Extracts|procyanidin B2|Resveratrol|Rosiglitazone|Silver|Sitagliptin Phosphate|Streptozocin|Telmisartan|titanium dioxide|Vehicle Emissions|Zinc,1,GPX1
glutathione transferase activity,GO:0004364,Diabetes Mellitus,MESH:D003920,37,"2,2',4,4'-tetrabromodiphenyl ether|alachlor|Alloxan|Arsenic|arsenite|Atrazine|Bezafibrate|bisphenol A|Cadmium|Chlorpyrifos|Chromium|Copper|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Iron|Lead|Mercury|Metals, Heavy|Metformin|o,p'-DDT|Ozone|Particulate Matter|Perindopril|Pesticides|Pioglitazone|Plant Extracts|Plant Preparations|Resveratrol|Selenium|Sodium Selenite|Streptozocin|Tetrachlorodibenzodioxin|Zinc",0,
glutathione transferase activity,GO:0004364,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
glutathione transferase activity,GO:0004364,"Diabetes Mellitus, Experimental",MESH:D003921,32,"7-hydroxycoumarin|Alloxan|Anthocyanins|Bezafibrate|bisphenol A|Chromium|Cyclophosphamide|Dietary Fats|Diosmin|Fatty Acids, Omega-3|Gallic Acid|Glucose|Glyburide|Inositol|Manganese|mangiferin|Metformin|Monocrotophos|Niacinamide|Nicotine|Pioglitazone|Plant Extracts|Plant Preparations|Quercetin|Resveratrol|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Taurine|thymoquinone|Vitamin E",0,
glutathione transferase activity,GO:0004364,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
glutathione transferase activity,GO:0004364,"Diabetes Mellitus, Type 1",MESH:D003922,16,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Iron|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Vitamin A,0,
glutathione transferase activity,GO:0004364,"Diabetes Mellitus, Type 2",MESH:D003924,50,"Alloxan|alpha-Tocopherol|Amoxicillin|Arsenic|Ascorbic Acid|Atrazine|Benzoic Acid|Bezafibrate|bisphenol A|bisphenol S|Cadmium|Calcium|Chromium|Copper|coumarin|Curcumin|Cysteine|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylnitrosamine|Diosmin|Drugs, Chinese Herbal|efavirenz|epigallocatechin gallate|Ethanol|Folic Acid|Glucose|Glutathione|Glyburide|Iron|Lead|Malathion|Manganese|mangiferin|Mercury|Metformin|Niacinamide|Nickel|Nicotine|Orlistat|Particulate Matter|Pesticides|Pioglitazone|Plant Extracts|Resveratrol|Silver|Streptozocin|titanium dioxide|Vehicle Emissions|Zinc",1,GSTM1
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0004365,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0004365,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
glycerol-3-phosphate dehydrogenase (quinone) activity,GO:0004368,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPD2
glycerol-3-phosphate dehydrogenase (quinone) activity,GO:0004368,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPD2
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,"Diabetes Mellitus, Experimental",MESH:D003921,4,Bile Acids and Salts|bisphenol A|Inositol|Resveratrol,1,GPAM
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Resveratrol,0,
glycogen binding,GO:2001069,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPP1R3A
glycogen phosphorylase activity,GO:0008184,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Glyburide|Metformin|Plant Extracts|Streptozocin,0,
glycogen phosphorylase activity,GO:0008184,"Diabetes Mellitus, Experimental",MESH:D003921,8,bisphenol A|chebulagic acid|Dietary Fats|Fructose|Glyburide|Metformin|Plant Extracts|Streptozocin,0,
glycogen phosphorylase activity,GO:0008184,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
glycogen phosphorylase activity,GO:0008184,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Dietary Fats|Fructose|Glyburide|Metformin|Plant Extracts|Streptozocin,0,
glycogen (starch) synthase activity,GO:0004373,Diabetes Mellitus,MESH:D003920,3,Glyburide|Plant Extracts|Streptozocin,0,
glycogen (starch) synthase activity,GO:0004373,"Diabetes Mellitus, Experimental",MESH:D003921,3,Glyburide|Plant Extracts|Streptozocin,0,
glycogen (starch) synthase activity,GO:0004373,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
glycogen (starch) synthase activity,GO:0004373,"Diabetes Mellitus, Type 2",MESH:D003924,3,Glyburide|Plant Extracts|Streptozocin,0,
glycosyltransferase activity,GO:0016757,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ST6GAL1
GPI-linked ephrin receptor activity,GO:0005004,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
GPI-linked ephrin receptor activity,GO:0005004,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
GPI-linked ephrin receptor activity,GO:0005004,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
G protein activity,GO:0003925,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
G protein activity,GO:0003925,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MRAS
G-protein beta/gamma-subunit complex binding,GO:0031683,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR4
G protein-coupled acetylcholine receptor activity,GO:0016907,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CHRM2
G protein-coupled acetylcholine receptor activity,GO:0016907,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,GO:0099579,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
G protein-coupled peptide receptor activity,GO:0008528,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
G protein-coupled peptide receptor activity,GO:0008528,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GLP1R|SCTR
G protein-coupled receptor activity,GO:0004930,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
G protein-coupled receptor activity,GO:0004930,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,ADRA1A|BDKRB1|CHRM2|S1PR2|S1PR4|S1PR5
G protein-coupled receptor activity,GO:0004930,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
G protein-coupled receptor activity,GO:0004930,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,EDNRA|EDNRB|GLP1R|MTNR1B|SCTR|SFRP4
G protein-coupled receptor binding,GO:0001664,Diabetes Mellitus,MESH:D003920,0,,1,POMC
G protein-coupled receptor binding,GO:0001664,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,S1PR2|S1PR4
G protein-coupled receptor binding,GO:0001664,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HBA1
G protein-coupled serotonin receptor activity,GO:0004993,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CHRM2
G protein-coupled serotonin receptor activity,GO:0004993,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
growth factor activity,GO:0008083,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,AGT|FGF21|IGF1|IL6|TGFB1|TIMP1|VEGFA
growth factor activity,GO:0008083,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,FGF21|IGF1|IL10|IL6
growth factor activity,GO:0008083,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,CASP8|FGF21|IL6|TIMP1
growth factor binding,GO:0019838,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
growth hormone receptor binding,GO:0005131,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
GTPase activating protein binding,GO:0032794,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
GTPase activating protein binding,GO:0032794,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
GTPase activator activity,GO:0005096,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,USP48
GTPase activity,GO:0003924,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
GTPase activity,GO:0003924,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,RELA|S1PR4
GTPase activity,GO:0003924,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,GNB3|ITLN1|MRAS
GTPase binding,GO:0051020,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
GTPase binding,GO:0051020,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L1|GNB3
GTP binding,GO:0005525,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
GTP binding,GO:0005525,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,INSR|PCK1|RELA
GTP binding,GO:0005525,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
GTP binding,GO:0005525,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ITLN1|MRAS
GTP-dependent protein binding,GO:0030742,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
GTP-dependent protein binding,GO:0030742,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MRAS
GTP diphosphatase activity,GO:0036219,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
guanine transmembrane transporter activity,GO:0015208,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
guanylate cyclase activity,GO:0004383,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
guanyl nucleotide binding,GO:0019001,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR4
guanyl-nucleotide exchange factor activity,GO:0005085,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
guanyl-nucleotide exchange factor activity,GO:0005085,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
H3K27me3 modified histone binding,GO:0061628,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Particulate Matter,0,
H3K27me3 modified histone binding,GO:0061628,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
H3K27me3 modified histone binding,GO:0061628,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
H3K27me3 modified histone binding,GO:0061628,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dichlorodiphenyl Dichloroethylene|Particulate Matter|Vehicle Emissions,0,
H3K9me3 modified histone binding,GO:0062072,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
haptoglobin binding,GO:0031720,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HBA1
heat shock protein binding,GO:0031072,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BAX|KCNJ11
heat shock protein binding,GO:0031072,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
heat shock protein binding,GO:0031072,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,KCNJ11
heat shock protein binding,GO:0031072,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BAX|KCNJ11|NFKB1
heme binding,GO:0020037,Diabetes Mellitus,MESH:D003920,0,,3,CAT|CYBB|PTGS2
heme binding,GO:0020037,"Diabetes Mellitus, Experimental",MESH:D003921,0,,14,CAT|CYBA|CYBB|CYP1A1|CYP2B10|CYP2B9|CYP3A11|CYP4A10|CYP4A14|HMOX1|MPO|NOS2|NOS3|PTGS2
heme binding,GO:0020037,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,CAT|NOS1|NOS3
heme binding,GO:0020037,"Diabetes Mellitus, Type 2",MESH:D003924,0,,11,CAT|CBS|CYBA|CYP1A2|CYP3A2|CYP3A23-3A1|HBA1|HMOX1|HPX|NOS2|NOS3
heme oxygenase (decyclizing) activity,GO:0004392,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,1,HMOX1
heme oxygenase (decyclizing) activity,GO:0004392,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
heme transmembrane transporter activity,GO:0015232,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HPX
hemoglobin binding,GO:0030492,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HP
hemoglobin binding,GO:0030492,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HP
heparan sulfate proteoglycan binding,GO:0043395,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
heparin binding,GO:0008201,Diabetes Mellitus,MESH:D003920,0,,2,FN1|THBS2
heparin binding,GO:0008201,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MPO|VEGFA
heparin binding,GO:0008201,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,LIPC|NOTCH2
hepatocyte growth factor receptor activity,GO:0005008,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
hepatocyte growth factor receptor activity,GO:0005008,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
hepatocyte growth factor receptor activity,GO:0005008,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
heterocyclic compound binding,GO:1901363,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
hexokinase activity,GO:0004396,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|Alloxan|Chlorpromazine|Clozapine|Glyburide|Particulate Matter|Streptozocin,0,
hexokinase activity,GO:0004396,"Diabetes Mellitus, Experimental",MESH:D003921,8,Alloxan|chebulagic acid|Dietary Fats|Diltiazem|Glyburide|Quercetin|sodium arsenite|Streptozocin,2,GCK|HK1
hexokinase activity,GO:0004396,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
hexokinase activity,GO:0004396,"Diabetes Mellitus, Type 1",MESH:D003922,3,Alloxan|sodium arsenite|Streptozocin,0,
hexokinase activity,GO:0004396,"Diabetes Mellitus, Type 2",MESH:D003924,8,Air Pollutants|Alloxan|bisphenol S|Clozapine|Dietary Fats|Glyburide|Particulate Matter|Streptozocin,2,GCK|HK1
hexose transmembrane transporter activity,GO:0015149,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC2A2|SLC2A4
hexose transmembrane transporter activity,GO:0015149,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,SLC2A1|SLC2A2|SLC2A4
high-affinity L-glutamate transmembrane transporter activity,GO:0005314,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
high-density lipoprotein particle binding,GO:0008035,Diabetes Mellitus,MESH:D003920,0,,1,PON1
high-density lipoprotein particle binding,GO:0008035,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
high voltage-gated calcium channel activity,GO:0008331,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
high voltage-gated calcium channel activity,GO:0008331,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Particulate Matter,0,
histone acetyltransferase activity,GO:0004402,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone acetyltransferase activity,GO:0004402,"Diabetes Mellitus, Experimental",MESH:D003921,3,astaxanthine|bisphenol A|Quercetin,0,
histone acetyltransferase activity,GO:0004402,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
histone acetyltransferase activity,GO:0004402,"Diabetes Mellitus, Type 2",MESH:D003924,5,Ascorbic Acid|astaxanthine|bisphenol A|Curcumin|Genistein,0,
histone acetyltransferase binding,GO:0035035,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
histone acetyltransferase binding,GO:0035035,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ETS1|PAX6
histone binding,GO:0042393,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,SIRT1
histone binding,GO:0042393,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,SIRT1
histone binding,GO:0042393,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone binding,GO:0042393,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,2,PRKCB|SIRT1
histone deacetylase activity,GO:0004407,Diabetes Mellitus,MESH:D003920,3,Metformin|Plant Extracts|Streptozocin,1,SIRT1
histone deacetylase activity,GO:0004407,"Diabetes Mellitus, Experimental",MESH:D003921,6,astaxanthine|Dietary Fats|Metformin|Plant Extracts|Quercetin|Streptozocin,1,SIRT1
histone deacetylase activity,GO:0004407,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Streptozocin,0,
histone deacetylase activity,GO:0004407,"Diabetes Mellitus, Type 2",MESH:D003924,8,Ascorbic Acid|astaxanthine|Curcumin|Dietary Fats|Genistein|Metformin|Plant Extracts|Streptozocin,1,SIRT1
histone deacetylase binding,GO:0042826,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
histone deacetylase binding,GO:0042826,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,RELA|TP53|TRP53
histone deacetylase regulator activity,GO:0035033,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
histone H2AS121 kinase activity,GO:0072371,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H2AS121 kinase activity,GO:0072371,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H2AS139 kinase activity,GO:0035979,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H2AS139 kinase activity,GO:0035979,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H2AS1 kinase activity,GO:0044024,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H2AS1 kinase activity,GO:0044024,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H2AT120 kinase activity,GO:1990244,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H2AT120 kinase activity,GO:1990244,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H2AY142 kinase activity,GO:0140801,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
histone H2BS14 kinase activity,GO:0044025,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H2BS14 kinase activity,GO:0044025,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H2BS36 kinase activity,GO:0140823,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H2BS36 kinase activity,GO:0140823,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H2Y142 phosphatase activity,GO:0140793,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
histone H2Y142 phosphatase activity,GO:0140793,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
histone H3K14 acetyltransferase activity,GO:0036408,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,JADE2
histone H3K27 dimethyltransferase activity,GO:0140952,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H3K27 dimethyltransferase activity,GO:0140952,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone H3K27 dimethyltransferase activity,GO:0140952,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone H3K27 dimethyltransferase activity,GO:0140952,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
histone H3K27 trimethyltransferase activity,GO:0140951,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H3K27 trimethyltransferase activity,GO:0140951,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone H3K27 trimethyltransferase activity,GO:0140951,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone H3K27 trimethyltransferase activity,GO:0140951,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
histone H3K4me/H3K4me2/H3K4me3 demethylase activity,GO:0034647,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
histone H3K4me/H3K4me2/H3K4me3 demethylase activity,GO:0034647,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H3K4 methyltransferase activity,GO:0042800,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H3K4 methyltransferase activity,GO:0042800,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
histone H3K4 methyltransferase activity,GO:0042800,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
histone H3K4 methyltransferase activity,GO:0042800,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
histone H3K9 demethylase activity,GO:0032454,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
histone H3K9 demethylase activity,GO:0032454,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
histone H3K9 demethylase activity,GO:0032454,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Particulate Matter,0,
histone H3K9 trimethyltransferase activity,GO:0140949,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H3K9 trimethyltransferase activity,GO:0140949,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone H3K9 trimethyltransferase activity,GO:0140949,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone H3K9 trimethyltransferase activity,GO:0140949,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
histone H3S10 kinase activity,GO:0035175,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H3S10 kinase activity,GO:0035175,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H3S28 kinase activity,GO:0044022,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,ALPK1
histone H3S28 kinase activity,GO:0044022,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone H3S28 kinase activity,GO:0044022,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone H3S28 kinase activity,GO:0044022,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H3S57 kinase activity,GO:0140855,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H3S57 kinase activity,GO:0140855,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H3T11 kinase activity,GO:0035402,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H3T11 kinase activity,GO:0035402,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H3T3 kinase activity,GO:0072354,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H3T3 kinase activity,GO:0072354,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H3T45 kinase activity,GO:0140857,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H3T45 kinase activity,GO:0140857,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone H3T6 kinase activity,GO:0035403,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H3T6 kinase activity,GO:0035403,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCA
histone H3T6 kinase activity,GO:0035403,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,AKT1|AKT2|BRAF|KSR2|PIK3CG|PRKCB
histone H3Y41 kinase activity,GO:0035401,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
histone H4K12 acetyltransferase activity,GO:0043997,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,JADE2
histone H4K12 deacetylase activity,GO:0140937,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
histone H4K12 deacetylase activity,GO:0140937,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
histone H4K12 deacetylase activity,GO:0140937,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
histone H4K5 acetyltransferase activity,GO:0043995,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,JADE2
histone H4K8 acetyltransferase activity,GO:0043996,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,JADE2
histone H4S1 kinase activity,GO:0044023,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
histone H4S1 kinase activity,GO:0044023,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
histone methyltransferase activity,GO:0042054,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
histone methyltransferase activity,GO:0042054,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,0,
HLA-A specific activating MHC class I receptor activity,GO:0030108,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
HLH domain binding,GO:0043398,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
HLH domain binding,GO:0043398,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
HLH domain binding,GO:0043398,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
HMG box domain binding,GO:0071837,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
HMG box domain binding,GO:0071837,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HHEX|PAX6
hormone activity,GO:0005179,Diabetes Mellitus,MESH:D003920,0,,4,ADIPOQ|INS|INS2|POMC
hormone activity,GO:0005179,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,AGT|EDN1|IAPP|IGF1|INS1|LEP
hormone activity,GO:0005179,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
hormone activity,GO:0005179,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IGF1|INS|INS2
hormone activity,GO:0005179,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,ADIPOQ|EDN1|GCG|IAPP|INS|INS1|KL|LEP|RETN
hormone binding,GO:0042562,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ESRRA
Hsp70 protein binding,GO:0030544,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BAX|CYP1A1|CYP2B10
Hsp70 protein binding,GO:0030544,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
Hsp90 protein binding,GO:0051879,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CYP1A1|CYP2B10|NOS2|NOS3
Hsp90 protein binding,GO:0051879,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
Hsp90 protein binding,GO:0051879,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
hydrolase activity,GO:0016787,Diabetes Mellitus,MESH:D003920,0,,1,PON1
hydrolase activity,GO:0016787,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,ACE|MMP2|MMP9|PCSK2|REN|STS
hydrolase activity,GO:0016787,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
hydrolase activity,GO:0016787,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CTSH|PTPN22
hydrolase activity,GO:0016787,"Diabetes Mellitus, Type 2",MESH:D003924,0,,8,ADAMTS9|CAPN10|ECE1|ENPP1|PCSK2|PEPD|PTPN1|USP48
"hydrolase activity, acting on ester bonds",GO:0016788,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
"hydrolase activity, acting on ester bonds",GO:0016788,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
"hydrolase activity, acting on ester bonds",GO:0016788,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|Diethylhexyl Phthalate,0,
"hydrolase activity, acting on ester bonds",GO:0016788,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
"hydrolase activity, acting on ester bonds",GO:0016788,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,1,ENPP1
"hydrolase activity, acting on glycosyl bonds",GO:0016798,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
"hydrolase activity, hydrolyzing O-glycosyl compounds",GO:0004553,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KL
hydroperoxy icosatetraenoate dehydratase activity,GO:0106256,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
hydroperoxy icosatetraenoate dehydratase activity,GO:0106256,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP1A2
identical protein binding,GO:0042802,Diabetes Mellitus,MESH:D003920,0,,14,ADIPOQ|AOC3|CAT|CPT1A|FN1|INS|INS2|KIF1A|KIF5B|LEPR|MAP3K5|PPARG|SIRT1|SOD1
identical protein binding,GO:0042802,"Diabetes Mellitus, Experimental",MESH:D003921,0,,37,AOC3|ATF3|BAX|BCL2|BCL2L1|CAT|CAV1|CPT1A|FAS|GSR|HK1|HMOX1|IAPP|ID1|IL6|INS1|INSR|LEPR|MAP3K5|MMP9|NOS2|NQO1|PCX|PFKM|PPARG|RELA|SIRT1|SLC9A1|SLC9A3|SOD1|SOD2|TGFB1|TNF|TP53|TRP53|VEGFA|YWHAH
identical protein binding,GO:0042802,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
identical protein binding,GO:0042802,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
identical protein binding,GO:0042802,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
identical protein binding,GO:0042802,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
identical protein binding,GO:0042802,"Diabetes Mellitus, Type 1",MESH:D003922,0,,15,C1QTNF6|CAT|CD69|CRP|CTSH|DDIT3|HNF1A|HP|IL6|INS|INS2|ITPR3|NOS1|STAT3|TNF
identical protein binding,GO:0042802,"Diabetes Mellitus, Type 2",MESH:D003924,0,,51,ADIPOQ|AKT1|ATF3|BAX|BCL2|BCL2L1|BHMT|BRAF|CASP8|CAT|CBS|CCDC92|CNKSR2|CPT1A|DGKD|ECE1|EGFR|ENPP1|ETS1|FAS|GCG|GSTM1|HK1|HMG20A|HMOX1|HNF1A|HNF1B|HP|IAPP|ID1|IL6|INS|INS1|ITLN1|KCNK16|KCNQ1|LEPR|LIPC|MAPK8IP1|MAT1A|NFKB1|NOS2|PAM|PCX|PIK3CG|PPARG|SIRT1|SLC2A1|SOD1|SOD2|TNF
IgA receptor activity,GO:0019766,Diabetes Mellitus,MESH:D003920,2,"2,4,5,2',4',5'-hexachlorobiphenyl|Dichlorodiphenyl Dichloroethylene",0,
IgA receptor activity,GO:0019766,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
IgG receptor activity,GO:0019770,Diabetes Mellitus,MESH:D003920,2,"2,4,5,2',4',5'-hexachlorobiphenyl|Dichlorodiphenyl Dichloroethylene",0,
IgG receptor activity,GO:0019770,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
IkappaB kinase activity,GO:0008384,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
IkappaB kinase activity,GO:0008384,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
IkappaB kinase activity,GO:0008384,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
IkappaB kinase activity,GO:0008384,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|Quercetin,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|Lipopolysaccharides,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
"inositol 1,3,4,5 tetrakisphosphate binding",GO:0043533,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
"inositol 1,4,5 trisphosphate binding",GO:0070679,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",GO:0005220,"Diabetes Mellitus, Experimental",MESH:D003921,1,Losartan,0,
"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",GO:0005220,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
inositol hexakisphosphate binding,GO:0000822,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
inositol phosphate phosphatase activity,GO:0052745,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,INPPL1
inositol-polyphosphate 5-phosphatase activity,GO:0004445,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,INPPL1
insulin binding,GO:0043559,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
insulin binding,GO:0043559,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-like growth factor I binding,GO:0031994,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
insulin-like growth factor I binding,GO:0031994,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-like growth factor II binding,GO:0031995,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
insulin-like growth factor II binding,GO:0031995,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-like growth factor receptor activity,GO:0005010,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
insulin-like growth factor receptor activity,GO:0005010,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-like growth factor receptor activity,GO:0005010,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
insulin-like growth factor receptor binding,GO:0005159,Diabetes Mellitus,MESH:D003920,0,,3,INS|INS2|IRS1
insulin-like growth factor receptor binding,GO:0005159,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,IGF1|INS1|INSR|IRS1|REN|YWHAH
insulin-like growth factor receptor binding,GO:0005159,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
insulin-like growth factor receptor binding,GO:0005159,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-like growth factor receptor binding,GO:0005159,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IGF1|INS|INS2
insulin-like growth factor receptor binding,GO:0005159,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,INS|INS1|IRS1
insulin receptor activity,GO:0005009,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
insulin receptor activity,GO:0005009,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin receptor activity,GO:0005009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
insulin receptor binding,GO:0005158,Diabetes Mellitus,MESH:D003920,0,,3,INS|INS2|IRS1
insulin receptor binding,GO:0005158,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,IGF1|INS1|IRS1|IRS2|SLC2A2
insulin receptor binding,GO:0005158,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
insulin receptor binding,GO:0005158,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IGF1|INS|INS2
insulin receptor binding,GO:0005158,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,ENPP1|INS|INS1|IRS1|IRS2|PTPN1|SLC2A2
insulin receptor substrate binding,GO:0043560,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,INSR|PRKCD
insulin receptor substrate binding,GO:0043560,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-responsive glucose:proton symporter activity,GO:0005360,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A4
insulin-responsive glucose:proton symporter activity,GO:0005360,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A4
integrin binding,GO:0005178,Diabetes Mellitus,MESH:D003920,0,,1,FN1
integrin binding,GO:0005178,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,CX3CL1|ICAM1|IGF1|IL1B|MFGE8|PRKCA|S1PR2|TIMP2
integrin binding,GO:0005178,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
integrin binding,GO:0005178,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,EGFR|ICAM1|ITGA1
interleukin-10 receptor binding,GO:0005141,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL10
interleukin-13 receptor activity,GO:0016515,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL13RA1
interleukin-1 receptor binding,GO:0005149,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL1B
interleukin-20 receptor binding,GO:0045517,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL20
interleukin-22 receptor binding,GO:0045518,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL20
interleukin-27 receptor binding,GO:0045523,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL27
interleukin-2 binding,GO:0019976,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
interleukin-2 binding,GO:0019976,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL2RA
interleukin-2 receptor activity,GO:0004911,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
interleukin-2 receptor activity,GO:0004911,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL2RA
interleukin-6 receptor binding,GO:0005138,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
interleukin-6 receptor binding,GO:0005138,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
interleukin-6 receptor binding,GO:0005138,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL6
intracellular cAMP-activated cation channel activity,GO:0005222,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
inward rectifier potassium channel activity,GO:0005242,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,KCNJ11
inward rectifier potassium channel activity,GO:0005242,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
inward rectifier potassium channel activity,GO:0005242,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
inward rectifier potassium channel activity,GO:0005242,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,ABCC8|KCNJ11
inward rectifier potassium channel activity,GO:0005242,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ABCC8|KCNJ11
inward rectifier potassium channel inhibitor activity,GO:0070320,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
iodide peroxidase activity,GO:0004447,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
iodide peroxidase activity,GO:0004447,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
iodide peroxidase activity,GO:0004447,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
iodide peroxidase activity,GO:0004447,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
iron ion binding,GO:0005506,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
iron ion binding,GO:0005506,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,CYP1A1|CYP2B10|CYP2B9|CYP3A11|CYP4A10|CYP4A14
iron ion binding,GO:0005506,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,5,CDO1|CYP1A2|CYP3A2|CYP3A23-3A1|HBA1
iron ion transmembrane transporter activity,GO:0005381,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
iron-sulfur cluster binding,GO:0051536,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CDKAL1|CISD2
ISG15 transferase activity,GO:0042296,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UBE2E2
I-SMAD binding,GO:0070411,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
isocitrate dehydrogenase (NAD+) activity,GO:0004449,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Zinc,0,
isocitrate dehydrogenase (NAD+) activity,GO:0004449,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|tributyltin,0,
isocitrate dehydrogenase (NAD+) activity,GO:0004449,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
isocitrate dehydrogenase (NAD+) activity,GO:0004449,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Zinc,0,
isocitrate dehydrogenase (NADP+) activity,GO:0004450,Diabetes Mellitus,MESH:D003920,1,Zinc,0,
isocitrate dehydrogenase (NADP+) activity,GO:0004450,"Diabetes Mellitus, Type 2",MESH:D003924,1,Zinc,0,
isocitrate dehydrogenase [NAD(P)+] activity,GO:0004448,Diabetes Mellitus,MESH:D003920,3,Cadmium|Copper|Iron,0,
isocitrate dehydrogenase [NAD(P)+] activity,GO:0004448,"Diabetes Mellitus, Experimental",MESH:D003921,1,corilagin,0,
isocitrate dehydrogenase [NAD(P)+] activity,GO:0004448,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,0,
isocitrate dehydrogenase [NAD(P)+] activity,GO:0004448,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Copper|Iron,0,
JUN kinase activity,GO:0004705,Diabetes Mellitus,MESH:D003920,2,Cadmium|Docosahexaenoic Acids,0,
JUN kinase activity,GO:0004705,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
JUN kinase activity,GO:0004705,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ascorbic Acid|Cadmium|Glutathione,0,
JUN kinase binding,GO:0008432,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
JUN kinase binding,GO:0008432,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAPK8IP1
JUN kinase kinase kinase activity,GO:0004706,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
JUN kinase kinase kinase activity,GO:0004706,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MAP3K5
K63-linked deubiquitinase activity,GO:0061578,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
K63-linked deubiquitinase activity,GO:0061578,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
K63-linked polyubiquitin modification-dependent protein binding,GO:0070530,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
K63-linked polyubiquitin modification-dependent protein binding,GO:0070530,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
keratin filament binding,GO:1990254,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
keratin filament binding,GO:1990254,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
keratin filament binding,GO:1990254,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
kinase activity,GO:0016301,Diabetes Mellitus,MESH:D003920,0,,2,ALPK1|MAP3K5
kinase activity,GO:0016301,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,GCK|HK1|MAP3K5|NEUROD1|PCK1|PDK4|PFKM|PKLR
kinase activity,GO:0016301,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
kinase activity,GO:0016301,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,PRKCQ|TYK2
kinase activity,GO:0016301,"Diabetes Mellitus, Type 2",MESH:D003924,0,,11,AKT1|AKT2|BRAF|CNKSR2|DGKD|EGFR|GCK|HK1|MAPK8IP1|NEUROD1|PIK3CG
kinase binding,GO:0019900,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CAV1|FAS|PFKM
kinase binding,GO:0019900,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
kinase binding,GO:0019900,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,AKT1|DGKD|EGFR|FAS|GCKR|SLC2A1
kinase inhibitor activity,GO:0019210,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCKR
kinesin binding,GO:0019894,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAPK8IP1
kininogen binding,GO:0030984,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
lactase activity,GO:0000016,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Streptozocin,0,
lactase activity,GO:0000016,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Streptozocin,0,
lactase activity,GO:0000016,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
lactase activity,GO:0000016,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Cysteine|Streptozocin,0,
lactate dehydrogenase activity,GO:0004457,Diabetes Mellitus,MESH:D003920,28,"Air Pollutants|Alloxan|Arsenic|arsenite|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Clozapine|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Lead|Mercury|Metformin|Ozone|Particulate Matter|Plant Extracts|Raloxifene Hydrochloride|Resveratrol|Selenium|Sodium Selenite|Streptozocin|Tetrachlorodibenzodioxin|Zinc",0,
lactate dehydrogenase activity,GO:0004457,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
lactate dehydrogenase activity,GO:0004457,"Diabetes Mellitus, Experimental",MESH:D003921,29,"Alloxan|Berberine|bisphenol A|cobaltiprotoporphyrin|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Fatty Acids, Omega-3|fenugreek seed meal|Fructose|Gallic Acid|Glucose|Hydrogen Peroxide|Imatinib Mesylate|Manganese|Metformin|Niacinamide|Nicotine|Plant Extracts|Quercetin|Resveratrol|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|thymoquinone|Valsartan",0,
lactate dehydrogenase activity,GO:0004457,"Diabetes Mellitus, Type 1",MESH:D003922,13,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Imatinib Mesylate|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin|Thioctic Acid,0,
lactate dehydrogenase activity,GO:0004457,"Diabetes Mellitus, Type 2",MESH:D003924,43,"Air Pollutants|Alloxan|alpha-Tocopherol|Amoxicillin|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|Clozapine|Curcumin|Cysteine|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|efavirenz|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|Glucose|Lactic Acid|Lead|Malathion|Manganese|Mercury|Metformin|Niacinamide|Nickel|Nicotine|Particulate Matter|Plant Extracts|Resveratrol|Silver|Sitagliptin Phosphate|Streptozocin|titanium dioxide|Zinc",0,
L-alanine:2-oxoglutarate aminotransferase activity,GO:0004021,Diabetes Mellitus,MESH:D003920,5,"2,2',4,4'-tetrabromodiphenyl ether|Alloxan|bisphenol A|Lead|Plant Extracts",0,
L-alanine:2-oxoglutarate aminotransferase activity,GO:0004021,"Diabetes Mellitus, Experimental",MESH:D003921,4,Alloxan|bisphenol A|Plant Extracts|Quercetin,0,
L-alanine:2-oxoglutarate aminotransferase activity,GO:0004021,"Diabetes Mellitus, Type 1",MESH:D003922,2,Alloxan|bisphenol A,0,
L-alanine:2-oxoglutarate aminotransferase activity,GO:0004021,"Diabetes Mellitus, Type 2",MESH:D003924,8,Alloxan|Ascorbic Acid|bisphenol A|Lead|perfluorodecanoic acid|perfluorooctanoic acid|Plant Extracts|Silver,0,
L-amino acid transmembrane transporter activity,GO:0015179,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
large conductance calcium-activated potassium channel activity,GO:0060072,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,1,KCNU1
L-ascorbic acid binding,GO:0031418,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,Diabetes Mellitus,MESH:D003920,24,"Alloxan|Arsenic|arsenite|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Cyclosporine|Docosahexaenoic Acids|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Iron|Lead|Metformin|Ozone|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|Uranium|Zinc",0,
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,"Diabetes Mellitus, Experimental",MESH:D003921,40,"2-Hydroxypropyl-beta-cyclodextrin|Alloxan|Berberine|bisphenol A|Coconut Oil|Cyclophosphamide|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Dronabinol|Fatty Acids, Omega-3|fenugreek seed meal|Fructose|Gallic Acid|Glyburide|Hydrogen Peroxide|Imatinib Mesylate|mangiferin|Metformin|Monocrotophos|Niacinamide|Nicotine|Palm Oil|Pioglitazone|Plant Extracts|Propolis|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sarpogrelate|sodium arsenite|Sodium Glutamate|Streptozocin|swietenine|Taurine|thymoquinone|Ursolic Acid|Valsartan|Vitamin E",0,
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,"Diabetes Mellitus, Type 1",MESH:D003922,13,Alloxan|bisphenol A|Cyclophosphamide|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Niacinamide|Palm Oil|Resveratrol|sodium arsenite|Streptozocin|Taurine,0,
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,"Diabetes Mellitus, Type 2",MESH:D003924,38,"Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|Cadmium|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|Genistein|Glutathione|Glyburide|Iron|Lead|Malathion|mangiferin|Metformin|Niacinamide|Nicotine|Orlistat|perfluorooctane sulfonic acid|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|Silver|Streptozocin|titanium dioxide|Vildagliptin|Zinc",0,
L-aspartate transmembrane transporter activity,GO:0015183,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
L-aspartate transmembrane transporter activity,GO:0015183,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
LBD domain binding,GO:0050693,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
LBD domain binding,GO:0050693,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
LBD domain binding,GO:0050693,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARG|PROX1
leptin receptor activity,GO:0038021,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
leptin receptor activity,GO:0038021,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
leptin receptor activity,GO:0038021,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEPR
leptin receptor binding,GO:1990460,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
leptin receptor binding,GO:1990460,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEP
leucine zipper domain binding,GO:0043522,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
leukotriene-B4 20-monooxygenase activity,GO:0050051,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP4A10|CYP4A14
L-glutamate transmembrane transporter activity,GO:0005313,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
L-iditol 2-dehydrogenase activity,GO:0003939,"Diabetes Mellitus, Type 2",MESH:D003924,1,efavirenz,0,
ligand-gated sodium channel activity,GO:0015280,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNFRSF1A
ligand-gated sodium channel activity,GO:0015280,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNFRSF1A
ligase activity,GO:0016874,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
ligase activity,GO:0016874,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCLC|GCLM
lipase activity,GO:0016298,Diabetes Mellitus,MESH:D003920,3,Berberine|Ozone|Plant Extracts,0,
lipase activity,GO:0016298,"Diabetes Mellitus, Experimental",MESH:D003921,2,Berberine|Plant Extracts,0,
lipase activity,GO:0016298,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HP
lipase activity,GO:0016298,"Diabetes Mellitus, Type 2",MESH:D003924,4,Berberine|Ethanol|Orlistat|Plant Extracts,2,HP|LIPC
lipid binding,GO:0008289,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,BAX|ESRRA|IAPP|PPARA|PRKCA|S1PR2|S1PR4|SNAP25
lipid binding,GO:0008289,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,BAX|C3|CD36|IAPP|LIPC|PLEKHA1|PPARA|SHBG|SNAP25
lipoic acid binding,GO:0031405,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
lipoic acid binding,GO:0031405,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
lipopolysaccharide binding,GO:0001530,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
lipoprotein lipase activity,GO:0004465,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,1,LIPC
lipoprotein particle binding,GO:0071813,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
lipoteichoic acid immune receptor activity,GO:0070892,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
L-lactate dehydrogenase activity,GO:0004459,Diabetes Mellitus,MESH:D003920,1,"Metals, Heavy",0,
lncRNA binding,GO:0106222,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ATP2A2|PPARGC1A
lncRNA binding,GO:0106222,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
lncRNA binding,GO:0106222,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ATP2A2|MIR195|PPARGC1A
long-chain acyl-CoA hydrolase activity,GO:0052816,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
long-chain fatty acid-CoA ligase activity,GO:0004467,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
long-chain fatty acid omega-1 hydroxylase activity,GO:0120319,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
long-chain fatty acid omega-hydroxylase activity,GO:0102033,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CYP1A1|CYP4A10|CYP4A14
long-chain fatty acid transporter activity,GO:0005324,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CD36|SLC2A1
long-chain fatty acyl-CoA binding,GO:0036042,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
low-density lipoprotein particle binding,GO:0030169,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
low-density lipoprotein particle binding,GO:0030169,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CD36|LIPC
low-density lipoprotein particle receptor activity,GO:0005041,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
low-density lipoprotein particle receptor binding,GO:0050750,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
lutropin-choriogonadotropic hormone receptor binding,GO:0031775,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A2
lutropin-choriogonadotropic hormone receptor binding,GO:0031775,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A2
lyase activity,GO:0016829,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
lyase activity,GO:0016829,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,ADCY5|CBS|CYP1A2|OGG1|PAM
lysine-acetylated histone binding,GO:0070577,Diabetes Mellitus,MESH:D003920,3,Arsenic|bisphenol A|Dichlorodiphenyl Dichloroethylene,1,SIRT1
lysine-acetylated histone binding,GO:0070577,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Manganese|Nicotine|sodium arsenite,1,SIRT1
lysine-acetylated histone binding,GO:0070577,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
lysine-acetylated histone binding,GO:0070577,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|bisphenol A|Dichlorodiphenyl Dichloroethylene|epigallocatechin gallate|Ethanol|Manganese|Nicotine,1,SIRT1
lysophospholipase activity,GO:0004622,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
lysozyme activity,GO:0003796,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
lysozyme activity,GO:0003796,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
lysozyme activity,GO:0003796,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lysozyme activity,GO:0003796,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
macrophage colony-stimulating factor receptor activity,GO:0005011,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
macrophage colony-stimulating factor receptor activity,GO:0005011,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
macrophage colony-stimulating factor receptor activity,GO:0005011,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
magnesium ion binding,GO:0000287,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
magnesium ion binding,GO:0000287,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,GCK|MAP3K5|PCK1|PKLR
magnesium ion binding,GO:0000287,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
magnesium ion binding,GO:0000287,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,GCK|GCLC|MAT1A|RNF6
malate dehydrogenase activity,GO:0016615,Diabetes Mellitus,MESH:D003920,6,Air Pollutants|Arsenic|arsenite|bisphenol A|Cadmium|Particulate Matter,0,
malate dehydrogenase activity,GO:0016615,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
malate dehydrogenase activity,GO:0016615,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|corilagin|Cyclophosphamide|thymoquinone,0,
malate dehydrogenase activity,GO:0016615,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Cyclophosphamide,0,
malate dehydrogenase activity,GO:0016615,"Diabetes Mellitus, Type 2",MESH:D003924,6,Air Pollutants|Arsenic|bisphenol A|Cadmium|Curcumin|Particulate Matter,0,
malate transmembrane transporter activity,GO:0015140,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
malate transmembrane transporter activity,GO:0015140,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
malic enzyme activity,GO:0004470,Diabetes Mellitus,MESH:D003920,2,Copper|Zinc,0,
malic enzyme activity,GO:0004470,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Glucose|Monocrotophos|thymoquinone,0,
malic enzyme activity,GO:0004470,"Diabetes Mellitus, Type 2",MESH:D003924,4,Copper|Dietary Fats|Glucose|Zinc,0,
maltose alpha-glucosidase activity,GO:0032450,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Streptozocin,0,
maltose alpha-glucosidase activity,GO:0032450,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Streptozocin,0,
maltose alpha-glucosidase activity,GO:0032450,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
maltose alpha-glucosidase activity,GO:0032450,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cysteine|Nickel|Streptozocin,0,
manganese ion binding,GO:0030145,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PCK1|SOD2
manganese ion binding,GO:0030145,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PEPD|SOD2
manganese ion transmembrane transporter activity,GO:0005384,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
mannokinase activity,GO:0019158,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GCK|HK1
mannokinase activity,GO:0019158,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
mannokinase activity,GO:0019158,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|HK1
mannose-6-phosphate isomerase activity,GO:0004476,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
MAP kinase activity,GO:0004707,Diabetes Mellitus,MESH:D003920,2,Cadmium|Sodium Selenite,0,
MAP kinase activity,GO:0004707,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dronabinol|Sodium Selenite|tributyltin,0,
MAP kinase activity,GO:0004707,"Diabetes Mellitus, Type 1",MESH:D003922,1,Vitamin A,0,
MAP kinase activity,GO:0004707,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ascorbic Acid|Cadmium|Glutathione,0,
MAP kinase kinase activity,GO:0004708,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BRAF|MIR140
MAP kinase kinase kinase activity,GO:0004709,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
MAP kinase kinase kinase activity,GO:0004709,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MAP3K5
MAP kinase kinase kinase activity,GO:0004709,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BRAF|EGFR
MAP-kinase scaffold activity,GO:0005078,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,KSR2|MAPK8IP1
MDM2/MDM4 family protein binding,GO:0097371,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BCL2L1|PPARA|TP53|TRP53
MDM2/MDM4 family protein binding,GO:0097371,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L1|PPARA
melanocortin receptor activity,GO:0004977,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
melanocortin receptor binding,GO:0031779,Diabetes Mellitus,MESH:D003920,0,,1,A
melanocortin receptor binding,GO:0031779,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,A
melatonin receptor activity,GO:0008502,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MTNR1B
mercury ion binding,GO:0045340,Diabetes Mellitus,MESH:D003920,0,,1,FN1
metal cation:proton antiporter activity,GO:0051139,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
metal chelating activity,GO:0046911,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
metal-dependent deubiquitinase activity,GO:0140492,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
metal-dependent deubiquitinase activity,GO:0140492,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
metal ion binding,GO:0046872,Diabetes Mellitus,MESH:D003920,0,,13,AOC3|CAT|CP|CYBB|MAP3K5|MT2A|NR1I2|NR1I3|PON1|PPARG|PTGS2|SIRT1|SOD1
metal ion binding,GO:0046872,"Diabetes Mellitus, Experimental",MESH:D003921,0,,35,ACE|AOC3|ATP2A3|CAT|COX2|CYBA|CYBB|CYP1A1|ESRRA|GPD2|HMOX1|KCNJ11|MAP3K5|MMP2|MMP9|MPO|NOS2|NOS3|PCK1|PCSK2|PCX|PFKM|PKLR|PPARA|PPARG|PRKCA|PRKCE|PTGS2|SIRT1|SOD1|SOD2|STS|TIMP1|TIMP2|TP53
metal ion binding,GO:0046872,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
metal ion binding,GO:0046872,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
metal ion binding,GO:0046872,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
metal ion binding,GO:0046872,"Diabetes Mellitus, Type 1",MESH:D003922,0,,9,ABCC8|CAT|CP|CRP|GLIS3|KCNJ11|NOS1|NOS3|PRKCQ
metal ion binding,GO:0046872,"Diabetes Mellitus, Type 2",MESH:D003924,0,,54,ABCC8|ADAMTS9|ADCY5|AKT2|ATP2A3|BHMT|BRAF|CAT|CBS|CDKAL1|CDO1|CISD2|CYBA|DGKD|ECE1|ENPP1|FTO|GLIS3|GPD2|HBA1|HMOX1|HNF4A|HPX|ITGA1|ITLN1|JADE2|JAZF1|KCNJ11|KCNK16|KSR2|LIPC|MAEA|MAT1A|NOS2|NOS3|NOTCH2|NUS1|PAM|PCSK2|PCX|PEPD|PPARA|PPARG|PRKCB|RNF6|SIRT1|SLC1A2|SLC30A8|SMAD5|SOD1|SOD2|TIMP1|ZC3HC1|ZFAND3
metal ion transmembrane transporter activity,GO:0046873,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
metalloaminopeptidase activity,GO:0070006,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PEPD
metallocarboxypeptidase activity,GO:0004181,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
metallocarboxypeptidase activity,GO:0004181,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PEPD|ZC3HC1
metallodipeptidase activity,GO:0070573,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
metalloendopeptidase activity,GO:0004222,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ACE|MMP2|MMP9
metalloendopeptidase activity,GO:0004222,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ADAMTS9|ECE1
metalloendopeptidase inhibitor activity,GO:0008191,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TIMP1|TIMP2
metalloendopeptidase inhibitor activity,GO:0008191,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TIMP1
metallopeptidase activity,GO:0008237,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
metallopeptidase activity,GO:0008237,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cholesterol,3,ACE|MMP2|MMP9
metallopeptidase activity,GO:0008237,"Diabetes Mellitus, Type 2",MESH:D003924,2,epigallocatechin gallate|Glutathione,3,ADAMTS9|ECE1|PEPD
methionine adenosyltransferase activity,GO:0004478,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAT1A
methylated-DNA-[protein]-cysteine S-methyltransferase activity,GO:0003908,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
methylated histone binding,GO:0035064,Diabetes Mellitus,MESH:D003920,2,Dichlorodiphenyl Dichloroethylene|Particulate Matter,0,
methylated histone binding,GO:0035064,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,ACOX1
methylated histone binding,GO:0035064,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
methylated histone binding,GO:0035064,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dichlorodiphenyl Dichloroethylene|Particulate Matter|Vehicle Emissions,0,
methylthiotransferase activity,GO:0035596,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDKAL1
methyltransferase activity,GO:0008168,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
methyltransferase activity,GO:0008168,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BHMT|KCNU1|TNFRSF1B
MHC class II receptor activity,GO:0032395,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,HLA-DQA1|HLA-DQB1|HLA-DRB1
microtubule binding,GO:0008017,Diabetes Mellitus,MESH:D003920,0,,2,KIF1A|KIF5B
microtubule binding,GO:0008017,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TIMP2
microtubule binding,GO:0008017,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L11|OGG1
microtubule lateral binding,GO:0099609,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
microtubule motor activity,GO:0003777,Diabetes Mellitus,MESH:D003920,0,,2,KIF1A|KIF5B
microtubule motor activity,GO:0003777,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Hydrogen Peroxide,0,
microtubule motor activity,GO:0003777,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
minor groove of adenine-thymine-rich DNA binding,GO:0003680,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
minor groove of adenine-thymine-rich DNA binding,GO:0003680,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HMGA1|PAX6
misfolded protein binding,GO:0051787,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
mitochondrial transcription factor activity,GO:0034246,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FOXO3
mitogen-activated protein kinase binding,GO:0051019,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
mitogen-activated protein kinase binding,GO:0051019,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ACE|SIRT1
mitogen-activated protein kinase binding,GO:0051019,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
mitogen-activated protein kinase kinase binding,GO:0031434,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
mitogen-activated protein kinase kinase binding,GO:0031434,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BRAF|KSR2|MAPK8IP1
mitogen-activated protein kinase kinase kinase binding,GO:0031435,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARA
mitogen-activated protein kinase kinase kinase binding,GO:0031435,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,MAPK8IP1|PPARA
modified amino acid binding,GO:0072341,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
molecular adaptor activity,GO:0060090,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BCL2|CAV1|CAV3|SLC9A1
molecular adaptor activity,GO:0060090,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,BCL2|GRB14|HMGA1|NFATC2
molecular condensate scaffold activity,GO:0140693,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
molecular_function,GO:0003674,Diabetes Mellitus,MESH:D003920,0,,2,A|POMC
molecular_function,GO:0003674,"Diabetes Mellitus, Type 2",MESH:D003924,0,,14,A|CCDC92|CMIP|FAM234A|FTO|MIR17HG|MIR181C|MIR192|MIR203A|SMIM43|THADA|TMEM18|ZC3HC1|ZFAND3
molecular function activator activity,GO:0140677,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
molecular function activator activity,GO:0140677,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT2|HMGA1
molecular function inhibitor activity,GO:0140678,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TIMP2
molecular sequestering activity,GO:0140313,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CD69
monoamine oxidase activity,GO:0097621,Diabetes Mellitus,MESH:D003920,3,Berberine|bisphenol A|Cadmium,0,
monoamine oxidase activity,GO:0097621,"Diabetes Mellitus, Experimental",MESH:D003921,3,Berberine|bisphenol A|Diethylhexyl Phthalate,0,
monoamine oxidase activity,GO:0097621,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Thioctic Acid|Vitamin A,0,
monoamine oxidase activity,GO:0097621,"Diabetes Mellitus, Type 2",MESH:D003924,4,Berberine|bisphenol A|Cadmium|Diethylhexyl Phthalate,0,
monoamine transmembrane transporter activity,GO:0008504,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
monoamine transmembrane transporter activity,GO:0008504,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
monoatomic anion transmembrane transporter activity,GO:0008509,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
monoatomic cation channel activity,GO:0005261,Diabetes Mellitus,MESH:D003920,1,Glyburide,0,
monoatomic cation channel activity,GO:0005261,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glyburide,0,
monoatomic cation channel activity,GO:0005261,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
monoatomic cation channel activity,GO:0005261,"Diabetes Mellitus, Type 2",MESH:D003924,2,Calcium|Glyburide,0,
monoatomic cation transmembrane transporter activity,GO:0008324,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC30A8
monoatomic ion channel activity,GO:0005216,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
monoatomic ion channel activity,GO:0005216,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNU1
monoatomic ion transmembrane transporter activity,GO:0015075,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S100A6
monoatomic ion transmembrane transporter activity,GO:0015075,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,S100A6
monodehydroascorbate reductase (NADH) activity,GO:0016656,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
monodehydroascorbate reductase (NADH) activity,GO:0016656,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
monooxygenase activity,GO:0004497,Diabetes Mellitus,MESH:D003920,1,Sulpiride,0,
monooxygenase activity,GO:0004497,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,CYP1A1|CYP2B10|CYP2B9|CYP3A11|CYP4A10|CYP4A14|YWHAH
monooxygenase activity,GO:0004497,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,CYP1A2|CYP3A2|CYP3A23-3A1|PAM
monosaccharide binding,GO:0048029,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
monosaccharide binding,GO:0048029,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PFKM|PKLR
mRNA 3'-UTR binding,GO:0003730,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
mRNA 3'-UTR binding,GO:0003730,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,2,TP53|TRP53
mRNA 3'-UTR binding,GO:0003730,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
mRNA 3'-UTR binding,GO:0003730,"Diabetes Mellitus, Type 2",MESH:D003924,0,,27,IGF2BP2|MIR10B|MIR125B1|MIR126|MIR127|MIR130B|MIR140|MIR141|MIR142|MIR144|MIR151A|MIR1908|MIR192|MIR195|MIR204|MIR205|MIR214|MIR27A|MIR30A|MIR3173|MIR335|MIR339|MIR33B|MIR483|MIR885|MIR92B|MIR98
mRNA 5'-UTR binding,GO:0048027,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
mRNA 5'-UTR binding,GO:0048027,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
mRNA 5'-UTR binding,GO:0048027,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
mRNA 5'-UTR binding,GO:0048027,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IGF2BP2
mRNA base-pairing translational repressor activity,GO:1903231,"Diabetes Mellitus, Type 2",MESH:D003924,0,,39,MIR10B|MIR125B1|MIR126|MIR1260B|MIR127|MIR130B|MIR140|MIR141|MIR142|MIR144|MIR151A|MIR181C|MIR1908|MIR192|MIR195|MIR200A|MIR203A|MIR204|MIR205|MIR214|MIR215|MIR221|MIR222|MIR27A|MIR30A|MIR3173|MIR335|MIR339|MIR33B|MIR409|MIR423|MIR4516|MIR483|MIR485|MIR487B|MIR885|MIR92B|MIR939|MIR98
mRNA binding,GO:0003729,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
mRNA binding,GO:0003729,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR409
mRNA CDS binding,GO:1990715,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
mRNA CDS binding,GO:1990715,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
mRNA CDS binding,GO:1990715,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR485
mRNA N6-methyladenosine dioxygenase activity,GO:1990931,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FTO
myosin binding,GO:0017022,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
myosin binding,GO:0017022,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
myosin binding,GO:0017022,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
myosin light chain kinase activity,GO:0004687,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
myosin light chain kinase activity,GO:0004687,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,0,
myosin phosphatase activity,GO:0017018,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
myosin phosphatase activity,GO:0017018,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
N6-methyladenosine-containing RNA binding,GO:1990247,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IGF2BP2
N6-threonylcarbomyladenosine methylthiotransferase activity,GO:0035598,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDKAL1
NAD binding,GO:0051287,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HSD11B2
NAD+ binding,GO:0070403,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD+ binding,GO:0070403,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD+ binding,GO:0070403,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone deacetylase activity,GO:0017136,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone deacetylase activity,GO:0017136,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone deacetylase activity,GO:0017136,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone decrotonylase activity,GO:0160012,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone decrotonylase activity,GO:0160012,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone decrotonylase activity,GO:0160012,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone H3K14 deacetylase activity,GO:0032041,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone H3K14 deacetylase activity,GO:0032041,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone H3K14 deacetylase activity,GO:0032041,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone H3K18 deacetylase activity,GO:0097372,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone H3K18 deacetylase activity,GO:0097372,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone H3K18 deacetylase activity,GO:0097372,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone H3K56 deacetylase activity,GO:0140765,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone H3K56 deacetylase activity,GO:0140765,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone H3K56 deacetylase activity,GO:0140765,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone H3K9 deacetylase activity,GO:0046969,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone H3K9 deacetylase activity,GO:0046969,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone H3K9 deacetylase activity,GO:0046969,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent histone H4K16 deacetylase activity,GO:0046970,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent histone H4K16 deacetylase activity,GO:0046970,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent histone H4K16 deacetylase activity,GO:0046970,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NAD-dependent protein deacetylase activity,GO:0034979,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
NAD-dependent protein deacetylase activity,GO:0034979,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
NAD-dependent protein deacetylase activity,GO:0034979,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
NADH dehydrogenase activity,GO:0003954,Diabetes Mellitus,MESH:D003920,2,Lead|Streptozocin,0,
NADH dehydrogenase activity,GO:0003954,"Diabetes Mellitus, Experimental",MESH:D003921,2,corilagin|Streptozocin,1,AIFM1
NADH dehydrogenase activity,GO:0003954,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,1,AIFM1
NADH dehydrogenase activity,GO:0003954,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ascorbic Acid|Lead|Streptozocin,0,
NADH dehydrogenase (quinone) activity,GO:0050136,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NQO1
NADH dehydrogenase (ubiquinone) activity,GO:0008137,Diabetes Mellitus,MESH:D003920,23,Air Pollutants|Arsenic|Atrazine|Berberine|Bezafibrate|bisphenol A|Cadmium|Chlorpromazine|Clozapine|Cyclosporine|Docosahexaenoic Acids|Lead|Mercury|Molybdenum|Ozone|Particulate Matter|Plant Extracts|Pyruvaldehyde|Resveratrol|Risperidone|Rosiglitazone|Sodium Selenite|Streptozocin,0,
NADH dehydrogenase (ubiquinone) activity,GO:0008137,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
NADH dehydrogenase (ubiquinone) activity,GO:0008137,"Diabetes Mellitus, Experimental",MESH:D003921,22,"Berberine|Bezafibrate|bisphenol A|Cyclophosphamide|Dietary Fats|Dronabinol|Exenatide|ginsenoside Re|Glucose|honokiol|Hydrogen Peroxide|Monocrotophos|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Selenite|Streptozocin|Taurine|Tetracyclines",1,ND1
NADH dehydrogenase (ubiquinone) activity,GO:0008137,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
NADH dehydrogenase (ubiquinone) activity,GO:0008137,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Cyclophosphamide|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid,0,
NADH dehydrogenase (ubiquinone) activity,GO:0008137,"Diabetes Mellitus, Type 2",MESH:D003924,26,Air Pollutants|Arsenic|Atrazine|Berberine|Bezafibrate|bisphenol A|Cadmium|Clozapine|Curcumin|Dietary Fats|epigallocatechin gallate|Ethanol|Exenatide|ginsenoside Re|Glucose|Lead|Malathion|Mercury|Particulate Matter|perfluorooctanoic acid|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|TAK-875|Vehicle Emissions,0,
NADP binding,GO:0050661,Diabetes Mellitus,MESH:D003920,0,,1,CAT
NADP binding,GO:0050661,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,CAT|GSR|HSD11B1|NOS2|NOS3
NADP binding,GO:0050661,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,CAT|NOS1|NOS3
NADP binding,GO:0050661,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CAT|NOS2|NOS3
NADPH binding,GO:0070402,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
NADPH binding,GO:0070402,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYBB
NADPH binding,GO:0070402,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
NADPH dehydrogenase activity,GO:0003959,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
NAD(P)H dehydrogenase (quinone) activity,GO:0003955,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NQO1
NADPH dehydrogenase (quinone) activity,GO:0008753,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NQO1
NADPH-hemoprotein reductase activity,GO:0003958,"Diabetes Mellitus, Experimental",MESH:D003921,3,Diethylhexyl Phthalate|Quercetin|Taurine,0,
NADPH-hemoprotein reductase activity,GO:0003958,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
NADPH-hemoprotein reductase activity,GO:0003958,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
NAD(P)H oxidase H2O2-forming activity,GO:0016174,Diabetes Mellitus,MESH:D003920,6,Air Pollutants|Heptachlor|Lead|Particulate Matter|Pyruvaldehyde|Resveratrol,0,
NAD(P)H oxidase H2O2-forming activity,GO:0016174,"Diabetes Mellitus, Experimental",MESH:D003921,7,eupafolin|Glucose|Hydrogen Peroxide|Nicotine|Quercetin|Resveratrol|sodium arsenite,1,AIFM1
NAD(P)H oxidase H2O2-forming activity,GO:0016174,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Resveratrol|sodium arsenite,1,AIFM1
NAD(P)H oxidase H2O2-forming activity,GO:0016174,"Diabetes Mellitus, Type 2",MESH:D003924,7,Air Pollutants|Ascorbic Acid|Glucose|Lead|Nicotine|Particulate Matter|Resveratrol,0,
NAD+-protein ADP-ribosyltransferase activity,GO:1990404,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
neuropeptide hormone activity,GO:0005184,Diabetes Mellitus,MESH:D003920,0,,1,POMC
neuropilin binding,GO:0038191,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
neurotransmitter transmembrane transporter activity,GO:0005326,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
neurotransmitter transmembrane transporter activity,GO:0005326,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
neutral L-amino acid transmembrane transporter activity,GO:0015175,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
NFAT protein binding,GO:0051525,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARA
NFAT protein binding,GO:0051525,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARA
NF-kappaB binding,GO:0051059,"Diabetes Mellitus, Experimental",MESH:D003921,1,platycodin D,1,RELA
NF-kappaB binding,GO:0051059,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
NF-kappaB binding,GO:0051059,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,1,NOTCH2
nickel cation binding,GO:0016151,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CDO1|GSTM1
nitric oxide binding,GO:0070026,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
nitric-oxide synthase activity,GO:0004517,Diabetes Mellitus,MESH:D003920,7,bisphenol A|Cadmium|Molybdenum|Resveratrol|Selenium|Sulfur Dioxide|Tobacco Smoke Pollution,0,
nitric-oxide synthase activity,GO:0004517,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dietary Fats|Quercetin|Resveratrol,2,NOS2|NOS3
nitric-oxide synthase activity,GO:0004517,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Thioctic Acid,2,NOS1|NOS3
nitric-oxide synthase activity,GO:0004517,"Diabetes Mellitus, Type 2",MESH:D003924,5,"bisphenol A|Cadmium|Dietary Fats|Drugs, Chinese Herbal|Resveratrol",2,NOS2|NOS3
nitric-oxide synthase binding,GO:0050998,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CAV1|CAV3|NOS2|NOS3
nitric-oxide synthase binding,GO:0050998,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
nitric-oxide synthase binding,GO:0050998,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
nitric-oxide synthase inhibitor activity,GO:0036487,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
nitric-oxide synthase regulator activity,GO:0030235,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
nitrite reductase (NO-forming) activity,GO:0050421,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CBS|CYP1A2
NMDA glutamate receptor activity,GO:0004972,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
NMDA glutamate receptor activity,GO:0004972,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
NMDA glutamate receptor activity,GO:0004972,"Diabetes Mellitus, Type 2",MESH:D003924,2,Genistein|Glucose,0,
non-membrane spanning protein tyrosine kinase activity,GO:0004715,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCD
non-membrane spanning protein tyrosine kinase activity,GO:0004715,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
non-membrane spanning protein tyrosine phosphatase activity,GO:0004726,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
non-membrane spanning protein tyrosine phosphatase activity,GO:0004726,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
norepinephrine binding,GO:0051380,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
norepinephrine binding,GO:0051380,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
Notch binding,GO:0005112,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
nuclear androgen receptor binding,GO:0050681,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PRKCB|RNF6
nuclear estrogen receptor activity,GO:0030284,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
nuclear estrogen receptor activity,GO:0030284,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
nuclear estrogen receptor activity,GO:0030284,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
nuclear estrogen receptor activity,GO:0030284,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
nuclear estrogen receptor binding,GO:0030331,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
nuclear estrogen receptor binding,GO:0030331,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PPARG|PPARGC1A
nuclear estrogen receptor binding,GO:0030331,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARG|PPARGC1A
nuclear glucocorticoid receptor binding,GO:0035259,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,YWHAH
nuclear glucocorticoid receptor binding,GO:0035259,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
nuclear receptor activity,GO:0004879,Diabetes Mellitus,MESH:D003920,1,bisphenol A,3,NR1I2|NR1I3|PPARG
nuclear receptor activity,GO:0004879,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,4,ESRRA|PPARA|PPARG|SREBF1
nuclear receptor activity,GO:0004879,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,STAT3
nuclear receptor activity,GO:0004879,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,3,HNF4A|PPARA|PPARG
nuclear receptor binding,GO:0016922,Diabetes Mellitus,MESH:D003920,0,,2,NR1I2|SIRT1
nuclear receptor binding,GO:0016922,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PPARGC1A|SIRT1
nuclear receptor binding,GO:0016922,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,PPARGC1A|PROX1|SIRT1|TCF7L2
nuclear receptor coactivator activity,GO:0030374,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
nuclear receptor coactivator activity,GO:0030374,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARGC1A|PRKCB
nuclear retinoic acid receptor binding,GO:0042974,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMGA1
nuclear retinoid X receptor binding,GO:0046965,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
nuclear retinoid X receptor binding,GO:0046965,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
nuclear retinoid X receptor binding,GO:0046965,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HMGA1|PPARG
nuclear steroid receptor activity,GO:0003707,Diabetes Mellitus,MESH:D003920,0,,1,NR1I2
nuclear steroid receptor activity,GO:0003707,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ESRRA|PPARA
nuclear steroid receptor activity,GO:0003707,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HNF4A|PPARA
nucleic acid binding,GO:0003676,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
nucleic acid binding,GO:0003676,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,CAV1|IGF1|MFGE8|PPARG|PPARGC1A|STS
nucleic acid binding,GO:0003676,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
nucleic acid binding,GO:0003676,"Diabetes Mellitus, Type 2",MESH:D003924,0,,10,CDKAL1|ENPP1|EPC2|ETS1|GCLC|IL13RA1|PPARG|PPARGC1A|ST6GAL1|TMEM18
nucleobase transmembrane transporter activity,GO:0015205,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
nucleoside diphosphate kinase activity,GO:0004550,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
nucleoside transmembrane transporter activity,GO:0005337,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
nucleoside triphosphate diphosphatase activity,GO:0047429,Diabetes Mellitus,MESH:D003920,2,Metformin|Streptozocin,0,
nucleoside triphosphate diphosphatase activity,GO:0047429,"Diabetes Mellitus, Experimental",MESH:D003921,3,Fructose|Metformin|Streptozocin,0,
nucleoside triphosphate diphosphatase activity,GO:0047429,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
nucleoside triphosphate diphosphatase activity,GO:0047429,"Diabetes Mellitus, Type 2",MESH:D003924,3,Fructose|Metformin|Streptozocin,1,ENPP1
nucleotide binding,GO:0000166,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
nucleotide binding,GO:0000166,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,ATP2A3|GCK|GSR|HK1|MAP3K5|PCK1|PDK4|PKLR
nucleotide binding,GO:0000166,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
nucleotide binding,GO:0000166,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
nucleotide binding,GO:0000166,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,ABCC8|PRKCQ|TYK2
nucleotide binding,GO:0000166,"Diabetes Mellitus, Type 2",MESH:D003924,0,,11,ABCC8|ADCY5|AKT1|AKT2|ATP2A3|BRAF|GCK|GCLC|HK1|MAT1A|UBE2E2
nutrient reservoir activity,GO:0045735,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
nutrient reservoir activity,GO:0045735,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
O-acyltransferase activity,GO:0008374,Diabetes Mellitus,MESH:D003920,0,,1,CPT1A
O-acyltransferase activity,GO:0008374,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CPT1A|GPAM
O-acyltransferase activity,GO:0008374,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CPT1A
oleate transmembrane transporter activity,GO:1901480,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
oleic acid binding,GO:0070538,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
oleoyl-CoA ligase activity,GO:0090434,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
olfactory receptor activity,GO:0004984,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
oligosaccharide binding,GO:0070492,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ITLN1
organic acid binding,GO:0043177,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HBA1
organic anion transmembrane transporter activity,GO:0008514,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
organic cation transmembrane transporter activity,GO:0015101,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
organic cation transmembrane transporter activity,GO:0015101,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
ornithine decarboxylase inhibitor activity,GO:0008073,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
ornithine decarboxylase inhibitor activity,GO:0008073,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
outward rectifier potassium channel activity,GO:0015271,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,KCNK16|KCNQ1
oxaloacetate transmembrane transporter activity,GO:0015131,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
oxaloacetate transmembrane transporter activity,GO:0015131,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
oxidative DNA demethylase activity,GO:0035516,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FTO
oxidative phosphorylation uncoupler activity,GO:0017077,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
oxidative phosphorylation uncoupler activity,GO:0017077,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
oxidative RNA demethylase activity,GO:0035515,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FTO
oxidised low-density lipoprotein particle receptor activity,GO:0150025,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
oxidized base lesion DNA N-glycosylase activity,GO:0000702,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
oxidized purine DNA binding,GO:0032357,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
oxidized purine nucleobase lesion DNA N-glycosylase activity,GO:0008534,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
oxidoreductase activity,GO:0016491,Diabetes Mellitus,MESH:D003920,1,Pyruvaldehyde,5,AOC3|CAT|CP|CYBB|SOD1
oxidoreductase activity,GO:0016491,"Diabetes Mellitus, Experimental",MESH:D003921,0,,19,ACOX1|AIFM1|AOC3|CAT|COX2|CYBA|CYBB|CYP1A1|CYP2B10|CYP3A11|GPD2|GSR|HSD11B1|MPO|NOS2|NOS3|SOD1|SOD2|YWHAH
oxidoreductase activity,GO:0016491,"Diabetes Mellitus, Type 1",MESH:D003922,0,,6,AIFM1|CAT|CP|HSD11B2|NOS1|NOS3
oxidoreductase activity,GO:0016491,"Diabetes Mellitus, Type 2",MESH:D003924,0,,12,CAT|CDO1|CYBA|CYP1A2|CYP3A2|FTO|GPD2|NOS2|NOS3|PAM|SOD1|SOD2
"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",GO:0016668,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GSR
"oxidoreductase activity, acting on diphenols and related substances as donors",GO:0016679,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
"oxidoreductase activity, acting on metal ions, oxygen as acceptor",GO:0016724,Diabetes Mellitus,MESH:D003920,0,,1,CP
"oxidoreductase activity, acting on metal ions, oxygen as acceptor",GO:0016724,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
"oxidoreductase activity, acting on NAD(P)H",GO:0016651,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AIFM1
"oxidoreductase activity, acting on NAD(P)H",GO:0016651,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
"oxidoreductase activity, acting on NAD(P)H",GO:0016651,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",GO:0016705,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP4A14
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",GO:0016705,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYP3A2|CYP3A23-3A1
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen",GO:0016715,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",GO:0016712,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",GO:0016712,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,4,CYP1A1|CYP2B10|CYP2B9|CYP3A11
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",GO:0016712,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",GO:0016712,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|bisphenol S|coumarin|Diethylnitrosamine,3,CYP1A2|CYP3A2|CYP3A23-3A1
"oxidoreductase activity, acting on peroxide as acceptor",GO:0016684,Diabetes Mellitus,MESH:D003920,0,,1,CAT
"oxidoreductase activity, acting on peroxide as acceptor",GO:0016684,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAT
"oxidoreductase activity, acting on peroxide as acceptor",GO:0016684,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CAT
"oxidoreductase activity, acting on peroxide as acceptor",GO:0016684,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAT
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",GO:0016701,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",GO:0016701,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PTGS2
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",GO:0016702,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",GO:0016702,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PTGS2
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",GO:0016702,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDO1
"oxidoreductase activity, acting on the CH-CH group of donors",GO:0016627,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACOX1
"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",GO:0016641,Diabetes Mellitus,MESH:D003920,0,,1,AOC3
"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",GO:0016641,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AOC3
oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004591,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004591,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004591,"Diabetes Mellitus, Experimental",MESH:D003921,2,corilagin|Cyclophosphamide,0,
oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004591,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|Thioctic Acid,0,
oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004591,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
oxygen binding,GO:0019825,Diabetes Mellitus,MESH:D003920,2,Atrazine|Resveratrol,0,
oxygen binding,GO:0019825,"Diabetes Mellitus, Experimental",MESH:D003921,2,Resveratrol|Taurine,2,CYP1A1|SOD2
oxygen binding,GO:0019825,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|Taurine,0,
oxygen binding,GO:0019825,"Diabetes Mellitus, Type 2",MESH:D003924,3,Atrazine|Curcumin|Resveratrol,3,CBS|HBA1|SOD2
oxygen carrier activity,GO:0005344,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HBA1
oxysterol binding,GO:0008142,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
p53 binding,GO:0002039,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
p53 binding,GO:0002039,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,SIRT1|TP53|TRP53
p53 binding,GO:0002039,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
palmitoyl-CoA ligase activity,GO:0090433,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
palmitoyl-CoA oxidase activity,GO:0016401,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACOX1
patched binding,GO:0005113,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
PDZ domain binding,GO:0030165,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
PDZ domain binding,GO:0030165,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ACOX1|SLC9A3
PDZ domain binding,GO:0030165,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PLEKHA1
peptidase activator activity,GO:0016504,Diabetes Mellitus,MESH:D003920,0,,1,FN1
peptidase activator activity,GO:0016504,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
peptidase activator activity involved in apoptotic process,GO:0016505,Diabetes Mellitus,MESH:D003920,3,Docosahexaenoic Acids|Plant Extracts|triphenyltin,0,
peptidase activator activity involved in apoptotic process,GO:0016505,"Diabetes Mellitus, Experimental",MESH:D003921,5,Glucose|Hydrogen Peroxide|Plant Extracts|tributyltin|triphenyltin chloride,0,
peptidase activator activity involved in apoptotic process,GO:0016505,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
peptidase activator activity involved in apoptotic process,GO:0016505,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ethanol|Glucose|Plant Extracts,0,
peptidase activity,GO:0008233,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
peptidase activity,GO:0008233,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,ACE|CASP3|MMP2|MMP9|PCSK2|REN
peptidase activity,GO:0008233,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
peptidase activity,GO:0008233,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CASP12|CTSH
peptidase activity,GO:0008233,"Diabetes Mellitus, Type 2",MESH:D003924,3,Particulate Matter|titanium dioxide|Vehicle Emissions,8,ADAMTS9|CAPN10|CASP3|CASP8|ECE1|PCSK2|PEPD|USP48
peptidase inhibitor activity,GO:0030414,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TIMP1|TIMP2
peptidase inhibitor activity,GO:0030414,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TIMP1
peptide antigen binding,GO:0042605,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,HLA-DQA1|HLA-DQB1|HLA-DRB1
peptide antigen binding,GO:0042605,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HLA-DRB5
peptide binding,GO:0042277,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
peptide binding,GO:0042277,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BDKRB1|PPARG|RELA
peptide binding,GO:0042277,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARG|SCTR
peptide hormone binding,GO:0017046,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
peptide hormone binding,GO:0017046,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
peptide hormone binding,GO:0017046,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,ECE1|EDNRB|GLP1R|LEPR|SCTR
peptide hormone receptor binding,GO:0051428,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
peptide hormone receptor binding,GO:0051428,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEP
peptide receptor activity,GO:0001653,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GLP1R
peptidoglycan binding,GO:0042834,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HK1
peptidoglycan binding,GO:0042834,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HK1|ITLN1
peptidylamidoglycolate lyase activity,GO:0004598,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
peptidyl-cysteine S-nitrosylase activity,GO:0035605,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
peptidyl-dipeptidase activity,GO:0008241,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
peptidylglycine monooxygenase activity,GO:0004504,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
peroxidase activity,GO:0004601,Diabetes Mellitus,MESH:D003920,3,Arsenic|Atrazine|bisphenol A,2,CAT|PTGS2
peroxidase activity,GO:0004601,"Diabetes Mellitus, Experimental",MESH:D003921,5,Anthocyanins|bisphenol A|Diethylhexyl Phthalate|platycodin D|sodium arsenite,4,CAT|GPX1|MPO|PTGS2
peroxidase activity,GO:0004601,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|decabromobiphenyl ether|sodium arsenite,1,CAT
peroxidase activity,GO:0004601,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|Atrazine|bisphenol A|Curcumin|Diethylhexyl Phthalate,3,CAT|GPX1|HBA1
peroxisome proliferator activated receptor binding,GO:0042975,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
peroxisome proliferator activated receptor binding,GO:0042975,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HMGA1|PPARGC1A
phosphatase activator activity,GO:0019211,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ITGA1
phosphatase activity,GO:0016791,Diabetes Mellitus,MESH:D003920,4,Cadmium|Magnesium|Potassium|Tungsten,0,
phosphatase activity,GO:0016791,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,PTPN22|SLC11A1
phosphatase activity,GO:0016791,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Magnesium,3,ENPP1|INPPL1|PTPN1
phosphatase binding,GO:0019902,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARA
phosphatase binding,GO:0019902,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NFATC2|PPARA
phosphate ion binding,GO:0042301,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
phosphate ion binding,GO:0042301,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
phosphate ion uniporter activity,GO:0140787,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
phosphate ion uniporter activity,GO:0140787,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
phosphatidylcholine binding,GO:0031210,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL27
phosphatidylcholine transporter activity,GO:0008525,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL27
"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity",GO:0034485,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,INPPL1
"phosphatidylinositol-3,4,5-trisphosphate binding",GO:0005547,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|INPPL1
"phosphatidylinositol-3,4-bisphosphate binding",GO:0043325,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
"phosphatidylinositol-3,4-bisphosphate binding",GO:0043325,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NCF1
"phosphatidylinositol-3,4-bisphosphate binding",GO:0043325,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|PLEKHA1
phosphatidylinositol 3-kinase binding,GO:0043548,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
phosphatidylinositol 3-kinase binding,GO:0043548,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,INSR|IRS1|IRS2
phosphatidylinositol 3-kinase binding,GO:0043548,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
phosphatidylinositol 3-kinase binding,GO:0043548,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IRS1|IRS2
"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",GO:0046934,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PIK3CG
"phosphatidylinositol-4,5-bisphosphate binding",GO:0005546,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC9A1
"phosphatidylinositol-4,5-bisphosphate binding",GO:0005546,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
phosphatidylinositol binding,GO:0035091,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
phosphatidylinositol binding,GO:0035091,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NCF1|SLC9A3
phosphatidylinositol binding,GO:0035091,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL27|ITPR3
phosphatidylinositol phospholipase C activity,GO:0004435,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
phosphatidylinositol phospholipase C activity,GO:0004435,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRA
phosphatidylinositol transfer activity,GO:0008526,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL27
phosphatidylserine 1-acylhydrolase activity,GO:0052739,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
phosphatidylserine binding,GO:0001786,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MFGE8
phosphatidylserine floppase activity,GO:0090556,Diabetes Mellitus,MESH:D003920,1,Reactive Oxygen Species,0,
phosphatidylserine floppase activity,GO:0090556,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
phosphatidylserine floppase activity,GO:0090556,"Diabetes Mellitus, Type 2",MESH:D003924,1,Reactive Oxygen Species,0,
phosphodiesterase I activity,GO:0004528,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
phosphoenolpyruvate carboxykinase activity,GO:0004611,Diabetes Mellitus,MESH:D003920,4,Arsenic|Glyburide|Plant Extracts|Streptozocin,0,
phosphoenolpyruvate carboxykinase activity,GO:0004611,"Diabetes Mellitus, Experimental",MESH:D003921,4,Glyburide|Plant Extracts|sodium arsenite|Streptozocin,1,PCK1
phosphoenolpyruvate carboxykinase activity,GO:0004611,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
phosphoenolpyruvate carboxykinase activity,GO:0004611,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|bisphenol S|Glyburide|Plant Extracts|Streptozocin,0,
phosphoenolpyruvate carboxykinase (GTP) activity,GO:0004613,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
phosphofructokinase activity,GO:0008443,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
phosphofructokinase activity,GO:0008443,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,PFKM
phosphofructokinase activity,GO:0008443,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
phosphofructokinase activity,GO:0008443,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
phospholipase A1 activity,GO:0008970,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
phospholipase A2 activator activity,GO:0016005,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
phospholipase A2 activator activity,GO:0016005,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
phospholipase A2 activity,GO:0004623,Diabetes Mellitus,MESH:D003920,3,Cadmium|Docosahexaenoic Acids|docosapentaenoic acid,0,
phospholipase A2 activity,GO:0004623,"Diabetes Mellitus, Experimental",MESH:D003921,4,Cholesterol|Cromolyn Sodium|Quercetin|thymoquinone,0,
phospholipase A2 activity,GO:0004623,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
phospholipase activity,GO:0004620,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
phospholipase D activity,GO:0004630,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HMOX1
phospholipase D activity,GO:0004630,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
phospholipid binding,GO:0005543,Diabetes Mellitus,MESH:D003920,0,,1,PON1
phospholipid binding,GO:0005543,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC9A1
phospholipid-hydroperoxide glutathione peroxidase activity,GO:0047066,Diabetes Mellitus,MESH:D003920,0,,1,CP
phospholipid-hydroperoxide glutathione peroxidase activity,GO:0047066,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPX1
phospholipid-hydroperoxide glutathione peroxidase activity,GO:0047066,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
phospholipid-hydroperoxide glutathione peroxidase activity,GO:0047066,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPX1
phosphoprotein binding,GO:0051219,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
phosphoprotein binding,GO:0051219,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GRB14
phosphoprotein phosphatase activity,GO:0004721,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
phosphoprotein phosphatase activity,GO:0004721,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
phosphoprotein phosphatase activity,GO:0004721,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
phosphoric diester hydrolase activity,GO:0008081,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ENPP1|UBE2E2
phosphorus-oxygen lyase activity,GO:0016849,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
"phosphotransferase activity, alcohol group as acceptor",GO:0016773,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GCK|HK1
"phosphotransferase activity, alcohol group as acceptor",GO:0016773,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
"phosphotransferase activity, alcohol group as acceptor",GO:0016773,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|HK1
phosphotyrosine residue binding,GO:0001784,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
phosphotyrosine residue binding,GO:0001784,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS1
phosphotyrosine residue binding,GO:0001784,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IRS1
phytanate-CoA ligase activity,GO:0050197,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
placental growth factor receptor activity,GO:0036332,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
placental growth factor receptor activity,GO:0036332,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
placental growth factor receptor activity,GO:0036332,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
platelet-derived growth factor alpha-receptor activity,GO:0005018,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
platelet-derived growth factor alpha-receptor activity,GO:0005018,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
platelet-derived growth factor alpha-receptor activity,GO:0005018,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
platelet-derived growth factor beta-receptor activity,GO:0005019,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
platelet-derived growth factor beta-receptor activity,GO:0005019,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
platelet-derived growth factor beta-receptor activity,GO:0005019,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
platelet-derived growth factor receptor binding,GO:0005161,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
plus-end-directed microtubule motor activity,GO:0008574,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
poly-ADP-D-ribose binding,GO:0072572,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AIFM1
poly-ADP-D-ribose binding,GO:0072572,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
polysaccharide binding,GO:0030247,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
polysaccharide binding,GO:0030247,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
polysome binding,GO:1905538,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
porphobilinogen synthase activity,GO:0004655,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
porphobilinogen synthase activity,GO:0004655,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
potassium channel activator activity,GO:0099104,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
potassium channel activity,GO:0005267,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
potassium channel activity,GO:0005267,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
potassium channel activity,GO:0005267,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ABCC8|KCNK16|KCNQ1|KCNU1
potassium channel inhibitor activity,GO:0019870,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV3
potassium ion binding,GO:0030955,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,KCNJ11|PKLR
potassium ion binding,GO:0030955,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
potassium ion binding,GO:0030955,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,KCNJ11
potassium ion binding,GO:0030955,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNJ11
potassium ion leak channel activity,GO:0022841,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNK16
potassium:proton antiporter activity,GO:0015386,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC9A1|SLC9A3
prenyltransferase activity,GO:0004659,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NUS1
primary amine oxidase activity,GO:0008131,Diabetes Mellitus,MESH:D003920,0,,1,AOC3
primary amine oxidase activity,GO:0008131,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AOC3
primary miRNA binding,GO:0070878,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
pristanate-CoA ligase activity,GO:0070251,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
proline dipeptidase activity,GO:0102009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PEPD
promoter-specific chromatin binding,GO:1990841,Diabetes Mellitus,MESH:D003920,0,,2,PPARG|SIRT1
promoter-specific chromatin binding,GO:1990841,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,PDX1|PPARG|PPARGC1A|SIRT1|TP53|TRP53
promoter-specific chromatin binding,GO:1990841,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,HNF1B|PDX1|PPARG|PPARGC1A|SIRT1|TCF7L2
prostaglandin-endoperoxide synthase activity,GO:0004666,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,1,PTGS2
prostaglandin-endoperoxide synthase activity,GO:0004666,"Diabetes Mellitus, Experimental",MESH:D003921,1,thymoquinone,1,PTGS2
prostaglandin-endoperoxide synthase activity,GO:0004666,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
prostaglandin receptor activity,GO:0004955,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
prostaglandin receptor activity,GO:0004955,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
prostaglandin receptor activity,GO:0004955,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARG
protease binding,GO:0002020,Diabetes Mellitus,MESH:D003920,0,,3,FN1|INS|INS2
protease binding,GO:0002020,"Diabetes Mellitus, Experimental",MESH:D003921,0,,11,BCL2|CASP3|FAS|INS1|SERPINE1|TIMP1|TIMP2|TNF|TNFRSF1A|TP53|TRP53
protease binding,GO:0002020,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
protease binding,GO:0002020,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,CASP12|INS|INS2|TNF
protease binding,GO:0002020,"Diabetes Mellitus, Type 2",MESH:D003924,0,,8,BCL2|CASP3|FAS|INS|INS1|TIMP1|TNF|TNFRSF1A
proteasome binding,GO:0070628,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ID1
proteasome binding,GO:0070628,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ID1|WFS1
protein-arginine deiminase activity,GO:0004668,Diabetes Mellitus,MESH:D003920,1,Dieldrin,0,
protein arginine kinase activity,GO:1990424,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
protein binding,GO:0005515,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
protein binding,GO:0005515,Diabetes Mellitus,MESH:D003920,2,Lead|Magnesium,27,A|ADIPOQ|ADRB1|ALPK1|AOC3|ATP6|CPT1A|CYBB|FN1|INS|IRS1|KIF1A|KIF5B|LEPR|MAP3K5|MT2A|NCF1|NR1I2|NR1I3|POMC|PPARG|PTGS2|RAC1|SIRT1|SOD1|THBS2|ZFP57
protein binding,GO:0005515,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
protein binding,GO:0005515,"Diabetes Mellitus, Experimental",MESH:D003921,0,,98,ACE|ACOT1|ACOX1|ADRA1A|ADRB3|AGT|AIFM1|AOC3|ATF3|ATP2A2|ATP2A3|BAX|BCL2|BCL2L1|BDKRB1|CASP3|CAV1|CAV3|CCL20|CD68|COX2|CPT1A|CPT1B|CX3CL1|CYBA|CYBB|CYP1A1|EDN1|ESRRA|FAS|FGF21|FOXO3|GCK|GPAM|GPX1|HK1|HMOX1|IAPP|ICAM1|ID1|IFNG|IGF1|IL1B|IL6|INSR|IRS1|IRS2|KCNJ11|LEP|LEPR|MAP3K5|MMP2|MMP9|MPO|NCF1|ND1|NEUROD1|NOS2|NOS3|NQO1|PAX6|PCSK2|PDK4|PDX1|PFKM|PKLR|PPARA|PPARG|PPARGC1A|PRKCA|PRKCD|PRKCE|PTGS2|RELA|REN|S100A6|S1PR2|S1PR4|S1PR5|SERPINE1|SIRT1|SLC2A4|SLC9A1|SLC9A3|SNAP25|SOD1|SOD2|SREBF1|TGFB1|TIMP1|TIMP2|TNF|TNFRSF1A|TP53|TRP53|UCP2|VEGFA|YWHAH
protein binding,GO:0005515,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
protein binding,GO:0005515,"Diabetes Mellitus, Insulin-Dependent, 12",MESH:C563326,0,,1,CTLA4
protein binding,GO:0005515,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
protein binding,GO:0005515,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
protein binding,GO:0005515,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
protein binding,GO:0005515,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein binding,GO:0005515,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
protein binding,GO:0005515,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
protein binding,GO:0005515,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
protein binding,GO:0005515,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
protein binding,GO:0005515,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
protein binding,GO:0005515,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
protein binding,GO:0005515,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
protein binding,GO:0005515,"Diabetes Mellitus, Type 1",MESH:D003922,0,,38,ABCC8|AIFM1|BACH2|C1QTNF6|CASP12|CCL20|CD69|CLEC16A|CRP|CTSH|DDIT3|FGF21|GLIS3|HLA-DQA1|HLA-DQB1|HLA-DRB1|HNF1A|HP|IFNG|IGF1|IL10|IL19|IL20|IL27|IL2RA|IL6|INS|ITPR3|KCNJ11|NOS1|NOS3|PRKCQ|PTPN22|SH2B3|SLC29A3|STAT3|TNF|TYK2
protein binding,GO:0005515,"Diabetes Mellitus, Type 2",MESH:D003924,4,Calcium|Glutathione|Lead|Magnesium,148,A|ABCC8|ADCY5|ADIPOQ|AKT1|AKT2|ATF3|ATP2A2|ATP2A3|AUTS2|BAX|BCL2|BCL2L1|BCL2L11|BRAF|C3|CAPN10|CASP3|CASP8|CBS|CCDC92|CCND2|CD36|CDKAL1|CISD2|CMIP|CNKSR2|CPT1A|CYBA|CYP1A2|DGKD|ECE1|EDN1|EDNRA|EDNRB|EGFR|ENPP1|ETS1|FAM234A|FAS|FGF21|FTO|GCG|GCK|GCKR|GCLC|GCLM|GLIS3|GLP1R|GNB3|GP2|GPX1|GRB14|GSTM1|HBA1|HECTD4|HHEX|HK1|HLA-DRB5|HMG20A|HMGA1|HMOX1|HNF1A|HNF1B|HNF4A|HP|HPX|IAPP|ICAM1|ID1|IGF2BP2|IL13RA1|IL6|INPPL1|INS|IRS1|IRS2|ITGA1|ITLN1|JADE2|JAZF1|KCNJ11|KCNK16|KCNQ1|KL|KSR2|LEP|LEPR|LIPC|MAEA|MAPK8IP1|MAT1A|MIR744|MRAS|MTNR1B|NEUROD1|NFATC2|NFKB1|NOS2|NOS3|NOTCH2|NUS1|OGG1|PAM|PAX6|PCSK2|PDX1|PEPD|PIK3CG|PLEKHA1|PPARA|PPARG|PPARGC1A|PRKCB|PROX1|PSMD6|PTPN1|RETN|RNF6|S100A6|SFRP4|SHBG|SIRT1|SLC1A2|SLC22A3|SLC2A1|SLC2A4|SLC30A8|SMAD5|SMIM43|SNAP25|SOD1|SOD2|ST6GAL1|TCF7L2|THADA|TIMP1|TMEM18|TNF|TNFRSF1A|TNFRSF1B|UBE2E2|UCP2|USP48|VPS26A|WFS1|ZC3HC1|ZFAND3
protein carrier chaperone,GO:0140597,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,WFS1
protein-containing complex binding,GO:0044877,Diabetes Mellitus,MESH:D003920,0,,3,IRS1|KIF5B|RAC1
protein-containing complex binding,GO:0044877,"Diabetes Mellitus, Experimental",MESH:D003921,0,,18,BAX|BCL2|BCL2L1|CASP3|CAV1|CAV3|FAS|HK1|ICAM1|INSR|IRS1|MMP9|PDX1|PPARA|RELA|SREBF1|TGFB1|TNFRSF1A
protein-containing complex binding,GO:0044877,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein-containing complex binding,GO:0044877,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,CTSH|ITPR3|SH2B3
protein-containing complex binding,GO:0044877,"Diabetes Mellitus, Type 2",MESH:D003924,0,,21,BAX|BCL2|BCL2L1|BHMT|BRAF|CASP3|CASP8|CD36|EGFR|FAS|GCLC|GCLM|HK1|HNF1B|HNF4A|ICAM1|IRS1|NFKB1|PDX1|PPARA|TNFRSF1A
protein dimerization activity,GO:0046983,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,AIFM1|ID1|NEUROD1|SREBF1
protein dimerization activity,GO:0046983,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
protein dimerization activity,GO:0046983,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
protein dimerization activity,GO:0046983,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,AIFM1|CRP|HNF1A|IL10|STAT3
protein dimerization activity,GO:0046983,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,HNF1A|ID1|NEUROD1|ST6GAL1
protein disulfide isomerase activity,GO:0003756,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
protein disulfide isomerase activity,GO:0003756,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
protein disulfide isomerase activity,GO:0003756,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
protein disulfide isomerase activity,GO:0003756,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
protein domain specific binding,GO:0019904,Diabetes Mellitus,MESH:D003920,0,,3,IRS1|MAP3K5|SIRT1
protein domain specific binding,GO:0019904,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,ESRRA|IL1B|INSR|IRS1|IRS2|MAP3K5|PPARA|SIRT1|SNAP25|YWHAH
protein domain specific binding,GO:0019904,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein domain specific binding,GO:0019904,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,GCKR|HNF4A|IRS1|IRS2|PPARA|SIRT1|SNAP25
protein folding chaperone,GO:0044183,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP8
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,Diabetes Mellitus,MESH:D003920,2,Cadmium|Cyclosporine,0,
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|thymoquinone,0,
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Calcium|titanium dioxide,0,
protein heterodimerization activity,GO:0046982,Diabetes Mellitus,MESH:D003920,0,,3,ADRB1|AOC3|CYBB
protein heterodimerization activity,GO:0046982,"Diabetes Mellitus, Experimental",MESH:D003921,0,,13,ADRA1A|AOC3|ATF3|BAX|BCL2|BCL2L1|CAV1|CYBA|CYBB|NEUROD1|TP53|TRP53|YWHAH
protein heterodimerization activity,GO:0046982,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
protein heterodimerization activity,GO:0046982,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,DDIT3|HNF1A
protein heterodimerization activity,GO:0046982,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,ATF3|BAX|BCL2|BCL2L1|CYBA|DGKD|HNF1A|KCNK16|NEUROD1
protein homodimerization activity,GO:0042803,Diabetes Mellitus,MESH:D003920,0,,6,ADIPOQ|CAT|MAP3K5|PON1|PTGS2|SOD1
protein homodimerization activity,GO:0042803,"Diabetes Mellitus, Experimental",MESH:D003921,0,,18,ACE|ACOX1|ADRB3|ATF3|BAX|BCL2|BCL2L1|CAT|HMOX1|HSD11B1|MAP3K5|NOS2|PTGS2|RELA|S100A6|SOD1|UCP2|VEGFA
protein homodimerization activity,GO:0042803,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
protein homodimerization activity,GO:0042803,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,CAT|DDIT3|HNF1A|SLC11A1|STAT3
protein homodimerization activity,GO:0042803,"Diabetes Mellitus, Type 2",MESH:D003924,0,,24,ADIPOQ|AKT1|ATF3|BAX|BCL2|BCL2L1|CAT|CBS|CISD2|DGKD|ECE1|ENPP1|GSTM1|HHEX|HMOX1|HNF1A|HNF1B|HNF4A|NOS2|S100A6|SLC30A8|SOD1|ST6GAL1|UCP2
protein-hormone receptor activity,GO:0016500,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
protein-hormone receptor activity,GO:0016500,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
protein-hormone receptor activity,GO:0016500,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEPR
protein kinase A catalytic subunit binding,GO:0034236,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
protein kinase activator activity,GO:0030295,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
protein kinase activator activity,GO:0030295,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
protein kinase activator activity,GO:0030295,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein kinase activity,GO:0004672,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
protein kinase activity,GO:0004672,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,7,HK1|INSR|MAP3K5|PDK4|PRKCA|PRKCD|PRKCE
protein kinase activity,GO:0004672,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein kinase activity,GO:0004672,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,2,PRKCQ|TYK2
protein kinase activity,GO:0004672,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,8,AKT1|AKT2|BRAF|EGFR|HK1|IL13RA1|KSR2|PIK3CG
protein kinase A regulatory subunit binding,GO:0034237,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
protein kinase B binding,GO:0043422,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
protein kinase B binding,GO:0043422,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
protein kinase B binding,GO:0043422,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
protein kinase binding,GO:0019901,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
protein kinase binding,GO:0019901,Diabetes Mellitus,MESH:D003920,0,,3,IRS1|MAP3K5|RAC1
protein kinase binding,GO:0019901,"Diabetes Mellitus, Experimental",MESH:D003921,0,,13,BCL2L1|CAV1|FOXO3|INSR|IRS1|IRS2|MAP3K5|NOS2|PAX6|PRKCD|PRKCE|RELA|SREBF1
protein kinase binding,GO:0019901,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
protein kinase binding,GO:0019901,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein kinase binding,GO:0019901,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
protein kinase binding,GO:0019901,"Diabetes Mellitus, Type 2",MESH:D003924,0,,16,AKT1|BCL2L1|BCL2L11|CCND2|CNKSR2|EGFR|GSTM1|IRS1|IRS2|MAPK8IP1|NOS2|PAM|PAX6|PTPN1|TCF7L2|ZC3HC1
protein kinase C activity,GO:0004697,Diabetes Mellitus,MESH:D003920,8,Aldrin|Chlordan|Chlorodiphenyl (54% Chlorine)|DDT|Dichlorodiphenyl Dichloroethylene|Heptachlor|Lead|Streptozocin,0,
protein kinase C activity,GO:0004697,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
protein kinase C activity,GO:0004697,"Diabetes Mellitus, Experimental",MESH:D003921,4,"Glucose|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin|Streptozocin",3,PRKCA|PRKCD|PRKCE
protein kinase C activity,GO:0004697,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,1,PRKCQ
protein kinase C activity,GO:0004697,"Diabetes Mellitus, Type 2",MESH:D003924,5,Calcium|Dichlorodiphenyl Dichloroethylene|Glucose|Lead|Streptozocin,1,PRKCB
protein kinase C binding,GO:0005080,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
protein kinase C binding,GO:0005080,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS1
protein kinase C binding,GO:0005080,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,AKT1|AKT2|IRS1|PRKCB
protein kinase inhibitor activity,GO:0004860,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
protein kinase inhibitor activity,GO:0004860,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAPK8IP1
protein lysine deacetylase activity,GO:0033558,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
protein lysine deacetylase activity,GO:0033558,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
protein lysine deacetylase activity,GO:0033558,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
protein-macromolecule adaptor activity,GO:0030674,Diabetes Mellitus,MESH:D003920,0,,2,CPT1A|IRS1
protein-macromolecule adaptor activity,GO:0030674,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,CAV1|CPT1A|IRS1|IRS2|SLC9A1
protein-macromolecule adaptor activity,GO:0030674,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,CPT1A|GRB14|IRS1|IRS2
protein phosphatase 1 binding,GO:0008157,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,KCNQ1|PPP1R3A
protein phosphatase 2A binding,GO:0051721,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BCL2|TP53|TRP53
protein phosphatase 2A binding,GO:0051721,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,AKT1|BCL2|PTPN1
protein phosphatase 2B binding,GO:0030346,Diabetes Mellitus,MESH:D003920,0,,1,SOD1
protein phosphatase 2B binding,GO:0030346,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC9A1|SOD1
protein phosphatase 2B binding,GO:0030346,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD1
protein phosphatase binding,GO:0019903,Diabetes Mellitus,MESH:D003920,0,,2,MAP3K5|PPARG
protein phosphatase binding,GO:0019903,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,BCL2|FAS|GCK|INSR|IRS2|MAP3K5|PPARG
protein phosphatase binding,GO:0019903,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein phosphatase binding,GO:0019903,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
protein phosphatase binding,GO:0019903,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
protein phosphatase binding,GO:0019903,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,BCL2|EGFR|FAS|GCK|IRS2|ITGA1|PPARG
protein-propionyllysine depropionylase activity,GO:0106231,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
protein-propionyllysine depropionylase activity,GO:0106231,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
protein-propionyllysine depropionylase activity,GO:0106231,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
protein sequestering activity,GO:0140311,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
protein sequestering activity,GO:0140311,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
protein sequestering activity,GO:0140311,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
protein serine kinase activity,GO:0106310,Diabetes Mellitus,MESH:D003920,0,,2,ALPK1|MAP3K5
protein serine kinase activity,GO:0106310,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,MAP3K5|PRKCA|PRKCD|PRKCE
protein serine kinase activity,GO:0106310,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PRKCQ
protein serine kinase activity,GO:0106310,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,AKT1|AKT2|BRAF|KSR2|PIK3CG|PRKCB
protein serine kinase activity (using GTP as donor),GO:0106264,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
protein serine/threonine kinase activator activity,GO:0043539,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
protein serine/threonine kinase activator activity,GO:0043539,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ACSL1|IGF1|TGFB1
protein serine/threonine kinase activator activity,GO:0043539,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
protein serine/threonine kinase activator activity,GO:0043539,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ADIPOQ|CCND2
protein serine/threonine kinase activity,GO:0004674,Diabetes Mellitus,MESH:D003920,1,Streptozocin,2,ALPK1|MAP3K5
protein serine/threonine kinase activity,GO:0004674,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,4,MAP3K5|PRKCA|PRKCD|PRKCE
protein serine/threonine kinase activity,GO:0004674,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,1,PRKCQ
protein serine/threonine kinase activity,GO:0004674,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,5,AKT1|AKT2|BRAF|KSR2|PRKCB
protein serine/threonine kinase binding,GO:0120283,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PRKCD|PRKCE
protein serine/threonine kinase binding,GO:0120283,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
protein serine/threonine kinase inhibitor activity,GO:0030291,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
protein serine/threonine phosphatase activity,GO:0004722,Diabetes Mellitus,MESH:D003920,1,Cyclosporine,0,
protein serine/threonine phosphatase activity,GO:0004722,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPP1R3A
protein serine/threonine/tyrosine kinase activity,GO:0004712,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDK4
protein serine/threonine/tyrosine kinase activity,GO:0004712,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
protein tag,GO:0031386,"Diabetes Mellitus, Insulin-Dependent, 5",MESH:C563958,0,,1,SUMO4
protein tyrosine kinase activator activity,GO:0030296,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
protein tyrosine kinase activity,GO:0004713,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,2,INSR|PRKCD
protein tyrosine kinase activity,GO:0004713,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein tyrosine kinase activity,GO:0004713,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
protein tyrosine kinase activity,GO:0004713,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BRAF|EGFR
protein tyrosine kinase binding,GO:1990782,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,PTPN22|SH2B3
protein tyrosine kinase collagen receptor activity,GO:0038062,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
protein tyrosine kinase collagen receptor activity,GO:0038062,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
protein tyrosine kinase collagen receptor activity,GO:0038062,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
protein tyrosine kinase inhibitor activity,GO:0030292,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
protein tyrosine phosphatase activity,GO:0004725,Diabetes Mellitus,MESH:D003920,2,Particulate Matter|Selenium,0,
protein tyrosine phosphatase activity,GO:0004725,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
protein tyrosine phosphatase activity,GO:0004725,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,1,PTPN1
"protein tyrosine phosphatase activity, metal-dependent",GO:0030946,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
"protein tyrosine phosphatase activity, metal-dependent",GO:0030946,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
proteoglycan binding,GO:0043394,Diabetes Mellitus,MESH:D003920,0,,1,FN1
proton channel activity,GO:0015252,Diabetes Mellitus,MESH:D003920,0,,1,ATP6
proton transmembrane transporter activity,GO:0015078,Diabetes Mellitus,MESH:D003920,0,,1,ATP6
proton transmembrane transporter activity,GO:0015078,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
proton transmembrane transporter activity,GO:0015078,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,Diabetes Mellitus,MESH:D003920,4,Arsenic|Chlorpromazine|Resveratrol|Zinc,0,
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,"Diabetes Mellitus, Experimental",MESH:D003921,3,Quercetin|Resveratrol|Taurine,0,
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,"Diabetes Mellitus, Type 1",MESH:D003922,3,Genistein|Resveratrol|Taurine,0,
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,"Diabetes Mellitus, Type 2",MESH:D003924,9,Amino Acids|Arsenic|Curcumin|daidzein|epigallocatechin gallate|Genistein|perfluorooctanoic acid|Resveratrol|Zinc,0,
"proton-transporting ATP synthase activity, rotational mechanism",GO:0046933,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,1,ATP6
"proton-transporting ATP synthase activity, rotational mechanism",GO:0046933,"Diabetes Mellitus, Experimental",MESH:D003921,1,Monocrotophos,0,
"proton-transporting ATP synthase activity, rotational mechanism",GO:0046933,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
PTB domain binding,GO:0051425,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
PTB domain binding,GO:0051425,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
P-type calcium transporter activity,GO:0005388,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Cadmium|Docosahexaenoic Acids|Tobacco Smoke Pollution,0,
P-type calcium transporter activity,GO:0005388,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Quercetin,2,ATP2A2|ATP2A3
P-type calcium transporter activity,GO:0005388,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|Thioctic Acid,0,
P-type calcium transporter activity,GO:0005388,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|bisphenol A|Cadmium|Curcumin,2,ATP2A2|ATP2A3
P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential,GO:0086039,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A2
P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential,GO:0086039,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A2
P-type magnesium transporter activity,GO:0015444,Diabetes Mellitus,MESH:D003920,3,Arsenic|Atrazine|Cadmium,0,
P-type magnesium transporter activity,GO:0015444,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Atrazine|Cadmium,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,Diabetes Mellitus,MESH:D003920,14,Arsenic|bisphenol A|Cadmium|Chlorpromazine|Chlorpyrifos|Docosahexaenoic Acids|Glyburide|Lead|Magnesium|Resveratrol|Serotonin|Streptozocin|Tobacco Smoke Pollution|Zinc,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,"Diabetes Mellitus, Experimental",MESH:D003921,11,bisphenol A|Dietary Fats|Glucose|Glyburide|Manganese|Resveratrol|sodium arsenite|Sodium Glutamate|Streptozocin|Taurine|Vitamin E,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,"Diabetes Mellitus, Type 2",MESH:D003924,15,Arsenic|bisphenol A|Cadmium|Curcumin|Dietary Fats|Ethanol|Folic Acid|Glucose|Glyburide|Lead|Magnesium|Manganese|Resveratrol|Streptozocin|Zinc,0,
purine nucleotide binding,GO:0017076,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
pyridoxal phosphate binding,GO:0030170,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
pyrophosphatase activity,GO:0016462,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
pyruvate carboxylase activity,GO:0004736,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCX
pyruvate carboxylase activity,GO:0004736,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCX
pyruvate dehydrogenase (acetyl-transferring) activity,GO:0004739,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
pyruvate dehydrogenase (acetyl-transferring) activity,GO:0004739,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
pyruvate dehydrogenase (acetyl-transferring) kinase activity,GO:0004740,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDK4
pyruvate dehydrogenase activity,GO:0004738,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
pyruvate dehydrogenase activity,GO:0004738,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Diethylhexyl Phthalate,0,
pyruvate dehydrogenase activity,GO:0004738,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
pyruvate dehydrogenase activity,GO:0004738,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Diethylhexyl Phthalate,0,
pyruvate kinase activity,GO:0004743,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|Lead|Particulate Matter|Streptozocin,0,
pyruvate kinase activity,GO:0004743,"Diabetes Mellitus, Experimental",MESH:D003921,5,Imatinib Mesylate|Monocrotophos|Quercetin|sodium arsenite|Streptozocin,1,PKLR
pyruvate kinase activity,GO:0004743,"Diabetes Mellitus, Type 1",MESH:D003922,3,Imatinib Mesylate|sodium arsenite|Streptozocin,0,
pyruvate kinase activity,GO:0004743,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|bisphenol S|Lead|Particulate Matter|Streptozocin,0,
quaternary ammonium group transmembrane transporter activity,GO:0015651,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
quinone binding,GO:0048038,Diabetes Mellitus,MESH:D003920,0,,1,AOC3
quinone binding,GO:0048038,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AOC3
receptor ligand activity,GO:0048018,Diabetes Mellitus,MESH:D003920,0,,2,FN1|INS2
receptor ligand activity,GO:0048018,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,AGT|EDN1|IAPP|IGF1|IL1B|INS1|TNF|VEGFA
receptor ligand activity,GO:0048018,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IGF1|INS2|TNF
receptor ligand activity,GO:0048018,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,C3|EDN1|GCG|IAPP|INS1|TNF
receptor serine/threonine kinase binding,GO:0033612,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
receptor tyrosine kinase binding,GO:0030971,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
receptor tyrosine kinase binding,GO:0030971,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GRB14|PTPN1
retinoic acid 4-hydroxylase activity,GO:0008401,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP3A11
retinoic acid 4-hydroxylase activity,GO:0008401,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
Rho-dependent protein serine/threonine kinase activity,GO:0072518,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
Rho-dependent protein serine/threonine kinase activity,GO:0072518,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
Rho-dependent protein serine/threonine kinase activity,GO:0072518,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
Rho GDP-dissociation inhibitor binding,GO:0051022,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
ribosomal protein S6 kinase activity,GO:0004711,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
ribosomal protein S6 kinase activity,GO:0004711,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|AKT2|BRAF|KSR2|PIK3CG
RNA binding,GO:0003723,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PAX6|PPARGC1A
RNA binding,GO:0003723,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
RNA binding,GO:0003723,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,GCLM|HMGA1|IGF2BP2|MIR125B1|PAX6|PPARGC1A
RNA polymerase binding,GO:0070063,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
RNA polymerase binding,GO:0070063,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,0,
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,5,NR1I2|NR1I3|PPARG|SIRT1|ZFP57
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Experimental",MESH:D003921,0,,14,ATF3|ESRRA|FOXO3|NEUROD1|NKX6-1|PAX6|PDX1|PPARA|PPARG|RELA|SIRT1|SREBF1|TP53|TRP53
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Type 1",MESH:D003922,0,,7,BACH2|CRP|DDIT3|GLIS3|HNF1A|PAX4|STAT3
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Diabetes Mellitus, Type 2",MESH:D003924,0,,24,ATF3|ETS1|GLIS3|HHEX|HMGA1|HNF1A|HNF1B|HNF4A|KLF14|NEUROD1|NFATC2|NFKB1|NKX6-1|OGG1|PAX4|PAX6|PDX1|PPARA|PPARG|PROX1|SIRT1|SMAD5|TCF7L2|ZNF257
RNA polymerase II complex binding,GO:0000993,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC30A8
RNA polymerase II core promoter sequence-specific DNA binding,GO:0000979,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
RNA polymerase II core promoter sequence-specific DNA binding,GO:0000979,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PAX6|PPARG|RELA
RNA polymerase II core promoter sequence-specific DNA binding,GO:0000979,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HMGA1|PAX6|PPARG
RNA polymerase II CTD heptapeptide repeat phosphatase activity,GO:0008420,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
RNA polymerase II C-terminal domain binding,GO:0099122,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC30A8
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,NEUROD1|PPARA|PPARGC1A|TP53|TRP53
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,DDIT3|NOS1|STAT3
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,ETS1|HNF4A|NEUROD1|PPARA|PPARGC1A|TCF7L2
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,Diabetes Mellitus,MESH:D003920,0,,4,NR1I2|NR1I3|PPARG|ZFP57
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,ATF3|PPARG|RELA|SREBF1|TP53|TRP53
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,GLIS3
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,ATF3|GLIS3|HHEX|NFKB1|PPARG|SMAD5
RNA sequestering activity,GO:0140610,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
Roundabout binding,GO:0048495,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
R-SMAD binding,GO:0070412,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
R-SMAD binding,GO:0070412,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PAX6|PPARG
R-SMAD binding,GO:0070412,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PAX6|PPARG
S100 protein binding,GO:0044548,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ATP2A2|S100A6
S100 protein binding,GO:0044548,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ATP2A2|S100A6
S-adenosyl-L-methionine binding,GO:1904047,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
S-adenosylmethionine-homocysteine S-methyltransferase activity,GO:0008898,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
scaffold protein binding,GO:0097110,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS3
scaffold protein binding,GO:0097110,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
scaffold protein binding,GO:0097110,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,ADCY5|BRAF|CASP8|KCNQ1|NOS3
scavenger receptor activity,GO:0005044,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CD36|ENPP1
secondary active sulfate transmembrane transporter activity,GO:0008271,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
secondary active sulfate transmembrane transporter activity,GO:0008271,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
secretin receptor activity,GO:0015055,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SCTR
sequence-specific DNA binding,GO:0043565,Diabetes Mellitus,MESH:D003920,0,,4,NR1I2|NR1I3|PPARG|ZFP57
sequence-specific DNA binding,GO:0043565,"Diabetes Mellitus, Experimental",MESH:D003921,0,,15,ATF3|BCL2|ESRRA|FOXO3|NEUROD1|NKX6-1|PAX6|PDX1|PPARA|PPARG|PPARGC1A|RELA|SREBF1|TP53|TRP53
sequence-specific DNA binding,GO:0043565,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
sequence-specific DNA binding,GO:0043565,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
sequence-specific DNA binding,GO:0043565,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
sequence-specific DNA binding,GO:0043565,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,CRP|DDIT3|HNF1A|STAT3
sequence-specific DNA binding,GO:0043565,"Diabetes Mellitus, Type 2",MESH:D003924,0,,21,ATF3|BCL2|ETS1|HHEX|HNF1A|HNF1B|HNF4A|KLF14|MIR214|NEUROD1|NFATC2|NFKB1|NKX6-1|PAX6|PDX1|PPARA|PPARG|PPARGC1A|PROX1|TCF7L2|TMEM18
sequence-specific double-stranded DNA binding,GO:1990837,Diabetes Mellitus,MESH:D003920,0,,2,NR1I2|NR1I3
sequence-specific double-stranded DNA binding,GO:1990837,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,ATF3|ESRRA|FOXO3|NEUROD1|PAX6|PDX1|SREBF1
sequence-specific double-stranded DNA binding,GO:1990837,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
sequence-specific double-stranded DNA binding,GO:1990837,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,BACH2|PAX4
sequence-specific double-stranded DNA binding,GO:1990837,"Diabetes Mellitus, Type 2",MESH:D003924,0,,12,ATF3|ETS1|HNF4A|KLF14|NEUROD1|NFATC2|NFKB1|PAX4|PAX6|PDX1|PROX1|SMAD5
serine-type endopeptidase activity,GO:0004252,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,MMP2|MMP9|PCSK2
serine-type endopeptidase activity,GO:0004252,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CTSH|HP
serine-type endopeptidase activity,GO:0004252,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,DGKD|HP|PCSK2|SLC1A2
serine-type endopeptidase inhibitor activity,GO:0004867,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,AGT|SERPINE1
serine-type peptidase activity,GO:0008236,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCSK2
serine-type peptidase activity,GO:0008236,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCSK2
SH2 domain binding,GO:0042169,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
SH2 domain binding,GO:0042169,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS1
SH2 domain binding,GO:0042169,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,INPPL1|IRS1
SH3 domain binding,GO:0017124,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
SH3 domain binding,GO:0017124,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CYBA|GPX1|NCF1|PRKCE
SH3 domain binding,GO:0017124,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
SH3 domain binding,GO:0017124,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CYBA|GPX1|INPPL1
short-chain fatty acid transmembrane transporter activity,GO:0015636,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
sialic acid binding,GO:0033691,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
sialic acid binding,GO:0033691,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADIPOQ
sialyltransferase activity,GO:0008373,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ST6GAL1
signaling adaptor activity,GO:0035591,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
signaling adaptor activity,GO:0035591,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IRS1|IRS2
signaling adaptor activity,GO:0035591,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,SH2B3|STAT3
signaling adaptor activity,GO:0035591,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IRS1|IRS2
signaling receptor activator activity,GO:0030546,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCE
signaling receptor activity,GO:0038023,Diabetes Mellitus,MESH:D003920,0,,1,CP
signaling receptor activity,GO:0038023,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,FAS|ICAM1|MFGE8|PPARA|TNFRSF1A
signaling receptor activity,GO:0038023,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
signaling receptor activity,GO:0038023,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,FAS|GLP1R|ICAM1|NOTCH2|PPARA|TNFRSF1A|TNFRSF1B
signaling receptor binding,GO:0005102,Diabetes Mellitus,MESH:D003920,0,,3,ADIPOQ|FN1|POMC
signaling receptor binding,GO:0005102,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
signaling receptor binding,GO:0005102,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,CAV1|CX3CL1|EDN1|IAPP|IL6|LEP|PRKCA|PRKCE|REN|SERPINE1
signaling receptor binding,GO:0005102,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,IL20|IL27|IL6|STAT3
signaling receptor binding,GO:0005102,"Diabetes Mellitus, Type 2",MESH:D003924,0,,11,ADIPOQ|C3|EDN1|EGFR|GCG|HNF4A|IAPP|IL6|ITGA1|LEP|PTPN1
signaling receptor complex adaptor activity,GO:0030159,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
signaling receptor complex adaptor activity,GO:0030159,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS1
signaling receptor complex adaptor activity,GO:0030159,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
signaling receptor complex adaptor activity,GO:0030159,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GNB3|IRS1
single-stranded RNA binding,GO:0003727,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CISD2|JAZF1|MIR181C
small GTPase binding,GO:0031267,Diabetes Mellitus,MESH:D003920,0,,2,RAC1|SOD1
small GTPase binding,GO:0031267,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CAV1|SOD1
small GTPase binding,GO:0031267,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BRAF|SOD1
S-methylmethionine-homocysteine S-methyltransferase activity,GO:0061627,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
SNAP receptor activity,GO:0005484,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
SNAP receptor activity,GO:0005484,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
SNARE binding,GO:0000149,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CAV1|SNAP25
SNARE binding,GO:0000149,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
SNARE binding,GO:0000149,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CAPN10|SNAP25
sodium channel activity,GO:0005272,Diabetes Mellitus,MESH:D003920,2,Cadmium|Resveratrol,0,
sodium channel activity,GO:0005272,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
sodium channel activity,GO:0005272,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
sodium channel activity,GO:0005272,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Resveratrol,0,
sodium channel regulator activity,GO:0017080,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,AGT|CAV3|YWHAH
sodium channel regulator activity,GO:0017080,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
sodium:proton antiporter activity,GO:0015385,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC9A1|SLC9A3
spectrin binding,GO:0030507,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GNB3
spermidine transmembrane transporter activity,GO:0015606,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
sphingosine-1-phosphate receptor activity,GO:0038036,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,S1PR2|S1PR4|S1PR5
starch synthase activity,GO:0009011,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
starch synthase activity,GO:0009011,"Diabetes Mellitus, Experimental",MESH:D003921,4,chebulagic acid|Dietary Fats|Nicotine|Streptozocin,0,
starch synthase activity,GO:0009011,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
starch synthase activity,GO:0009011,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dietary Fats|Nicotine|Streptozocin,0,
STAT family protein binding,GO:0097677,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
STAT family protein binding,GO:0097677,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
STAT family protein binding,GO:0097677,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARG
stearic acid binding,GO:0070540,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
stem cell factor receptor activity,GO:0005020,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
stem cell factor receptor activity,GO:0005020,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
stem cell factor receptor activity,GO:0005020,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
stem cell factor receptor binding,GO:0005173,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
steroid 17-alpha-monooxygenase activity,GO:0004508,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
steroid 17-alpha-monooxygenase activity,GO:0004508,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP1A2
steroid binding,GO:0005496,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ESRRA|HSD11B1|IGF1
steroid binding,GO:0005496,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,HSD11B2|IGF1
steroid binding,GO:0005496,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CYP3A2|GSTM1|SHBG
"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0033764,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0033764,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|Valsartan,0,
"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0033764,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
steroid delta-isomerase activity,GO:0004769,Diabetes Mellitus,MESH:D003920,2,Docosahexaenoic Acids|docosapentaenoic acid,0,
steroid hydroxylase activity,GO:0008395,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
steroid hydroxylase activity,GO:0008395,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,CYP1A1|CYP2B10
steroid hydroxylase activity,GO:0008395,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
steroid hydroxylase activity,GO:0008395,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,CYP3A2
sterol response element binding,GO:0032810,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SREBF1
steryl-sulfatase activity,GO:0004773,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,STS
structural constituent of chromatin,GO:0030527,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMGA1
structural constituent of cytoskeleton,GO:0005200,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
structural constituent of muscle,GO:0008307,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
structural constituent of myelin sheath,GO:0019911,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
structural constituent of myelin sheath,GO:0019911,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
structural constituent of ribosome,GO:0003735,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
structural constituent of ribosome,GO:0003735,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NQO1
structural constituent of ribosome,GO:0003735,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BRAF
structural molecule activity,GO:0005198,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
structural molecule activity,GO:0005198,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,HMOX1|INSR
structural molecule activity,GO:0005198,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
structural molecule activity,GO:0005198,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
succinate dehydrogenase activity,GO:0000104,Diabetes Mellitus,MESH:D003920,10,Arsenic|Bezafibrate|bisphenol A|Cadmium|Gallic Acid|Niacin|Plant Extracts|Streptozocin|Tobacco Smoke Pollution|Zinc,0,
succinate dehydrogenase activity,GO:0000104,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
succinate dehydrogenase activity,GO:0000104,"Diabetes Mellitus, Experimental",MESH:D003921,10,Bezafibrate|bisphenol A|corilagin|Cyclophosphamide|Dietary Fats|Gallic Acid|Hydrogen Peroxide|Plant Extracts|Streptozocin|thymoquinone,0,
succinate dehydrogenase activity,GO:0000104,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
succinate dehydrogenase activity,GO:0000104,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Cyclophosphamide|Lipopolysaccharides|Streptozocin,0,
succinate dehydrogenase activity,GO:0000104,"Diabetes Mellitus, Type 2",MESH:D003924,9,Arsenic|Bezafibrate|bisphenol A|Cadmium|Curcumin|Dietary Fats|Plant Extracts|Streptozocin|Zinc,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,Diabetes Mellitus,MESH:D003920,13,Arsenic|Aspirin|Berberine|Bezafibrate|bisphenol A|Cadmium|Docosahexaenoic Acids|Gallic Acid|Lead|Mercury|Molybdenum|Pyruvaldehyde|Streptozocin,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,"Diabetes Mellitus, Experimental",MESH:D003921,13,Berberine|Bezafibrate|bisphenol A|Cyclophosphamide|Dietary Fats|Dronabinol|Gallic Acid|ginsenoside Re|Glucose|Monocrotophos|Quercetin|sodium arsenite|Streptozocin,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Cyclophosphamide|Mercury|sodium arsenite|Streptozocin|Thioctic Acid,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,"Diabetes Mellitus, Type 2",MESH:D003924,16,Arsenic|Berberine|Bezafibrate|bisphenol A|Cadmium|Curcumin|Dietary Fats|epigallocatechin gallate|Ethanol|ginsenoside Re|Glucose|Lead|Mercury|perfluorooctanoic acid|Streptozocin|TAK-875,0,
sucrose alpha-glucosidase activity,GO:0004575,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Lead|Streptozocin,0,
sucrose alpha-glucosidase activity,GO:0004575,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Streptozocin,0,
sucrose alpha-glucosidase activity,GO:0004575,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
sucrose alpha-glucosidase activity,GO:0004575,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Cysteine|Folic Acid|Lead|Nickel|Streptozocin,0,
sulfate binding,GO:0043199,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
sulfonylurea receptor activity,GO:0008281,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
sulfonylurea receptor activity,GO:0008281,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
sulfonylurea receptor activity,GO:0008281,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ABCC8
sulfotransferase activity,GO:0008146,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
sulfotransferase activity,GO:0008146,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
sulfotransferase activity,GO:0008146,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
sulfuric ester hydrolase activity,GO:0008484,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,STS
superoxide dismutase activity,GO:0004784,Diabetes Mellitus,MESH:D003920,52,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Alloxan|Arsenic|arsenite|Aspirin|Atrazine|Berberine|Bezafibrate|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Copper|Cyclosporine|DDT|Dichlorvos|Docosahexaenoic Acids|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Gliclazide|Glyburide|Hexachlorobenzene|Iron|Lead|Liraglutide|Mercury|Metformin|morroniside|Niacin|Ozone|Particulate Matter|Perindopril|Pesticides|Pioglitazone|Plant Extracts|Plant Preparations|Prednisolone|puerarin|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Sulfur Dioxide|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Trichlorfon|Zinc",1,SOD1
superoxide dismutase activity,GO:0004784,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
superoxide dismutase activity,GO:0004784,"Diabetes Mellitus, Experimental",MESH:D003921,64,"7-hydroxycoumarin|Alloxan|Anthocyanins|astaxanthine|Berberine|Bezafibrate|Bile Acids and Salts|bisphenol A|Capsaicin|chebulagic acid|cinnamaldehyde|cobaltiprotoporphyrin|corilagin|costunolide|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Dronabinol|Eucalyptol|Exenatide|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fructose|Gallic Acid|Gliclazide|Glucose|Glyburide|Hemin|Hydrogen Peroxide|Inositol|Losartan|Manganese|mangiferin|Metformin|Niacinamide|Nicotine|pimagedine|pinitol|Pioglitazone|Plant Extracts|Plant Preparations|pterostilbene|puerarin|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sarpogrelate|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|swietenine|tangeretin|Taurine|Telmisartan|thymoquinone|tributyltin|Ursolic Acid|Valsartan|Vitamin E|Zinc Compounds",3,NQO1|SOD1|SOD2
superoxide dismutase activity,GO:0004784,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
superoxide dismutase activity,GO:0004784,"Diabetes Mellitus, Type 1",MESH:D003922,18,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Genistein|Iron|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Uric Acid|Vitamin A,0,
superoxide dismutase activity,GO:0004784,"Diabetes Mellitus, Type 2",MESH:D003924,71,"2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid|Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Benzoic Acid|Berberine|Bezafibrate|bisphenol A|bisphenol S|Boron|Cadmium|cinnamaldehyde|Copper|Curcumin|Cysteine|daidzein|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|Gliclazide|Glucose|Glutathione|Glyburide|Hemin|Irbesartan|Iron|Lead|Linagliptin|Liraglutide|Malathion|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nickel|Nicotine|Orlistat|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Phthalic Acids|Pioglitazone|Plant Extracts|procyanidin B2|Resveratrol|Rosiglitazone|Silver|Sitagliptin Phosphate|Streptozocin|Telmisartan|titanium dioxide|Topiramate|Vehicle Emissions|Zinc",2,SOD1|SOD2
superoxide-generating NADPH oxidase activator activity,GO:0016176,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
superoxide-generating NADPH oxidase activator activity,GO:0016176,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,AGT|NCF1
superoxide-generating NAD(P)H oxidase activity,GO:0016175,Diabetes Mellitus,MESH:D003920,0,,2,CYBB|NCF1
superoxide-generating NAD(P)H oxidase activity,GO:0016175,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CYBA|CYBB|NCF1|NOS3
superoxide-generating NAD(P)H oxidase activity,GO:0016175,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
superoxide-generating NAD(P)H oxidase activity,GO:0016175,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYBA|NOS3
superoxide-generating NADPH oxidase activity,GO:0106292,Diabetes Mellitus,MESH:D003920,2,bisphenol A|puerarin,1,CYBB
superoxide-generating NADPH oxidase activity,GO:0106292,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Glucose|puerarin|Quercetin,1,CYBB
superoxide-generating NADPH oxidase activity,GO:0106292,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
superoxide-generating NADPH oxidase activity,GO:0106292,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Curcumin|Glucose,0,
symporter activity,GO:0015293,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
syntaxin-1 binding,GO:0017075,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
syntaxin-1 binding,GO:0017075,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,RETN|SNAP25
syntaxin-3 binding,GO:0030348,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,RETN
syntaxin binding,GO:0019905,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CAV1|SNAP25
syntaxin binding,GO:0019905,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
TBP-class protein binding,GO:0017025,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
T cell receptor binding,GO:0042608,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
telomerase activity,GO:0003720,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|bisphenol A|Particulate Matter,0,
telomerase activity,GO:0003720,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
telomerase activity,GO:0003720,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
telomerase activity,GO:0003720,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|bisphenol A|Glutathione|Particulate Matter,0,
testosterone 16-alpha-hydroxylase activity,GO:0008390,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP2B10|CYP2B9
testosterone 16-beta-hydroxylase activity,GO:0062184,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP2B10|CYP2B9
testosterone 6-beta-hydroxylase activity,GO:0050649,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP3A11
testosterone 6-beta-hydroxylase activity,GO:0050649,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYP3A2|CYP3A23-3A1
testosterone dehydrogenase [NAD(P)] activity,GO:0030283,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
testosterone dehydrogenase [NAD(P)] activity,GO:0030283,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
testosterone dehydrogenase [NAD(P)] activity,GO:0030283,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
testosterone dehydrogenase [NAD(P)] activity,GO:0030283,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
tetrahydrobiopterin binding,GO:0034617,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS2|NOS3
tetrahydrobiopterin binding,GO:0034617,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
tetrahydrobiopterin binding,GO:0034617,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
TFIID-class transcription factor complex binding,GO:0001094,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
thioesterase binding,GO:0031996,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
thiolester hydrolase activity,GO:0016790,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACOT1
thioredoxin-disulfide reductase activity,GO:0004791,Diabetes Mellitus,MESH:D003920,5,Cadmium|Iron|Mercury|Selenium|Streptozocin,0,
thioredoxin-disulfide reductase activity,GO:0004791,"Diabetes Mellitus, Experimental",MESH:D003921,4,Quercetin|sodium arsenite|Streptozocin|thymoquinone,0,
thioredoxin-disulfide reductase activity,GO:0004791,"Diabetes Mellitus, Type 1",MESH:D003922,4,Iron|Mercury|sodium arsenite|Streptozocin,0,
thioredoxin-disulfide reductase activity,GO:0004791,"Diabetes Mellitus, Type 2",MESH:D003924,6,Ascorbic Acid|Cadmium|Curcumin|Iron|Mercury|Streptozocin,0,
thrombospondin receptor activity,GO:0070053,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
thyroid hormone binding,GO:0070324,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
TIR domain binding,GO:0070976,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCD
Toll-like receptor binding,GO:0035325,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
TORC2 complex binding,GO:1904841,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
toxin transmembrane transporter activity,GO:0019534,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
transaminase activity,GO:0008483,Diabetes Mellitus,MESH:D003920,3,"Arsenic|Metals, Heavy|Plant Extracts",0,
transaminase activity,GO:0008483,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
transaminase activity,GO:0008483,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Plant Extracts,0,
transcription cis-regulatory region binding,GO:0000976,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
transcription cis-regulatory region binding,GO:0000976,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,ATF3|FOXO3|PAX6|PPARG|RELA|TNF|TP53|TRP53
transcription cis-regulatory region binding,GO:0000976,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
transcription cis-regulatory region binding,GO:0000976,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,DDIT3|HNF1A|STAT3|TNF
transcription cis-regulatory region binding,GO:0000976,"Diabetes Mellitus, Type 2",MESH:D003924,0,,15,ATF3|ETS1|HHEX|HNF1A|HNF1B|HNF4A|NFATC2|NFKB1|PAX6|PPARG|PROX1|RETN|SMAD5|TCF7L2|TNF
transcription coactivator activity,GO:0003713,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
transcription coactivator activity,GO:0003713,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PPARGC1A|SIRT1
transcription coactivator activity,GO:0003713,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,ETS1|HMGA1|PPARGC1A|PRKCB|SIRT1
transcription coactivator binding,GO:0001223,Diabetes Mellitus,MESH:D003920,0,,2,PPARG|SIRT1
transcription coactivator binding,GO:0001223,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,PPARA|PPARG|RELA|SIRT1
transcription coactivator binding,GO:0001223,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
transcription coactivator binding,GO:0001223,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
transcription coactivator binding,GO:0001223,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,HNF1A|NFKB1|PPARA|PPARG|SIRT1
transcription coregulator activity,GO:0003712,Diabetes Mellitus,MESH:D003920,1,Docosahexaenoic Acids,0,
transcription coregulator activity,GO:0003712,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
transcription coregulator activity,GO:0003712,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HMGA1|NFKB1|PPARGC1A
transcription coregulator binding,GO:0001221,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
transcription coregulator binding,GO:0001221,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,FOXO3|PAX6|PPARG|SREBF1|TP53|TRP53
transcription coregulator binding,GO:0001221,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
transcription coregulator binding,GO:0001221,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
transcription coregulator binding,GO:0001221,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,HMGA1|HNF1A|HNF1B|HNF4A|PAX6|PPARG
transcription corepressor activity,GO:0003714,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
transcription corepressor activity,GO:0003714,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
transcription corepressor activity,GO:0003714,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
transcription corepressor activity,GO:0003714,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,JAZF1|SIRT1
transcription corepressor binding,GO:0001222,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ETS1|HNF4A
transcription factor binding,GO:0008134,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BCL2|PPARA|PPARGC1A
transcription factor binding,GO:0008134,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
transcription factor binding,GO:0008134,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BCL2|KLF14|NFATC2|PPARA|PPARGC1A
transcription regulator activator activity,GO:0140537,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
transcription regulator activity,GO:0140110,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ID1|RELA
transcription regulator activity,GO:0140110,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ID1
transcription regulator inhibitor activity,GO:0140416,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ID1
transcription regulator inhibitor activity,GO:0140416,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
transcription regulator inhibitor activity,GO:0140416,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ID1
transferase activity,GO:0016740,Diabetes Mellitus,MESH:D003920,0,,3,ALPK1|MAP3K5|SIRT1
transferase activity,GO:0016740,"Diabetes Mellitus, Experimental",MESH:D003921,0,,9,CPT1B|GCK|GPAM|HK1|MAP3K5|PCK1|PDK4|PKLR|SIRT1
transferase activity,GO:0016740,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
transferase activity,GO:0016740,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,PRKCQ|TYK2
transferase activity,GO:0016740,"Diabetes Mellitus, Type 2",MESH:D003924,0,,16,AKT1|AKT2|BHMT|BRAF|CDKAL1|FTO|GCK|GSTM1|HK1|MAEA|MAT1A|NUS1|PIK3CG|SIRT1|ST6GAL1|UBE2E2
"transferase activity, transferring alkyl or aryl (other than methyl) groups",GO:0016765,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NUS1
transforming growth factor beta binding,GO:0050431,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
transforming growth factor beta receptor binding,GO:0005160,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
transition metal ion transmembrane transporter activity,GO:0046915,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
transketolase activity,GO:0004802,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
transketolase activity,GO:0004802,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
translation regulator activity,GO:0045182,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IGF2BP2
transmembrane-ephrin receptor activity,GO:0005005,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
transmembrane-ephrin receptor activity,GO:0005005,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
transmembrane-ephrin receptor activity,GO:0005005,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
transmembrane receptor protein tyrosine kinase activator activity,GO:0030297,Diabetes Mellitus,MESH:D003920,0,,1,INS2
transmembrane receptor protein tyrosine kinase activator activity,GO:0030297,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,IGF1|INS1|VEGFA
transmembrane receptor protein tyrosine kinase activator activity,GO:0030297,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IGF1|INS2
transmembrane receptor protein tyrosine kinase activator activity,GO:0030297,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,INS1
transmembrane receptor protein tyrosine kinase activity,GO:0004714,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
transmembrane receptor protein tyrosine kinase activity,GO:0004714,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
transmembrane receptor protein tyrosine kinase activity,GO:0004714,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005068,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005068,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IRS1|IRS2
transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005068,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005068,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IRS1|IRS2
transmembrane signaling receptor activity,GO:0004888,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
transmembrane signaling receptor activity,GO:0004888,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,FAS|ICAM1|LEPR
transmembrane signaling receptor activity,GO:0004888,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CD69
transmembrane signaling receptor activity,GO:0004888,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,EGFR|FAS|GLP1R|ICAM1|LEPR|SCTR|TNFRSF1B
transmembrane transporter activity,GO:0022857,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC2A2|SLC2A4
transmembrane transporter activity,GO:0022857,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
transmembrane transporter activity,GO:0022857,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,SLC22A3|SLC2A1|SLC2A2|SLC2A4
transmembrane transporter binding,GO:0044325,"Diabetes Mellitus, Experimental",MESH:D003921,0,,9,ATP2A2|ATP2A3|CAV1|CAV3|KCNJ11|SNAP25|TP53|TRP53|YWHAH
transmembrane transporter binding,GO:0044325,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
transmembrane transporter binding,GO:0044325,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
transmembrane transporter binding,GO:0044325,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,ABCC8|KCNJ11|NOS1
transmembrane transporter binding,GO:0044325,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,ABCC8|ATP2A2|ATP2A3|KCNJ11|KCNQ1|SMIM43|SNAP25
trehalase activity,GO:0015927,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
triglyceride lipase activity,GO:0004806,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
triglyceride lipase activity,GO:0004806,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,1,LIPC
tripeptidyl-peptidase activity,GO:0008240,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
triplet codon-amino acid adaptor activity,GO:0030533,Noninsulin-dependent diabetes mellitus with deafness,MESH:C536246,0,,1,TRNL1
tRNA demethylase activity,GO:1990984,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FTO
tRNA-intron endonuclease activity,GO:0000213,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
tRNA-intron endonuclease activity,GO:0000213,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
tRNA-intron endonuclease activity,GO:0000213,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARG
tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,GO:0061712,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDKAL1
tropomyosin binding,GO:0005523,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S100A6
tropomyosin binding,GO:0005523,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,S100A6
"tryptophan 2,3-dioxygenase activity",GO:0004833,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
"tryptophan 2,3-dioxygenase activity",GO:0004833,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
"tryptophan 2,3-dioxygenase activity",GO:0004833,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|Quercetin,0,
"tryptophan 2,3-dioxygenase activity",GO:0004833,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
"tryptophan 2,3-dioxygenase activity",GO:0004833,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
tryptophan-tRNA ligase activity,GO:0004830,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
tryptophan-tRNA ligase activity,GO:0004830,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
tumor necrosis factor binding,GO:0043120,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNFRSF1A
tumor necrosis factor binding,GO:0043120,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,TNFRSF1A|TNFRSF1B
tumor necrosis factor receptor activity,GO:0005031,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,FAS|TNFRSF1A
tumor necrosis factor receptor activity,GO:0005031,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,FAS|TNFRSF1A|TNFRSF1B
tumor necrosis factor receptor binding,GO:0005164,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
tumor necrosis factor receptor binding,GO:0005164,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNF
tumor necrosis factor receptor binding,GO:0005164,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
tumor necrosis factor receptor binding,GO:0005164,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CASP8|TNF
type 1 angiotensin receptor binding,GO:0031702,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
type 1 angiotensin receptor binding,GO:0031702,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
type 1 angiotensin receptor binding,GO:0031702,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRB
type 1 melanocortin receptor binding,GO:0070996,Diabetes Mellitus,MESH:D003920,0,,1,POMC
type 2 angiotensin receptor binding,GO:0031703,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
type 3 melanocortin receptor binding,GO:0031781,Diabetes Mellitus,MESH:D003920,0,,2,A|POMC
type 3 melanocortin receptor binding,GO:0031781,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,A
type 4 melanocortin receptor binding,GO:0031782,Diabetes Mellitus,MESH:D003920,0,,2,A|POMC
type 4 melanocortin receptor binding,GO:0031782,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,A
type II interferon receptor binding,GO:0005133,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IFNG
type II interferon receptor binding,GO:0005133,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IFNG
type III transforming growth factor beta receptor binding,GO:0034714,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
type II transforming growth factor beta receptor binding,GO:0005114,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
type I transforming growth factor beta receptor binding,GO:0034713,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
tyrosinase activity,GO:0004503,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
tyrosinase activity,GO:0004503,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,0,
tyrosinase activity,GO:0004503,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
tyrosinase activity,GO:0004503,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Diethylhexyl Phthalate,0,
ubiquinol-cytochrome-c reductase activity,GO:0008121,Diabetes Mellitus,MESH:D003920,9,Arsenic|bisphenol A|Cadmium|Chlorpromazine|Docosahexaenoic Acids|Gallic Acid|Lead|Mercury|Molybdenum,0,
ubiquinol-cytochrome-c reductase activity,GO:0008121,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
ubiquinol-cytochrome-c reductase activity,GO:0008121,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Cyclophosphamide|Gallic Acid|honokiol|sodium arsenite,0,
ubiquinol-cytochrome-c reductase activity,GO:0008121,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Cyclophosphamide|Mercury|sodium arsenite|Thioctic Acid,0,
ubiquinol-cytochrome-c reductase activity,GO:0008121,"Diabetes Mellitus, Type 2",MESH:D003924,8,Arsenic|bisphenol A|Cadmium|Curcumin|epigallocatechin gallate|Lead|Mercury|perfluorooctanoic acid,0,
ubiquitin conjugating enzyme activity,GO:0061631,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UBE2E2
ubiquitin conjugating enzyme binding,GO:0031624,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARA
ubiquitin conjugating enzyme binding,GO:0031624,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARA
ubiquitin-like protein ligase binding,GO:0044389,"Diabetes Mellitus, Insulin-Dependent, 5",MESH:C563958,0,,1,SUMO4
ubiquitin protein ligase activity,GO:0061630,Diabetes Mellitus,MESH:D003920,0,,1,INS
ubiquitin protein ligase activity,GO:0061630,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
ubiquitin protein ligase activity,GO:0061630,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,INS
ubiquitin protein ligase activity,GO:0061630,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,INS|JADE2|MAEA|RNF6
ubiquitin protein ligase binding,GO:0031625,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,BCL2|PAX6|PPARGC1A|RELA|TP53|TRP53
ubiquitin protein ligase binding,GO:0031625,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
ubiquitin protein ligase binding,GO:0031625,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,BCL2|CASP8|CBS|EGFR|PAX6|PPARGC1A|SMAD5|TNFRSF1B|WFS1
ubiquitin-protein transferase activity,GO:0004842,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
ubiquitin-protein transferase activity,GO:0004842,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,HECTD4|MAEA|RNF6|UBE2E2
unfolded protein binding,GO:0051082,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,STS
uracil transmembrane transporter activity,GO:0015210,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
uridine transmembrane transporter activity,GO:0015213,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
UTP diphosphatase activity,GO:0036221,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
UUA codon-amino acid adaptor activity,GO:0033403,Noninsulin-dependent diabetes mellitus with deafness,MESH:C536246,0,,1,TRNL1
vascular endothelial growth factor receptor 1 binding,GO:0043183,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
vascular endothelial growth factor receptor 2 binding,GO:0043184,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
vascular endothelial growth factor receptor activity,GO:0005021,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
vascular endothelial growth factor receptor activity,GO:0005021,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
vascular endothelial growth factor receptor activity,GO:0005021,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
vascular endothelial growth factor receptor binding,GO:0005172,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
vasoactive intestinal polypeptide receptor activity,GO:0004999,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SCTR
virus receptor activity,GO:0001618,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ICAM1
virus receptor activity,GO:0001618,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
virus receptor activity,GO:0001618,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EGFR|ICAM1
vitamin D 24-hydroxylase activity,GO:0070576,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
vitamin D 24-hydroxylase activity,GO:0070576,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
vitamin D3 25-hydroxylase activity,GO:0030343,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
vitamin D binding,GO:0005499,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KL
vitamin-K-epoxide reductase (warfarin-sensitive) activity,GO:0047057,"Diabetes Mellitus, Type 1",MESH:D003922,1,Warfarin,0,
voltage-gated calcium channel activity,GO:0005245,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Diazoxide,0,
voltage-gated calcium channel activity,GO:0005245,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Glucose,0,
voltage-gated calcium channel activity,GO:0005245,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
voltage-gated calcium channel activity,GO:0005245,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|Glucose,0,
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,GO:0099508,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,KCNJ11
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,GO:0099508,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,GO:0099508,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,KCNJ11
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,GO:0099508,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNJ11
voltage-gated potassium channel activity,GO:0005249,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlordan,0,
voltage-gated potassium channel activity,GO:0005249,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Glucose,2,KCNJ11|SNAP25
voltage-gated potassium channel activity,GO:0005249,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
voltage-gated potassium channel activity,GO:0005249,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,KCNJ11
voltage-gated potassium channel activity,GO:0005249,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Glucose,3,KCNJ11|KCNQ1|SNAP25
voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,GO:0086089,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,GO:0086008,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,GO:1902282,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
voltage-gated sodium channel activity,GO:0005248,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
voltage-gated sodium channel activity,GO:0005248,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
voltage-gated sodium channel activity,GO:0005248,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
voltage-gated sodium channel activity,GO:0005248,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086006,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086006,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086006,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086006,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
Wnt-protein binding,GO:0017147,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SFRP4
WW domain binding,GO:0050699,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
WW domain binding,GO:0050699,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
WW domain binding,GO:0050699,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARG
xanthine oxidase activity,GO:0004855,Diabetes Mellitus,MESH:D003920,1,Zinc,0,
xanthine oxidase activity,GO:0004855,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
xanthine oxidase activity,GO:0004855,"Diabetes Mellitus, Type 1",MESH:D003922,1,Uric Acid,0,
xanthine oxidase activity,GO:0004855,"Diabetes Mellitus, Type 2",MESH:D003924,2,efavirenz|Zinc,0,
xenobiotic transmembrane transporter activity,GO:0042910,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A1
zinc ion binding,GO:0008270,Diabetes Mellitus,MESH:D003920,1,Arsenic,7,INS2|MT2A|NR1I2|NR1I3|PPARG|SOD1|ZFP57
zinc ion binding,GO:0008270,"Diabetes Mellitus, Experimental",MESH:D003921,0,,16,ACE|ESRRA|MFGE8|MMP2|MMP9|PPARA|PPARG|PRKCA|PRKCD|PRKCE|S100A6|SERPINE1|SOD1|TIMP1|TIMP2|TP53
zinc ion binding,GO:0008270,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
zinc ion binding,GO:0008270,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
zinc ion binding,GO:0008270,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
zinc ion binding,GO:0008270,"Diabetes Mellitus, Type 1",MESH:D003922,0,,6,ABCC8|GLIS3|INS2|ITPR3|NOS1|PRKCQ
zinc ion binding,GO:0008270,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,30,ABCC8|ADAMTS9|BHMT|BRAF|CDO1|DGKD|ECE1|ENPP1|GLIS3|HNF4A|JADE2|JAZF1|KLF14|KSR2|MAEA|OGG1|PAM|PPARA|PPARG|PRKCB|PTPN1|RNF6|S100A6|SFRP4|SLC30A8|SOD1|TIMP1|ZC3HC1|ZFAND3|ZNF257
zinc ion transmembrane transporter activity,GO:0005385,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC30A8
zinc:proton antiporter activity,GO:0140826,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC30A8
